#CHROM	POS	ID	REF	ALT	#chr	pos(1-based)	ref	alt	aaref	aaalt	rs_dbSNP147	hg19_chr	hg19_pos(1-based)	hg18_chr	hg18_pos(1-based)	genename	cds_strand	refcodon	codonpos	codon_degeneracy	Ancestral_allele	AltaiNeandertal	Denisova	Ensembl_geneid	Ensembl_transcriptid	Ensembl_proteinid	aapos	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Uniprot_acc_Polyphen2	Uniprot_id_Polyphen2	Uniprot_aapos_Polyphen2	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	LRT_Omega	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationTaster_model	MutationTaster_AAE	MutationAssessor_UniprotID	MutationAssessor_variant	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	Transcript_id_VEST3	Transcript_var_VEST3	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	Reliability_index	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	fathmm-MKL_coding_group	Eigen_coding_or_noncoding	Eigen-raw	Eigen-phred	Eigen-PC-raw	Eigen-PC-phred	Eigen-PC-raw_rankscore	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GM12878_fitCons_score	GM12878_fitCons_score_rankscore	GM12878_confidence_value	H1-hESC_fitCons_score	H1-hESC_fitCons_score_rankscore	H1-hESC_confidence_value	HUVEC_fitCons_score	HUVEC_fitCons_score_rankscore	HUVEC_confidence_value	GERP++_NR	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_pi	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	1000Gp3_AC	1000Gp3_AF	1000Gp3_AFR_AC	1000Gp3_AFR_AF	1000Gp3_EUR_AC	1000Gp3_EUR_AF	1000Gp3_AMR_AC	1000Gp3_AMR_AF	1000Gp3_EAS_AC	1000Gp3_EAS_AF	1000Gp3_SAS_AC	1000Gp3_SAS_AF	TWINSUK_AC	TWINSUK_AF	ALSPAC_AC	ALSPAC_AF	ESP6500_AA_AC	ESP6500_AA_AF	ESP6500_EA_AC	ESP6500_EA_AF	ExAC_AC	ExAC_AF	ExAC_Adj_AC	ExAC_Adj_AF	ExAC_AFR_AC	ExAC_AFR_AF	ExAC_AMR_AC	ExAC_AMR_AF	ExAC_EAS_AC	ExAC_EAS_AF	ExAC_FIN_AC	ExAC_FIN_AF	ExAC_NFE_AC	ExAC_NFE_AF	ExAC_SAS_AC	ExAC_SAS_AF	ExAC_nonTCGA_AC	ExAC_nonTCGA_AF	ExAC_nonTCGA_Adj_AC	ExAC_nonTCGA_Adj_AF	ExAC_nonTCGA_AFR_AC	ExAC_nonTCGA_AFR_AF	ExAC_nonTCGA_AMR_AC	ExAC_nonTCGA_AMR_AF	ExAC_nonTCGA_EAS_AC	ExAC_nonTCGA_EAS_AF	ExAC_nonTCGA_FIN_AC	ExAC_nonTCGA_FIN_AF	ExAC_nonTCGA_NFE_AC	ExAC_nonTCGA_NFE_AF	ExAC_nonTCGA_SAS_AC	ExAC_nonTCGA_SAS_AF	ExAC_nonpsych_AC	ExAC_nonpsych_AF	ExAC_nonpsych_Adj_AC	ExAC_nonpsych_Adj_AF	ExAC_nonpsych_AFR_AC	ExAC_nonpsych_AFR_AF	ExAC_nonpsych_AMR_AC	ExAC_nonpsych_AMR_AF	ExAC_nonpsych_EAS_AC	ExAC_nonpsych_EAS_AF	ExAC_nonpsych_FIN_AC	ExAC_nonpsych_FIN_AF	ExAC_nonpsych_NFE_AC	ExAC_nonpsych_NFE_AF	ExAC_nonpsych_SAS_AC	ExAC_nonpsych_SAS_AF	clinvar_rs	clinvar_clnsig	clinvar_trait	clinvar_golden_stars	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Gene_old_names	Gene_other_names	Uniprot_acc	Uniprot_id	Entrez_gene_id	CCDS_id	Refseq_id	ucsc_id	MIM_id	Gene_full_name	Pathway(Uniprot)	Pathway(BioCarta)_short	Pathway(BioCarta)_full	Pathway(ConsensusPathDB)	Pathway(KEGG)_id	Pathway(KEGG)_full	Function_description	Disease_description	MIM_phenotype_id	MIM_disease	Trait_association(GWAS)	GO_biological_process	GO_cellular_component	GO_molecular_function	Tissue_specificity(Uniprot)	Expression(egenetics)	Expression(GNF/Atlas)	Adipose-Subcutaneousminimum	Adipose-Subcutaneousmaximum	Adipose-Subcutaneousaverage	Adipose-Subcutaneousnsample	Adipose-Visceral(Omentum)minimum	Adipose-Visceral(Omentum)maximum	Adipose-Visceral(Omentum)average	Adipose-Visceral(Omentum)nsample	AdrenalGlandminimum	AdrenalGlandmaximum	AdrenalGlandaverage	AdrenalGlandnsample	Artery-Aortaminimum	Artery-Aortamaximum	Artery-Aortaaverage	Artery-Aortansample	Artery-Coronaryminimum	Artery-Coronarymaximum	Artery-Coronaryaverage	Artery-Coronarynsample	Artery-Tibialminimum	Artery-Tibialmaximum	Artery-Tibialaverage	Artery-Tibialnsample	Bladderminimum	Bladdermaximum	Bladderaverage	Bladdernsample	Brain-Amygdalaminimum	Brain-Amygdalamaximum	Brain-Amygdalaaverage	Brain-Amygdalansample	Brain-Anteriorcingulatecortex(BA24)minimum	Brain-Anteriorcingulatecortex(BA24)maximum	Brain-Anteriorcingulatecortex(BA24)average	Brain-Anteriorcingulatecortex(BA24)nsample	Brain-Caudate(basalganglia)minimum	Brain-Caudate(basalganglia)maximum	Brain-Caudate(basalganglia)average	Brain-Caudate(basalganglia)nsample	Brain-CerebellarHemisphereminimum	Brain-CerebellarHemispheremaximum	Brain-CerebellarHemisphereaverage	Brain-CerebellarHemispherensample	Brain-Cerebellumminimum	Brain-Cerebellummaximum	Brain-Cerebellumaverage	Brain-Cerebellumnsample	Brain-Cortexminimum	Brain-Cortexmaximum	Brain-Cortexaverage	Brain-Cortexnsample	Brain-FrontalCortex(BA9)minimum	Brain-FrontalCortex(BA9)maximum	Brain-FrontalCortex(BA9)average	Brain-FrontalCortex(BA9)nsample	Brain-Hippocampusminimum	Brain-Hippocampusmaximum	Brain-Hippocampusaverage	Brain-Hippocampusnsample	Brain-Hypothalamusminimum	Brain-Hypothalamusmaximum	Brain-Hypothalamusaverage	Brain-Hypothalamusnsample	Brain-Nucleusaccumbens(basalganglia)minimum	Brain-Nucleusaccumbens(basalganglia)maximum	Brain-Nucleusaccumbens(basalganglia)average	Brain-Nucleusaccumbens(basalganglia)nsample	Brain-Putamen(basalganglia)minimum	Brain-Putamen(basalganglia)maximum	Brain-Putamen(basalganglia)average	Brain-Putamen(basalganglia)nsample	Brain-Spinalcord(cervicalc-1)minimum	Brain-Spinalcord(cervicalc-1)maximum	Brain-Spinalcord(cervicalc-1)average	Brain-Spinalcord(cervicalc-1)nsample	Brain-Substantianigraminimum	Brain-Substantianigramaximum	Brain-Substantianigraaverage	Brain-Substantianigransample	Breast-MammaryTissueminimum	Breast-MammaryTissuemaximum	Breast-MammaryTissueaverage	Breast-MammaryTissuensample	Cells-EBV-transformedlymphocytesminimum	Cells-EBV-transformedlymphocytesmaximum	Cells-EBV-transformedlymphocytesaverage	Cells-EBV-transformedlymphocytesnsample	Cells-Transformedfibroblastsminimum	Cells-Transformedfibroblastsmaximum	Cells-Transformedfibroblastsaverage	Cells-Transformedfibroblastsnsample	Cervix-Ectocervixminimum	Cervix-Ectocervixmaximum	Cervix-Ectocervixaverage	Cervix-Ectocervixnsample	Cervix-Endocervixminimum	Cervix-Endocervixmaximum	Cervix-Endocervixaverage	Cervix-Endocervixnsample	Colon-Sigmoidminimum	Colon-Sigmoidmaximum	Colon-Sigmoidaverage	Colon-Sigmoidnsample	Colon-Transverseminimum	Colon-Transversemaximum	Colon-Transverseaverage	Colon-Transversensample	Esophagus-GastroesophagealJunctionminimum	Esophagus-GastroesophagealJunctionmaximum	Esophagus-GastroesophagealJunctionaverage	Esophagus-GastroesophagealJunctionnsample	Esophagus-Mucosaminimum	Esophagus-Mucosamaximum	Esophagus-Mucosaaverage	Esophagus-Mucosansample	Esophagus-Muscularisminimum	Esophagus-Muscularismaximum	Esophagus-Muscularisaverage	Esophagus-Muscularisnsample	FallopianTubeminimum	FallopianTubemaximum	FallopianTubeaverage	FallopianTubensample	Heart-AtrialAppendageminimum	Heart-AtrialAppendagemaximum	Heart-AtrialAppendageaverage	Heart-AtrialAppendagensample	Heart-LeftVentricleminimum	Heart-LeftVentriclemaximum	Heart-LeftVentricleaverage	Heart-LeftVentriclensample	Kidney-Cortexminimum	Kidney-Cortexmaximum	Kidney-Cortexaverage	Kidney-Cortexnsample	Liverminimum	Livermaximum	Liveraverage	Livernsample	Lungminimum	Lungmaximum	Lungaverage	Lungnsample	MinorSalivaryGlandminimum	MinorSalivaryGlandmaximum	MinorSalivaryGlandaverage	MinorSalivaryGlandnsample	Muscle-Skeletalminimum	Muscle-Skeletalmaximum	Muscle-Skeletalaverage	Muscle-Skeletalnsample	Nerve-Tibialminimum	Nerve-Tibialmaximum	Nerve-Tibialaverage	Nerve-Tibialnsample	Ovaryminimum	Ovarymaximum	Ovaryaverage	Ovarynsample	Pancreasminimum	Pancreasmaximum	Pancreasaverage	Pancreasnsample	Pituitaryminimum	Pituitarymaximum	Pituitaryaverage	Pituitarynsample	Prostateminimum	Prostatemaximum	Prostateaverage	Prostatensample	Skin-NotSunExposed(Suprapubic)minimum	Skin-NotSunExposed(Suprapubic)maximum	Skin-NotSunExposed(Suprapubic)average	Skin-NotSunExposed(Suprapubic)nsample	Skin-SunExposed(Lowerleg)minimum	Skin-SunExposed(Lowerleg)maximum	Skin-SunExposed(Lowerleg)average	Skin-SunExposed(Lowerleg)nsample	SmallIntestine-TerminalIleumminimum	SmallIntestine-TerminalIleummaximum	SmallIntestine-TerminalIleumaverage	SmallIntestine-TerminalIleumnsample	Spleenminimum	Spleenmaximum	Spleenaverage	Spleennsample	Stomachminimum	Stomachmaximum	Stomachaverage	Stomachnsample	Testisminimum	Testismaximum	Testisaverage	Testisnsample	Thyroidminimum	Thyroidmaximum	Thyroidaverage	Thyroidnsample	Uterusminimum	Uterusmaximum	Uterusaverage	Uterusnsample	Vaginaminimum	Vaginamaximum	Vaginaaverage	Vaginansample	WholeBloodminimum	WholeBloodmaximum	WholeBloodaverage	WholeBloodnsample	Interactions(IntAct)	Interactions(BioGRID)	Interactions(ConsensusPathDB)	P(HI)	P(rec)	Known_rec_info	RVIS	RVIS_percentile	RVIS_ExAC_0.05%(AnyPopn)	%RVIS_ExAC_0.05%(AnyPopn)	GDI	GDI-Phred	Gene damage prediction (all disease-causing genes)	Gene damage prediction (all Mendelian disease-causing genes)	Gene damage prediction (Mendelian AD disease-causing genes)	Gene damage prediction (Mendelian AR disease-causing genes)	Gene damage prediction (all PID disease-causing genes)	Gene damage prediction (PID AD disease-causing genes)	Gene damage prediction (PID AR disease-causing genes)	Gene damage prediction (all cancer disease-causing genes)	Gene damage prediction (cancer recessive disease-causing genes)	Gene damage prediction (cancer dominant disease-causing genes)	LoFtool_score	Essential_gene	MGI_mouse_gene	MGI_mouse_phenotype	ZFIN_zebrafish_gene	ZFIN_zebrafish_structure	ZFIN_zebrafish_phenotype_quality	ZFIN_zebrafish_phenotype_tag
12	49415905	.	C	T	12	49022122	C	T	C	Y	.	12	49415905	12	47702172	KMT2D	-	TGT	2	0	c	C/C	C/C	ENSG00000167548	ENST00000301067;ENST00000526209	ENSP00000301067;ENSP00000435714	5481;162	0.0	0.91219	D	O14686	MLL2_HUMAN	5481	1.0	0.89865	D	0.999	0.91584	D	0.001642	0.38369	N	0.000000	1	0.81033	D	simple_aae	C5481Y	KMT2D_HUMAN	C5481Y	4.415	0.98729	H	-2.53;-2.53	0.89444	D;D	-10.5;-10.94	0.99265	D	ENST00000526209;NM_003482.3	C162Y;C5481Y	0.994;0.907	0.99729	1.0550	0.98226	D	0.8952	0.96524	D	10	0.89169713061	0.99185	D	3.838112	0.51807	23.4	0.94918905179280788	0.25196	0.99123	0.91502	D	AEFDBCI	c	1.00608743939848	14.11423	0.896735424463156	13.61308	0.94973	0.999999999999977	0.74713	0.67177	0.52245	0	0.702456	0.74369	0	0.702456	0.68477	0	0.711	0.71304	0	4.97	4.97	0.65285	7.818000	0.84622	0.850000	0.34959	1.000000	0.71511	0.996000	0.62468	0.0:1.0:0.0:0.0	17.4382	0.87392	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	SET domain	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49416063	.	C	G	12	49022280	C	G	R	T	.	12	49416063	12	47702330	KMT2D	-	AGG	2	0	C	C/C	C/C	ENSG00000167548	ENST00000301067;ENST00000526209	ENSP00000301067;ENSP00000435714	5471;152	0.0	0.91219	D	O14686	MLL2_HUMAN	5471	1.0	0.89865	D	0.998	0.87503	D	0.001213	0.39806	N	0.000000	1	0.81033	D	simple_aae	R5471T	KMT2D_HUMAN	R5471T	4.685	0.99458	H	-2.0;-2.0	0.85404	D;D	-5.71;-5.95	0.89125	D	ENST00000526209;NM_003482.3	R152T;R5471T	0.977;0.961	0.97884	1.0202	0.97539	D	0.8658	0.95538	D	9	0.887514370026	0.99152	D	3.712403	0.50315	23.3	0.92011790795463322	0.20754	0.98907	0.88373	D	AEFBCI	c	1.06105317159166	15.96978	0.945326366055395	15.84059	0.96777	0.999999999999923	0.74713	0.67177	0.52245	0	0.697927	0.68521	0	0.702456	0.68477	0	0.711	0.71304	0	5.11	5.11	0.69066	7.794000	0.84309	0.852000	0.36166	1.000000	0.71511	0.995000	0.60354	0.0:1.0:0.0:0.0	17.7533	0.88296	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	SET domain	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49416428	.	C	T	12	49022645	C	T	G	D	.	12	49416428	12	47702695	KMT2D	-	GGC	2	0	C	C/C	C/C	ENSG00000167548	ENST00000301067;ENST00000526209	ENSP00000301067;ENSP00000435714	5428;109	0.0	0.91219	D	O14686	MLL2_HUMAN	5428	1.0	0.89865	D	1.0	0.97092	D	0.001782	0.37985	N	0.000000	1	0.81033	D	simple_aae	G5428D	KMT2D_HUMAN	G5428D	4.065	0.97194	H	-2.06;-2.06	0.85886	D;D	-6.47;-6.98	0.93565	D	ENST00000526209;NM_003482.3	G109D;G5428D	0.952;0.913	0.94854	0.9546	0.96466	D	0.8446	0.94814	D	10	0.824142449232	0.98642	D	3.242204	0.44875	22.8	0.90592251262203349	0.19261	0.97959	0.78285	D	AEFBCI	c	1.00931015403931	14.21761	0.911278914390691	14.24214	0.95581	0.999999999999902	0.74713	0.67177	0.52245	0	0.702456	0.74369	0	0.702456	0.68477	0	0.711	0.71304	0	5.09	5.09	0.68524	7.905000	0.86375	0.807000	0.32947	1.000000	0.71511	1.000000	0.88762	0.0:1.0:0.0:0.0	17.6392	0.87977	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	SET domain	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49420108	.	C	T	12	49026325	C	T	R	H	rs398123729	12	49420108	12	47706375	KMT2D	-	CGC	2	0	C	C/C	C/C	ENSG00000167548	ENST00000301067	ENSP00000301067	5214	0.0	0.91219	D	O14686	MLL2_HUMAN	5214	1.0	0.89865	D	0.999	0.91584	D	0.002172	0.37082	N	0.000000	1	0.81033	D	simple_aae	R5214H	KMT2D_HUMAN	R5214H	3.575	0.93651	H	-2.59	0.89836	D	-4.8	0.80645	D	NM_003482.3	R5214H	0.915	0.90583	0.9548	0.96469	D	0.8654	0.95525	D	10	0.651863272279	0.97070	D	4.108362	0.55129	23.7	0.98678765092510701	0.44126	0.96396	0.68724	D	AEFDBCI	c	0.955001813308443	12.56242	0.880990060412008	12.96184	0.94244	0.999999999997468	0.74713	0.706548	0.72963	0	0.702456	0.74369	0	0.702456	0.68477	0	0.714379	0.83238	0	5.12	5.12	0.69338	7.905000	0.86375	0.935000	0.48983	1.000000	0.71511	0.996000	0.62468	0.0:1.0:0.0:0.0	17.7186	0.88197	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs398123729	4|4	not provided|Kabuki make-up syndrome	0|1	FY-rich, N-terminal	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49420120	.	T	C	12	49026337	T	C	Y	C	.	12	49420120	12	47706387	KMT2D	-	TAC	2	0	T	T/T	T/T	ENSG00000167548	ENST00000301067	ENSP00000301067	5210	0.0	0.91219	D	O14686	MLL2_HUMAN	5210	0.668	0.39189	P	0.329	0.40283	B	0.004979	0.33204	N	0.000000	0.999996	0.58814	D	simple_aae	Y5210C	KMT2D_HUMAN	Y5210C	3.325	0.90972	M	-2.29	0.87605	D	-8.24	0.96876	D	NM_003482.3	Y5210C	0.838	0.82538	0.3263	0.87977	D	0.6638	0.88334	D	10	0.298606937342	0.90839	D	1.609347	0.25492	13.90	0.98131320617992146	0.38018	0.93935	0.59366	D	AEFBCI	c	0.398614746593454	4.334555	0.388391453944229	4.277218	0.61086	0.999939370746483	0.46657	0.706548	0.72963	0	0.702456	0.74369	0	0.702456	0.68477	0	0.714379	0.83238	0	5.12	3.97	0.45071	6.258000	0.72252	1.061000	0.80716	1.000000	0.71511	0.998000	0.69722	0.0:0.0818:0.0:0.9182	10.0363	0.41111	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FY-rich, N-terminal	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49420213	.	C	T	12	49026430	C	T	R	H	rs267607237	12	49420213	12	47706480	KMT2D	-	CGT	2	0	C	C/C	./.	ENSG00000167548	ENST00000301067	ENSP00000301067	5179	0.01	0.56404	D	O14686	MLL2_HUMAN	5179	0.84	0.44514	P	0.116	0.30348	B	0.003273	0.35170	N	0.000000	0.999994	0.58814	D	simple_aae	R5179H	KMT2D_HUMAN	R5179H	3.225	0.89678	M	-1.59	0.82090	D	-4.8	0.80645	D	NM_003482.3	R5179H	0.667	0.67754	0.0936	0.84066	D	0.4959	0.80915	T	10	0.352679582596	0.92337	D	3.694012	0.50100	23.3	0.97982422130032765	0.36820	0.95400	0.64340	D	AEFBCI	c	0.468580748862999	4.800786	0.470991354473543	4.905196	0.66220	0.999999537149925	0.74713	0.706548	0.72963	0	0.702456	0.74369	0	0.697927	0.64085	0	0.714379	0.83238	0	5.12	4.23	0.49151	7.905000	0.86375	0.935000	0.48983	1.000000	0.71511	0.955000	0.43271	0.0:0.9182:0.0:0.0818	12.7397	0.56438	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs267607237	5	Kabuki make-up syndrome	1	FY-rich, N-terminal	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49420288	.	C	T	12	49026505	C	T	R	Q	.	12	49420288	12	47706555	KMT2D	-	CGG	2	0	C	C/C	C/C	ENSG00000167548	ENST00000301067	ENSP00000301067	5154	0.002	0.72092	D	O14686	MLL2_HUMAN	5154	1.0	0.89865	D	0.994	0.80656	D	0.004328	0.33846	N	0.000000	0.999993	0.58814	D	simple_aae	R5154Q	KMT2D_HUMAN	R5154Q	3.225	0.89678	M	-1.52	0.81492	D	-3.84	0.72195	D	NM_003482.3	R5154Q	0.881	0.86897	0.4570	0.89940	D	0.6677	0.88480	D	10	0.30966581658	0.91176	D	4.170768	0.55917	23.8	0.99052682663859748	0.50898	0.97713	0.76433	D	AEFBCI	c	0.819783187251735	9.179697	0.775638945787559	9.440354	0.87742	0.99999999999224	0.74713	0.706548	0.72963	0	0.702456	0.74369	0	0.697927	0.64085	0	0.714379	0.83238	0	4.9	4.9	0.63503	7.905000	0.86375	0.935000	0.48983	1.000000	0.71511	0.996000	0.62468	0.0:1.0:0.0:0.0	17.2324	0.86810	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49420573	.	T	G	12	49026790	T	G	H	P	.	12	49420573	12	47706840	KMT2D	-	CAC	2	0	T	T/T	T/T	ENSG00000167548	ENST00000301067	ENSP00000301067	5059	0.001	0.78421	D	O14686	MLL2_HUMAN	5059	1.0	0.89865	D	0.999	0.91584	D	0.001097	0.40290	N	0.000000	1	0.81033	D	simple_aae	H5059P	KMT2D_HUMAN	H5059P	3.765	0.95245	H	-1.81	0.83982	D	-9.6	0.98522	D	NM_003482.3	H5059P	0.859	0.84630	0.8875	0.95504	D	0.8225	0.94035	D	10	0.698511333675	0.97541	D	1.974805	0.29816	16.05	0.78887674036422195	0.12072	0.98797	0.86884	D	AEFDBCI	c	0.91412533650093	11.42114	0.80259926394923	10.201	0.89631	0.999999999928213	0.74713	0.67177	0.52245	0	0.702456	0.74369	0	0.702456	0.68477	0	0.711	0.71304	0	4.62	4.62	0.56785	8.017000	0.88645	0.964000	0.58031	1.000000	0.71511	0.998000	0.69722	0.0:0.0:0.0:1.0	13.3283	0.59743	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49420606	.	C	T	12	49026823	C	T	R	H	.	12	49420606	12	47706873	KMT2D	-	CGT	2	0	C	C/C	C/C	ENSG00000167548	ENST00000301067	ENSP00000301067	5048	0.011	0.55478	D	O14686	MLL2_HUMAN	5048	1.0	0.89865	D	0.997	0.85043	D	0.001500	0.38841	N	0.000000	1	0.81033	D	simple_aae	R5048H	KMT2D_HUMAN	R5048H	3.185	0.89121	M	-1.73	0.83340	D	-4.8	0.80645	D	NM_003482.3	R5048H	0.803	0.79221	0.6358	0.92367	D	0.7354	0.90958	D	10	0.740063727039	0.97928	D	4.137782	0.55500	23.8	0.98108718716071941	0.37828	0.98947	0.88937	D	AEFDBCI	c	0.865229234983197	10.19068	0.806959896615817	10.33286	0.89914	0.999999999999972	0.74713	0.67177	0.52245	0	0.702456	0.74369	0	0.702456	0.68477	0	0.711	0.71304	0	4.86	4.86	0.62479	7.861000	0.85307	0.852000	0.36166	1.000000	0.71511	0.995000	0.60354	0.0:1.0:0.0:0.0	17.1536	0.86602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49425430	.	G	A	12	49031647	G	A	P	L	rs778418522	12	49425430	12	47711697	KMT2D	-	CCG	2	0	g	G/G	G/G	ENSG00000167548	ENST00000301067	ENSP00000301067	4353	0.217	0.19128	T	O14686	MLL2_HUMAN	4353	0.0	0.02634	B	0.0	0.01257	B	0.217277	0.16211	N	0.349316	0.720937	0.33601	D	simple_aae	P4353L	KMT2D_HUMAN	P4353L	0	0.06535	N	-1.08	0.77085	T	0.69	0.02202	N	NM_003482.3	P4353L	0.124	0.13954	-0.8272	0.53508	T	0.1664	0.50530	T	10	0.326068797637	0.91645	D	1.968223	0.29738	16.01	0.74199722508094323	0.10259	0.15377	0.18683	N	AEFDBCI	c	-0.758979104384999	0.7164482	-0.588966385590578	1.062805	0.19463	0.998892427262306	0.37854	0.67177	0.52245	0	0.702456	0.74369	0	0.702456	0.68477	0	0.711	0.71304	0	4.73	3.58	0.39969	0.002000	0.12859	0.163000	0.24525	0.000000	0.06329	0.999000	0.74975	0.7658:0.0:0.0845:0.1497	5.6409	0.16725	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	2.484e-05	1	1.269e-05	0	0	0	0	0	0	0	0	1	2.280e-05	0	0	2	1.894e-05	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	3.329e-05	1	1.673e-05	0	0	0	0	0	0	0	0	1	3.545e-05	0	0	rs778418522	3	not provided	1	.	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49432618	.	G	T	12	49038835	G	T	P	T	rs763347763	12	49432618	12	47718885	KMT2D	-	CCT	1	0	G	G/G	G/G	ENSG00000167548	ENST00000301067	ENSP00000301067	2841	0.01	0.56404	D	O14686	MLL2_HUMAN	2841	0.009	0.13938	B	0.015	0.16179	B	0.004006	0.34207	N	0.000000	0.902811	0.36203	D	simple_aae	P2841T	KMT2D_HUMAN	P2841T	0.55	0.14488	N	-1.35	0.80047	T	-1.45	0.35575	N	NM_003482.3	P2841T	0.133	0.15302	-0.5889	0.65291	T	0.3217	0.69095	T	10	0.226160370296	0.88074	D	1.896938	0.28876	15.57	0.82748748703092434	0.13867	0.89870	0.50337	D	AEFDGBI	c	-0.282620513515547	1.657077	-0.155584397814911	1.896271	0.33100	0.255264929457926	0.18724	0.706548	0.72963	0	0.702456	0.74369	0	0.724815	0.87840	0	0.711	0.71304	0	5.21	2.27	0.27373	1.108000	0.30527	0.100000	0.19893	0.567000	0.27246	1.000000	0.88762	0.075:0.2682:0.6568:0.0	9.6099	0.38632	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	8.874e-06	0	0	0	0	0	0	0	0	0	0	0	0	0	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1.182e-05	0	0	0	0	0	0	0	0	0	0	0	0	0	0	.	.	.	.	.	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49440398	.	C	T	12	49046615	C	T	C	Y	.	12	49440398	12	47726665	KMT2D	-	TGC	2	0	C	C/C	C/C	ENSG00000167548	ENST00000301067	ENSP00000301067	1471	0.0	0.91219	D	O14686	MLL2_HUMAN	1471	1.0	0.89865	D	0.999	0.91584	D	0.001212	0.39806	N	0.000000	1	0.81033	D	simple_aae	C1471Y	KMT2D_HUMAN	C1471Y	3.945	0.96495	H	-8.73	0.99949	D	-9.43	0.98397	D	NM_003482.3	C1471Y	0.976	0.97762	0.9462	0.96340	D	0.9988	0.99964	D	10	0.972557875389	0.99839	D	4.745650	0.63642	24.7	0.94071311514999401	0.23617	0.96004	0.66880	D	AEFDGBCI	c	1.11080357699319	17.98635	0.982233536366709	17.79475	0.97755	0.99999999999948	0.74713	0.706548	0.72963	0	0.577304	0.32598	0	0.702456	0.68477	0	0.714379	0.83238	0	5.23	5.23	0.72462	7.905000	0.86375	0.852000	0.36166	1.000000	0.71511	1.000000	0.88762	0.0:1.0:0.0:0.0	17.5848	0.87820	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, RING/FYVE/PHD-type	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49440399	.	A	G	12	49046616	A	G	C	R	.	12	49440399	12	47726666	KMT2D	-	TGC	1	0	A	A/A	A/A	ENSG00000167548	ENST00000301067	ENSP00000301067	1471	0.0	0.91219	D	O14686	MLL2_HUMAN	1471	1.0	0.89865	D	0.999	0.91584	D	0.001212	0.39806	N	0.000000	1	0.81033	D	simple_aae	C1471R	KMT2D_HUMAN	C1471R	3.945	0.96495	H	-8.73	0.99949	D	-10.28	0.98953	D	NM_003482.3	C1471R	0.958	0.95572	0.9331	0.96148	D	0.9987	0.99963	D	10	0.96619266134	0.99789	D	4.127266	0.55369	23.8	0.95109459152992193	0.25602	0.96032	0.67007	D	AEFDGBCI	c	1.04177587095632	15.28845	0.910178702804522	14.19445	0.95534	0.999999999285232	0.74713	0.706548	0.72963	0	0.577304	0.32598	0	0.702456	0.68477	0	0.714379	0.83238	0	5.23	5.23	0.72462	7.477000	0.79917	1.088000	0.86599	1.000000	0.71511	1.000000	0.88762	1.0:0.0:0.0:0.0	14.1176	0.64542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, RING/FYVE/PHD-type	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49440452	.	T	C	12	49046669	T	C	H	R	.	12	49440452	12	47726719	KMT2D	-	CAC	2	0	T	T/T	T/T	ENSG00000167548	ENST00000301067	ENSP00000301067	1453	0.0	0.91219	D	O14686	MLL2_HUMAN	1453	1.0	0.89865	D	0.998	0.87503	D	0.001663	0.38312	N	0.000000	0.999988	0.54846	D	simple_aae	H1453R	KMT2D_HUMAN	H1453R	3.945	0.96495	H	-5.32	0.98989	D	-6.86	0.93117	D	NM_003482.3	H1453R	0.953	0.94972	1.0009	0.97204	D	0.9862	0.99588	D	10	0.866610854057	0.98985	D	3.389015	0.46562	23.0	0.94359866334891085	0.24119	0.95852	0.66207	D	AEFDGBCI	c	1.02134354382302	14.60574	0.903872649087699	13.91833	0.95281	0.999999999970364	0.74713	0.706548	0.72963	0	0.702456	0.74369	0	0.702456	0.68477	0	0.714379	0.83238	0	5.23	5.23	0.72462	8.017000	0.88645	0.964000	0.58031	1.000000	0.71511	1.000000	0.88762	0.0:0.0:0.0:1.0	14.1176	0.64542	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, RING/FYVE/PHD-type	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49440522	.	A	G	12	49046739	A	G	C	R	.	12	49440522	12	47726789	KMT2D	-	TGT	1	0	A	A/A	A/A	ENSG00000167548	ENST00000301067	ENSP00000301067	1430	0.0	0.91219	D	O14686	MLL2_HUMAN	1430	1.0	0.89865	D	0.999	0.91584	D	0.001286	0.39507	N	0.000000	1	0.81033	D	simple_aae	C1430R	KMT2D_HUMAN	C1430R	3.93	0.96400	H	-5.63	0.99243	D	-10.28	0.98953	D	NM_003482.3	C1430R	0.971	0.97154	0.9667	0.96651	D	0.9894	0.99705	D	10	0.969569056972	0.99816	D	3.826819	0.51673	23.4	0.94038508594479431	0.23560	0.99100	0.91161	D	AEFBCI	c	1.06623686846748	16.16076	0.934566933722209	15.31497	0.96433	0.999999999786754	0.74713	0.706548	0.72963	0	0.702456	0.74369	0	0.702456	0.68477	0	0.714379	0.83238	0	5.09	5.09	0.68524	9.325000	0.95975	1.088000	0.86599	1.000000	0.71511	1.000000	0.88762	1.0:0.0:0.0:0.0	13.8716	0.62964	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, RING/FYVE/PHD-type	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49441846	.	A	G	12	49048063	A	G	C	R	.	12	49441846	12	47728113	KMT2D	-	TGT	1	0	A	A/A	A/A	ENSG00000167548	ENST00000301067	ENSP00000301067	1380	0.0	0.91219	D	O14686	MLL2_HUMAN	1380	1.0	0.89865	D	0.999	0.91584	D	0.001255	0.39655	N	0.000000	1	0.81033	D	simple_aae	C1380R	KMT2D_HUMAN	C1380R	2.08	0.57591	M	-5.63	0.99243	D	-9.86	0.98708	D	NM_003482.3	C1380R	0.943	0.93789	1.0839	0.99011	D	0.9769	0.99284	D	10	0.895721523593	0.99218	D	4.336582	0.58065	24.0	0.95355210096308185	0.26156	0.99533	0.97134	D	AEFGBI	c	0.871393831074986	10.33713	0.856004403129256	11.99263	0.92942	0.99999999999731	0.74713	0.706548	0.72963	0	0.702456	0.74369	0	0.702456	0.68477	0	0.714379	0.83238	0	5.83	5.83	0.93035	9.287000	0.95026	1.199000	0.96014	1.000000	0.71511	1.000000	0.88762	1.0:0.0:0.0:0.0	15.1973	0.72671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Zinc finger, FYVE/PHD-type|Zinc finger, PHD-finger|Zinc finger, PHD-type|Zinc finger, RING-type|Zinc finger, RING/FYVE/PHD-type	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49443797	.	C	T	12	49050014	C	T	V	M	.	12	49443797	12	47730064	KMT2D	-	GTG	1	0	C	C/C	C/C	ENSG00000167548	ENST00000301067	ENSP00000301067	1192	0.041	0.41865	D	O14686	MLL2_HUMAN	1192	0.001	0.06737	B	0.003	0.07978	B	0.060704	0.22215	N	0.231155	1	0.08979	N	simple_aae	V1192M	KMT2D_HUMAN	V1192M	0.205	0.09372	N	-1.28	0.79387	T	0.1	0.05821	N	NM_003482.3	V1192M	0.668	0.67832	-0.7951	0.55460	T	0.2337	0.60052	T	10	0.0954783524239	0.76522	D	1.272938	0.21772	12.13	0.93938160557223227	0.23393	0.48890	0.28065	N	AEFDGBCI	c	-0.431161884613241	1.316198	-0.259410504345374	1.64995	0.28936	0.999998217289012	0.74713	0.722319	0.85350	0	0.577304	0.32598	0	0.702456	0.68477	0	0.735409	0.98420	0	5.4	3.43	0.38212	0.648000	0.24335	0.077000	0.18463	0.599000	0.27503	0.978000	0.48280	0.0:0.6794:0.1479:0.1728	8.0764	0.29705	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49445526	.	G	T	12	49051743	G	T	P	Q	rs200088180	12	49445526	12	47731793	KMT2D	-	CCA	2	0	G	G/G	G/G	ENSG00000167548	ENST00000301067	ENSP00000301067	647	0.111	0.28989	T	O14686	MLL2_HUMAN	647	0.855	0.45138	P	0.289	0.38909	B	.	.	.	.	1	0.08979	N	simple_aae	P647Q	KMT2D_HUMAN	P647Q	0.55	0.14488	N	-1.19	0.78436	T	-0.9	0.24242	N	NM_003482.3	P647Q	0.688	0.69418	-0.8364	0.52912	T	0.2205	0.58397	T	9	0.365914851854	0.92654	D	0.194622	0.11256	4.622	0.50182013045762275	0.04268	0.27792	0.23155	N	AEFDBCI	c	-0.463269136221188	1.249769	-0.531477816759567	1.151626	0.20951	0.999696718608487	0.41807	0.706548	0.72963	0	0.577304	0.32598	0	0.724815	0.87840	0	0.714379	0.83238	0	4.67	3.76	0.42200	1.495000	0.35011	0.997000	0.60617	0.015000	0.18933	0.996000	0.62468	0.0961:0.1845:0.7195:0.0	6.5811	0.21646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	2.3934897079942556E-4	5	5.939653124257543E-4	49	4.048e-04	49	4.181e-04	3	3.156e-04	1	8.661e-05	0	0	1	1.514e-04	34	5.213e-04	9	6.070e-04	46	4.346e-04	46	4.502e-04	3	3.662e-04	1	8.941e-05	0	0	1	1.514e-04	31	5.851e-04	9	6.113e-04	37	4.094e-04	37	4.274e-04	3	3.162e-04	1	8.670e-05	0	0	1	2.630e-04	22	5.413e-04	9	6.075e-04	.	.	.	.	.	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
12	49448090	.	C	G	12	49054307	C	G	Q	H	.	12	49448090	12	47734357	KMT2D	-	CAG	3	2	C	C/C	C/C	ENSG00000167548	ENST00000301067	ENSP00000301067	170	0.016	0.51801	D	O14686	MLL2_HUMAN	170	0.998	0.71542	D	0.961	0.68796	D	0.006849	0.31743	N	0.000000	0.919706	0.36632	D	simple_aae	Q170H	KMT2D_HUMAN	Q170H	1.59	0.40434	L	-0.55	0.71078	T	-2.32	0.51437	N	NM_003482.3	Q170H	0.507	0.55115	-0.1772	0.78266	T	0.4287	0.77142	T	9	0.525152137943	0.95523	D	1.891671	0.28814	15.54	0.94816624571828323	0.24987	0.98089	0.79359	D	AEFDGBCI	c	0.638679156755672	6.341501	0.638031214958964	6.734411	0.77629	0.999999999177895	0.74713	0.706548	0.72963	0	0.552637	0.16849	0	0.724815	0.87840	0	0.711	0.71304	0	5.05	5.05	0.67438	6.009000	0.70198	0.852000	0.36166	1.000000	0.71511	0.992000	0.56220	0.0:1.0:0.0:0.0	17.2137	0.86758	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TNRC21;MLL2	ALR;MLL4;CAGL114	O14686	KMT2D_HUMAN	8085	CCDS44873	NM_003482	.	602113	lysine methyltransferase 2D	.	.	.	Lysine degradation - Homo sapiens (human);Histone Modifications;formation of the beta-catenin:TCF transactivating complex;TCF dependent signaling in response to WNT;Chromatin organization;Signaling by Wnt;Signal Transduction;PKMTs methylate histone lysines;Chromatin modifying enzymes	.	.	FUNCTION: Histone methyltransferase. Methylates 'Lys-4' of histone H3 (H3K4me). H3K4me represents a specific tag for epigenetic transcriptional activation. Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription. {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:17851529}.; 	DISEASE: Kabuki syndrome 1 (KABUK1) [MIM:147920]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:20711175, ECO:0000269|PubMed:21280141, ECO:0000269|PubMed:21607748, ECO:0000269|PubMed:21658225, ECO:0000269|PubMed:21671394, ECO:0000269|PubMed:22126750, ECO:0000269|PubMed:23320472, ECO:0000269|PubMed:23913813, ECO:0000269|PubMed:24739679}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	147920;	[MIM:147920]Kabuki syndrome 1;	.	positive regulation of transcription from RNA polymerase II promoter;methylation;positive regulation of intracellular estrogen receptor signaling pathway;in utero embryonic development;transcription, DNA-templated;oogenesis;response to estrogen;regulation of transcription, DNA-templated;chromatin organization;oocyte growth;chromatin silencing;histone H3-K4 methylation;positive regulation of cell proliferation	nucleoplasm;histone methyltransferase complex;nucleus	histone methyltransferase activity (H3-K4 specific);DNA binding;methyltransferase activity;transcription regulatory region DNA binding;protein binding;zinc ion binding	TISSUE SPECIFICITY: Expressed in most adult tissues, including a variety of hematoipoietic cells, with the exception of the liver.; 	.	.	1.00848615169525	11.8290023803711	5.869742780412946	350.0	1.30134475231171	7.94957971572876	4.892205798678461	227.0	1.66825413703918	10.2305793762207	5.649617833104627	145.0	1.39764070510864	9.26386737823486	5.00879744174225	224.0	1.36067628860474	10.6840343475342	5.281838749584399	133.0	0.530496597290039	11.3825216293335	5.376866455537727	332.0	5.18281030654907	9.32663345336914	7.20801392468539	11.0	0.389710068702698	4.60074281692505	2.308834368156062	72.0	0.56784200668335	5.48483991622925	2.782793403381393	84.0	0.804854333400726	7.38249444961548	2.948411836073949	117.0	2.29358649253845	15.4715518951416	7.985355851763772	105.0	1.80948376655579	16.0803146362305	8.823392581939697	125.0	0.938228607177734	11.8356657028198	3.5972855122465837	114.0	0.57907897233963	5.44641160964966	3.0113047797370847	108.0	0.466378897428513	6.49441432952881	2.689999517925242	94.0	0.433862864971161	5.74229383468628	2.769361876261731	96.0	0.546778619289398	7.36079216003418	3.0833156646880426	113.0	0.434027910232544	4.64157152175903	2.3024439529045337	97.0	0.750487864017487	5.80940103530884	2.7444080173129763	71.0	0.72170215845108	8.37475681304932	2.324393461620997	63.0	0.947582125663757	12.8056030273438	6.486342293079768	214.0	0.485966384410858	14.0028409957886	7.5627809884184485	118.0	0.270348280668259	18.9045372009277	6.4580969157773	284.0	3.22073531150818	8.57573509216309	6.019942323366801	6.0	3.18334746360779	9.12591075897217	6.488473749160766	5.0	1.19799971580505	9.87677383422852	5.351737876066426	149.0	1.39160811901093	11.4228773117065	5.589275003087764	196.0	0.539830386638641	9.04757499694824	5.697362568253785	153.0	1.20293796062469	9.07795143127441	5.516304258700018	286.0	0.64962500333786	9.23762893676758	5.755939557002141	247.0	6.37062501907349	10.4400186538696	7.892319043477372	6.0	0.370079606771469	6.32346820831299	3.5031648295134614	194.0	0.322144240140915	8.10744953155518	3.3126034702456324	218.0	0.99717116355896	10.6574630737305	4.650523923337461	32.0	0.66372662782669	4.71149778366089	2.2989809523109628	119.0	0.789882063865662	15.025580406189	7.588737846910954	320.0	1.14990282058716	9.9564323425293	6.1434847430179	57.0	0.835830390453339	12.5508069992065	5.65911499081656	430.0	0.433754712343216	15.0134029388428	7.474365148791357	304.0	2.9120352268219	11.9823017120361	7.823664033535829	97.0	1.38089668750763	9.00404453277588	4.934485683664244	171.0	2.15988755226135	19.2270793914795	7.8273612966815245	103.0	2.70688676834106	13.6009225845337	7.2214006208023935	106.0	0.689357995986938	15.0967493057251	7.612342144012451	250.0	0.865677535533905	14.1314134597778	8.038771501275338	357.0	2.14353132247925	15.0290975570679	7.957261250777678	88.0	2.32706117630005	15.3488178253174	7.633469808560152	104.0	1.27805864810944	11.2112436294556	6.107827980283629	193.0	2.60347270965576	14.6463308334351	7.690135379170263	172.0	1.86098027229309	22.3714771270752	10.217792092462073	323.0	4.02786636352539	16.2969989776611	9.230035000536816	83.0	2.33581590652466	10.1526718139648	5.794359505176544	96.0	0.199203416705132	27.7184028625488	3.9355707268299343	393.0	16	29	150	0.69282	0.10507	.	-5.294103076	0.064873791	-5.184334326	0.078308536	1281.52205	6.74114	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	.	.	Kmt2d	respiratory system phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); muscle phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); 	kmt2d	chondrocyte	position	abnormal
13	32907320	.	C	A	13	32333183	C	A	Q	K	rs397507274	13	32907320	13	31805320	BRCA2	+	CAG	1	0	C	C/C	C/C	ENSG00000139618	ENST00000380152;ENST00000544455	ENSP00000369497;ENSP00000439902	569	0.205	0.19972	T	P51587;A1YBP1	BRCA2_HUMAN;.	569	0.001;0.039	0.19721	B	0.003;0.014	0.15762	B	0.981030	0.07833	N	1.008310	1;1	0.08979	N;N	simple_aae;simple_aae	Q569K;Q569K	BRCA2_HUMAN	Q569K	1.1	0.28137	L	5.92;5.92	0.00661	T;T	-0.36	0.13052	N	NM_000059.3;CCDS9344.1;ENST00000544455;ENST00000380152;ENST00000530893	Q569K;Q569K;Q569K;Q569K;Q567K	0.561;0.169;0.492;0.561;0.69	0.69577	-0.9150	0.46248	T	0.0017	0.00556	T	10	0.06298774046	0.68939	D	-0.313203	0.06743	0.620	0.40085738108442009	0.02788	0.02737	0.07323	N	AEFBI	c	-1.29110823367403	0.1695447	-1.27184407375612	0.2280415	0.04732	0.987698643868835	0.31275	0.6512	0.46512	0	0.546412	0.11376	0	0.463624	0.06112	0	0.683762	0.67193	0	5.5	0.606	0.16665	-0.095000	0.10953	-0.437000	0.05760	0.000000	0.06329	0.003000	0.07409	0.2771:0.3109:0.2571:0.1548	1.3636	0.02044	.	.	.	.	.	.	.	.	.	.	.	.	0	0.0	1	2.594706798131811E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs397507274	5	Breast-ovarian cancer, familial 2	0	.	.	.	FANCD1;FACD;FANCD	FAD;FAD1;BRCC2;XRCC11	P51587	BRCA2_HUMAN	675	CCDS9344	NM_000059	uc001uub.1	600185	breast cancer 2	.	atrbrcaPathway	Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);Homologous recombination - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Integrated Breast Cancer Pathway;Homologous recombination;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;Validated transcriptional targets of deltaNp63 isoforms;Double-Strand Break Repair;Fanconi Anemia pathway;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;DNA Repair;Fanconi anemia pathway;p73 transcription factor network;FOXM1 transcription factor network;ATR signaling pathway;role of brca1 brca2 and atr in cancer susceptibility	hsa03440;hsa05212	Homologous recombination;Pancreatic cancer	FUNCTION: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SHFM1/DSS1, and is required to prevent R-loop- associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). {ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	114480;605724;612555;613029;613347;	[MIM:114480]Breast cancer;[MIM:613347]Pancreatic cancer 2;[MIM:612555]Breast-ovarian cancer, familial, 2;[MIM:605724]Fanconi anemia complementation group D1;[MIM:613029]Glioma 3;	LDL cholesterol[24097068];Breast cancer[23535733;23535729];Lung cancer[24880342;24880342];	cytokinesis;chromosome breakage;brain development;spermatogenesis;mammary gland development;response to X-ray;positive regulation of transcription, DNA-templated;histone H4 acetylation;DNA repair;histone H3 acetylation;cell aging;multicellular organism growth;double-strand break repair;establishment of protein localization to telomere;double-strand break repair via synthesis-dependent strand annealing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;inner cell mass cell proliferation;centrosome duplication;male meiosis I;positive regulation of mitotic cell cycle;homologous chromosome orientation involved in meiotic metaphase I plate congression;nucleotide-excision repair;response to estradiol;double-strand break repair via homologous recombination;response to nutrient;response to gamma radiation;hemopoiesis;oocyte maturation;replication fork protection;regulation of cytokinesis;homologous recombination-dependent replication fork processing;response to UV-C;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;female gonad development	nucleus;nuclear chromosome, telomeric region;secretory granule;BRCA2-MAGE-D1 complex;centrosome;nucleoplasm;cytoplasm;protein complex	gamma-tubulin binding;H4 histone acetyltransferase activity;histone acetyltransferase activity;protein binding;protease binding;single-stranded DNA binding;H3 histone acetyltransferase activity	TISSUE SPECIFICITY: Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.; 	.	.	0.0386491604149342	0.789966583251953	0.21840648076363972	350.0	0.0261966250836849	0.627283990383148	0.1532959161153974	227.0	0.00360413757152855	0.508728742599487	0.08873969377660802	145.0	0.0275050234049559	0.439617872238159	0.14775150204409981	224.0	0.0134975835680962	0.434071570634842	0.1415261957458311	133.0	0.00311911990866065	0.625425577163696	0.09565634742597993	332.0	0.0131933083757758	0.346350371837616	0.13482188628139824	11.0	0.0	0.0764816179871559	0.025678130798041824	72.0	0.0	0.089766912162304	0.02264447471437355	84.0	0.0	0.159767091274261	0.02878004898372878	117.0	0.0	0.0668455138802528	0.028201542113951983	105.0	0.00414298707619309	0.096252977848053	0.027465961769223213	125.0	0.00183988490607589	0.144220739603043	0.027416063834128812	114.0	0.0	0.197936370968819	0.029612684359394573	108.0	0.0	0.0860378742218018	0.021427220280995554	94.0	0.0	0.0860995203256607	0.029131149455982566	96.0	0.0	0.0796989724040031	0.02534040163757395	113.0	0.0	0.103563718497753	0.02345568586870567	97.0	0.0	0.254904985427856	0.037821265649129174	71.0	0.00130503869149834	0.0912929400801659	0.027300415592016798	63.0	0.0152158234268427	0.754492402076721	0.17172436485780734	214.0	0.924876928329468	6.95442008972168	4.2121621602672645	118.0	0.0822805389761925	5.31887531280518	1.2939329475531696	284.0	0.0469802878797054	0.51663327217102	0.1733355304847161	6.0	0.0811218246817589	0.214063838124275	0.1291183471679686	5.0	0.00338022876530886	0.19717313349247	0.05506244508999606	149.0	0.0219646636396646	0.766862213611603	0.2041167096729029	196.0	0.0	0.23247866332531	0.05357713536268065	153.0	0.0192123018205166	1.51587378978729	0.36972343315976064	286.0	0.00363687612116337	0.402099043130875	0.05411798112388505	247.0	0.0666519775986671	0.271506130695343	0.11361012856165568	6.0	0.0036618581507355	0.156499445438385	0.04247624001144096	194.0	0.0	0.53164404630661	0.030785672040869815	218.0	0.00811624340713024	0.484728544950485	0.09076629715855232	32.0	0.00217394577339292	0.593903601169586	0.08869283164640057	119.0	0.0242612492293119	1.11004567146301	0.3051230304117781	320.0	0.0430110394954681	0.540771007537842	0.19247657413545408	57.0	0.0	0.106620170176029	0.02000922083876334	430.0	0.0187872592359781	0.38687852025032	0.10597535470917233	304.0	0.0272566229104996	0.341938108205795	0.1153565020943733	97.0	0.010019063949585	0.360765546560287	0.08702453699681843	171.0	0.00478192046284676	0.111925005912781	0.03669655274201944	103.0	0.0196626707911491	0.402852416038513	0.09553105016854012	106.0	0.033243291079998	0.554867744445801	0.2041259383559227	250.0	0.0342679992318153	1.075843334198	0.2125019361199785	357.0	0.0465507991611958	1.1457953453064	0.392270712139593	88.0	0.0803521052002907	1.53617215156555	0.46940724300937003	104.0	0.00582461943849921	1.06559646129608	0.18674498396669875	193.0	0.801662147045135	2.97125601768494	1.600011796798817	172.0	0.0106517914682627	0.327193021774292	0.0850142633899954	323.0	0.0150496633723378	0.242446079850197	0.09555354816502477	83.0	0.0148512851446867	0.642841041088104	0.18005569372326133	96.0	0.00371881085447967	1.29646110534668	0.102415874589154	393.0	24	66	192	0.97144	0.70346	.	3.731883424	99.58716678	-0.142205075	40.50358412	775.59808	5.51436	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	8.96E-02	E	Brca2	limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; tumorigenesis; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 	brca2	spermatocyte	apoptotic	abnormal
13	32907414	.	A	G	13	32333277	A	G	Y	C	rs397507276	13	32907414	13	31805414	BRCA2	+	TAT	2	0	A	A/A	A/A	ENSG00000139618	ENST00000380152;ENST00000544455	ENSP00000369497;ENSP00000439902	600	0.098	0.30758	T	P51587;A1YBP1	BRCA2_HUMAN;.	600	0.013;0.03	0.18649	B	0.01;0.017	0.16985	B	0.257787	0.15367	N	0.618193	0.999889;0.999889	0.19844	N;N	simple_aae;simple_aae	Y600C;Y600C	BRCA2_HUMAN	Y600C	1.5	0.37962	L	5.53;5.53	0.00935	T;T	-0.73	0.20582	N	NM_000059.3;CCDS9344.1;ENST00000544455;ENST00000380152;ENST00000530893	Y600C;Y600C;Y600C;Y600C;Y598C	0.686;0.215;0.699;0.686;0.716	0.71683	-0.8988	0.48142	T	0.0031	0.00994	T	10	0.0307140769669	0.53119	D	0.826390	0.17275	9.626	0.90769576876255431	0.19432	0.06003	0.11825	N	AEFBI	c	-0.808106256170627	0.6431733	-0.87331736672991	0.6564117	0.12538	0.998213037692968	0.36533	0.6512	0.46512	0	0.653731	0.59439	0	0.463624	0.06112	0	0.683762	0.67193	0	5.39	-4.16	0.03585	0.047000	0.13831	0.158000	0.24349	0.002000	0.15122	0.984000	0.50655	0.4019:0.1287:0.2201:0.2492	0.4282	0.00431	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs397507276	5	Breast-ovarian cancer, familial 2	0	.	.	.	FANCD1;FACD;FANCD	FAD;FAD1;BRCC2;XRCC11	P51587	BRCA2_HUMAN	675	CCDS9344	NM_000059	uc001uub.1	600185	breast cancer 2	.	atrbrcaPathway	Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);Homologous recombination - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Integrated Breast Cancer Pathway;Homologous recombination;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;Validated transcriptional targets of deltaNp63 isoforms;Double-Strand Break Repair;Fanconi Anemia pathway;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;DNA Repair;Fanconi anemia pathway;p73 transcription factor network;FOXM1 transcription factor network;ATR signaling pathway;role of brca1 brca2 and atr in cancer susceptibility	hsa03440;hsa05212	Homologous recombination;Pancreatic cancer	FUNCTION: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SHFM1/DSS1, and is required to prevent R-loop- associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). {ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	114480;605724;612555;613029;613347;	[MIM:114480]Breast cancer;[MIM:613347]Pancreatic cancer 2;[MIM:612555]Breast-ovarian cancer, familial, 2;[MIM:605724]Fanconi anemia complementation group D1;[MIM:613029]Glioma 3;	LDL cholesterol[24097068];Breast cancer[23535733;23535729];Lung cancer[24880342;24880342];	cytokinesis;chromosome breakage;brain development;spermatogenesis;mammary gland development;response to X-ray;positive regulation of transcription, DNA-templated;histone H4 acetylation;DNA repair;histone H3 acetylation;cell aging;multicellular organism growth;double-strand break repair;establishment of protein localization to telomere;double-strand break repair via synthesis-dependent strand annealing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;inner cell mass cell proliferation;centrosome duplication;male meiosis I;positive regulation of mitotic cell cycle;homologous chromosome orientation involved in meiotic metaphase I plate congression;nucleotide-excision repair;response to estradiol;double-strand break repair via homologous recombination;response to nutrient;response to gamma radiation;hemopoiesis;oocyte maturation;replication fork protection;regulation of cytokinesis;homologous recombination-dependent replication fork processing;response to UV-C;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;female gonad development	nucleus;nuclear chromosome, telomeric region;secretory granule;BRCA2-MAGE-D1 complex;centrosome;nucleoplasm;cytoplasm;protein complex	gamma-tubulin binding;H4 histone acetyltransferase activity;histone acetyltransferase activity;protein binding;protease binding;single-stranded DNA binding;H3 histone acetyltransferase activity	TISSUE SPECIFICITY: Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.; 	.	.	0.0386491604149342	0.789966583251953	0.21840648076363972	350.0	0.0261966250836849	0.627283990383148	0.1532959161153974	227.0	0.00360413757152855	0.508728742599487	0.08873969377660802	145.0	0.0275050234049559	0.439617872238159	0.14775150204409981	224.0	0.0134975835680962	0.434071570634842	0.1415261957458311	133.0	0.00311911990866065	0.625425577163696	0.09565634742597993	332.0	0.0131933083757758	0.346350371837616	0.13482188628139824	11.0	0.0	0.0764816179871559	0.025678130798041824	72.0	0.0	0.089766912162304	0.02264447471437355	84.0	0.0	0.159767091274261	0.02878004898372878	117.0	0.0	0.0668455138802528	0.028201542113951983	105.0	0.00414298707619309	0.096252977848053	0.027465961769223213	125.0	0.00183988490607589	0.144220739603043	0.027416063834128812	114.0	0.0	0.197936370968819	0.029612684359394573	108.0	0.0	0.0860378742218018	0.021427220280995554	94.0	0.0	0.0860995203256607	0.029131149455982566	96.0	0.0	0.0796989724040031	0.02534040163757395	113.0	0.0	0.103563718497753	0.02345568586870567	97.0	0.0	0.254904985427856	0.037821265649129174	71.0	0.00130503869149834	0.0912929400801659	0.027300415592016798	63.0	0.0152158234268427	0.754492402076721	0.17172436485780734	214.0	0.924876928329468	6.95442008972168	4.2121621602672645	118.0	0.0822805389761925	5.31887531280518	1.2939329475531696	284.0	0.0469802878797054	0.51663327217102	0.1733355304847161	6.0	0.0811218246817589	0.214063838124275	0.1291183471679686	5.0	0.00338022876530886	0.19717313349247	0.05506244508999606	149.0	0.0219646636396646	0.766862213611603	0.2041167096729029	196.0	0.0	0.23247866332531	0.05357713536268065	153.0	0.0192123018205166	1.51587378978729	0.36972343315976064	286.0	0.00363687612116337	0.402099043130875	0.05411798112388505	247.0	0.0666519775986671	0.271506130695343	0.11361012856165568	6.0	0.0036618581507355	0.156499445438385	0.04247624001144096	194.0	0.0	0.53164404630661	0.030785672040869815	218.0	0.00811624340713024	0.484728544950485	0.09076629715855232	32.0	0.00217394577339292	0.593903601169586	0.08869283164640057	119.0	0.0242612492293119	1.11004567146301	0.3051230304117781	320.0	0.0430110394954681	0.540771007537842	0.19247657413545408	57.0	0.0	0.106620170176029	0.02000922083876334	430.0	0.0187872592359781	0.38687852025032	0.10597535470917233	304.0	0.0272566229104996	0.341938108205795	0.1153565020943733	97.0	0.010019063949585	0.360765546560287	0.08702453699681843	171.0	0.00478192046284676	0.111925005912781	0.03669655274201944	103.0	0.0196626707911491	0.402852416038513	0.09553105016854012	106.0	0.033243291079998	0.554867744445801	0.2041259383559227	250.0	0.0342679992318153	1.075843334198	0.2125019361199785	357.0	0.0465507991611958	1.1457953453064	0.392270712139593	88.0	0.0803521052002907	1.53617215156555	0.46940724300937003	104.0	0.00582461943849921	1.06559646129608	0.18674498396669875	193.0	0.801662147045135	2.97125601768494	1.600011796798817	172.0	0.0106517914682627	0.327193021774292	0.0850142633899954	323.0	0.0150496633723378	0.242446079850197	0.09555354816502477	83.0	0.0148512851446867	0.642841041088104	0.18005569372326133	96.0	0.00371881085447967	1.29646110534668	0.102415874589154	393.0	24	66	192	0.97144	0.70346	.	3.731883424	99.58716678	-0.142205075	40.50358412	775.59808	5.51436	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	8.96E-02	E	Brca2	limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; tumorigenesis; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 	brca2	spermatocyte	apoptotic	abnormal
13	32913572	.	A	G	13	32339435	A	G	R	G	rs200265692	13	32913572	13	31811572	BRCA2	+	AGA	1	2	A	A/A	A/A	ENSG00000139618	ENST00000380152;ENST00000544455	ENSP00000369497;ENSP00000439902	1694	0.001	0.78421	D	P51587	BRCA2_HUMAN	1694	0.92	0.49036	P	0.721	0.53058	P	0.251458	0.15491	N	0.644399	0.992913;0.992913	0.23779	N;N	simple_aae;simple_aae	R1694G;R1694G	BRCA2_HUMAN	R1694G	2.715	0.79682	M	-0.91;-0.91	0.75009	T;T	-5.7	0.87350	D	NM_000059.3;CCDS9344.1;ENST00000544455;ENST00000380152	R1694G;R1694G;R1694G;R1694G	0.685;0.251;0.727;0.685	0.72587	-0.6671	0.61987	T	0.3373	0.70408	T	10	0.229680032644	0.88237	D	4.987524	0.67096	25.1	0.9958141429086439	0.72816	0.63331	0.31792	D	AEFBI	c	0.244901836539914	3.507797	0.235611074065026	3.362703	0.52198	0.928605057058661	0.26899	0.615465	0.37169	0	0.633656	0.55475	0	0.602189	0.34140	0	0.655142	0.61628	0	5.82	3.19	0.35566	0.949000	0.28507	1.199000	0.96014	0.966000	0.33739	0.997000	0.65342	0.5859:0.1598:0.1005:0.1538	2.1891	0.03626	1	1.9968051118210862E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	0	0.0	.	.	.	.	.	.	.	.	1	8.244e-06	1	8.427e-06	1	1.026e-04	0	0	0	0	0	0	0	0	0	0	1	9.425e-06	1	9.648e-06	1	1.189e-04	0	0	0	0	0	0	0	0	0	0	1	1.103e-05	1	1.136e-05	1	1.028e-04	0	0	0	0	0	0	0	0	0	0	.	.	.	.	.	.	.	FANCD1;FACD;FANCD	FAD;FAD1;BRCC2;XRCC11	P51587	BRCA2_HUMAN	675	CCDS9344	NM_000059	uc001uub.1	600185	breast cancer 2	.	atrbrcaPathway	Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);Homologous recombination - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Integrated Breast Cancer Pathway;Homologous recombination;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;Validated transcriptional targets of deltaNp63 isoforms;Double-Strand Break Repair;Fanconi Anemia pathway;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;DNA Repair;Fanconi anemia pathway;p73 transcription factor network;FOXM1 transcription factor network;ATR signaling pathway;role of brca1 brca2 and atr in cancer susceptibility	hsa03440;hsa05212	Homologous recombination;Pancreatic cancer	FUNCTION: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SHFM1/DSS1, and is required to prevent R-loop- associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). {ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	114480;605724;612555;613029;613347;	[MIM:114480]Breast cancer;[MIM:613347]Pancreatic cancer 2;[MIM:612555]Breast-ovarian cancer, familial, 2;[MIM:605724]Fanconi anemia complementation group D1;[MIM:613029]Glioma 3;	LDL cholesterol[24097068];Breast cancer[23535733;23535729];Lung cancer[24880342;24880342];	cytokinesis;chromosome breakage;brain development;spermatogenesis;mammary gland development;response to X-ray;positive regulation of transcription, DNA-templated;histone H4 acetylation;DNA repair;histone H3 acetylation;cell aging;multicellular organism growth;double-strand break repair;establishment of protein localization to telomere;double-strand break repair via synthesis-dependent strand annealing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;inner cell mass cell proliferation;centrosome duplication;male meiosis I;positive regulation of mitotic cell cycle;homologous chromosome orientation involved in meiotic metaphase I plate congression;nucleotide-excision repair;response to estradiol;double-strand break repair via homologous recombination;response to nutrient;response to gamma radiation;hemopoiesis;oocyte maturation;replication fork protection;regulation of cytokinesis;homologous recombination-dependent replication fork processing;response to UV-C;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;female gonad development	nucleus;nuclear chromosome, telomeric region;secretory granule;BRCA2-MAGE-D1 complex;centrosome;nucleoplasm;cytoplasm;protein complex	gamma-tubulin binding;H4 histone acetyltransferase activity;histone acetyltransferase activity;protein binding;protease binding;single-stranded DNA binding;H3 histone acetyltransferase activity	TISSUE SPECIFICITY: Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.; 	.	.	0.0386491604149342	0.789966583251953	0.21840648076363972	350.0	0.0261966250836849	0.627283990383148	0.1532959161153974	227.0	0.00360413757152855	0.508728742599487	0.08873969377660802	145.0	0.0275050234049559	0.439617872238159	0.14775150204409981	224.0	0.0134975835680962	0.434071570634842	0.1415261957458311	133.0	0.00311911990866065	0.625425577163696	0.09565634742597993	332.0	0.0131933083757758	0.346350371837616	0.13482188628139824	11.0	0.0	0.0764816179871559	0.025678130798041824	72.0	0.0	0.089766912162304	0.02264447471437355	84.0	0.0	0.159767091274261	0.02878004898372878	117.0	0.0	0.0668455138802528	0.028201542113951983	105.0	0.00414298707619309	0.096252977848053	0.027465961769223213	125.0	0.00183988490607589	0.144220739603043	0.027416063834128812	114.0	0.0	0.197936370968819	0.029612684359394573	108.0	0.0	0.0860378742218018	0.021427220280995554	94.0	0.0	0.0860995203256607	0.029131149455982566	96.0	0.0	0.0796989724040031	0.02534040163757395	113.0	0.0	0.103563718497753	0.02345568586870567	97.0	0.0	0.254904985427856	0.037821265649129174	71.0	0.00130503869149834	0.0912929400801659	0.027300415592016798	63.0	0.0152158234268427	0.754492402076721	0.17172436485780734	214.0	0.924876928329468	6.95442008972168	4.2121621602672645	118.0	0.0822805389761925	5.31887531280518	1.2939329475531696	284.0	0.0469802878797054	0.51663327217102	0.1733355304847161	6.0	0.0811218246817589	0.214063838124275	0.1291183471679686	5.0	0.00338022876530886	0.19717313349247	0.05506244508999606	149.0	0.0219646636396646	0.766862213611603	0.2041167096729029	196.0	0.0	0.23247866332531	0.05357713536268065	153.0	0.0192123018205166	1.51587378978729	0.36972343315976064	286.0	0.00363687612116337	0.402099043130875	0.05411798112388505	247.0	0.0666519775986671	0.271506130695343	0.11361012856165568	6.0	0.0036618581507355	0.156499445438385	0.04247624001144096	194.0	0.0	0.53164404630661	0.030785672040869815	218.0	0.00811624340713024	0.484728544950485	0.09076629715855232	32.0	0.00217394577339292	0.593903601169586	0.08869283164640057	119.0	0.0242612492293119	1.11004567146301	0.3051230304117781	320.0	0.0430110394954681	0.540771007537842	0.19247657413545408	57.0	0.0	0.106620170176029	0.02000922083876334	430.0	0.0187872592359781	0.38687852025032	0.10597535470917233	304.0	0.0272566229104996	0.341938108205795	0.1153565020943733	97.0	0.010019063949585	0.360765546560287	0.08702453699681843	171.0	0.00478192046284676	0.111925005912781	0.03669655274201944	103.0	0.0196626707911491	0.402852416038513	0.09553105016854012	106.0	0.033243291079998	0.554867744445801	0.2041259383559227	250.0	0.0342679992318153	1.075843334198	0.2125019361199785	357.0	0.0465507991611958	1.1457953453064	0.392270712139593	88.0	0.0803521052002907	1.53617215156555	0.46940724300937003	104.0	0.00582461943849921	1.06559646129608	0.18674498396669875	193.0	0.801662147045135	2.97125601768494	1.600011796798817	172.0	0.0106517914682627	0.327193021774292	0.0850142633899954	323.0	0.0150496633723378	0.242446079850197	0.09555354816502477	83.0	0.0148512851446867	0.642841041088104	0.18005569372326133	96.0	0.00371881085447967	1.29646110534668	0.102415874589154	393.0	24	66	192	0.97144	0.70346	.	3.731883424	99.58716678	-0.142205075	40.50358412	775.59808	5.51436	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	8.96E-02	E	Brca2	limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; tumorigenesis; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 	brca2	spermatocyte	apoptotic	abnormal
13	32914347	.	T	G	13	32340210	T	G	L	W	rs375064902	13	32914347	13	31812347	BRCA2	+	TTG	2	0	T	T/T	T/T	ENSG00000139618	ENST00000380152;ENST00000544455	ENSP00000369497;ENSP00000439902	1952	0.047	0.40270	D	P51587	BRCA2_HUMAN	1952	0.07	0.22377	B	0.023	0.18752	B	0.836139	0.09062	N	0.920209	1;1	0.08979	N;N	simple_aae;simple_aae	L1952W;L1952W	BRCA2_HUMAN	L1952W	2.77	0.81157	M	5.61;5.61	0.00857	T;T	-5.0	0.82308	D	NM_000059.3;CCDS9344.1;ENST00000544455;ENST00000380152	L1952W;L1952W;L1952W;L1952W	0.603;0.26;0.654;0.603	0.66735	-0.9188	0.45743	T	0.0040	0.01296	T	10	0.0475289816335	0.63088	D	0.979616	0.18768	10.54	0.90200019731212022	0.18892	0.03656	0.08805	N	AEFBI	c	-0.802134285359567	0.651721	-0.867574811353664	0.6642969	0.12673	0.763768930479234	0.23533	0.615465	0.37169	0	0.633656	0.55475	0	0.536957	0.11182	0	0.655142	0.61628	0	5.72	-0.0733	0.13007	-1.157000	0.03244	0.141000	0.22457	0.000000	0.06329	0.186000	0.21403	0.1409:0.2267:0.1032:0.5292	2.12	0.03467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FANCD1;FACD;FANCD	FAD;FAD1;BRCC2;XRCC11	P51587	BRCA2_HUMAN	675	CCDS9344	NM_000059	uc001uub.1	600185	breast cancer 2	.	atrbrcaPathway	Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);Homologous recombination - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Integrated Breast Cancer Pathway;Homologous recombination;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;Validated transcriptional targets of deltaNp63 isoforms;Double-Strand Break Repair;Fanconi Anemia pathway;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;DNA Repair;Fanconi anemia pathway;p73 transcription factor network;FOXM1 transcription factor network;ATR signaling pathway;role of brca1 brca2 and atr in cancer susceptibility	hsa03440;hsa05212	Homologous recombination;Pancreatic cancer	FUNCTION: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SHFM1/DSS1, and is required to prevent R-loop- associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). {ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	114480;605724;612555;613029;613347;	[MIM:114480]Breast cancer;[MIM:613347]Pancreatic cancer 2;[MIM:612555]Breast-ovarian cancer, familial, 2;[MIM:605724]Fanconi anemia complementation group D1;[MIM:613029]Glioma 3;	LDL cholesterol[24097068];Breast cancer[23535733;23535729];Lung cancer[24880342;24880342];	cytokinesis;chromosome breakage;brain development;spermatogenesis;mammary gland development;response to X-ray;positive regulation of transcription, DNA-templated;histone H4 acetylation;DNA repair;histone H3 acetylation;cell aging;multicellular organism growth;double-strand break repair;establishment of protein localization to telomere;double-strand break repair via synthesis-dependent strand annealing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;inner cell mass cell proliferation;centrosome duplication;male meiosis I;positive regulation of mitotic cell cycle;homologous chromosome orientation involved in meiotic metaphase I plate congression;nucleotide-excision repair;response to estradiol;double-strand break repair via homologous recombination;response to nutrient;response to gamma radiation;hemopoiesis;oocyte maturation;replication fork protection;regulation of cytokinesis;homologous recombination-dependent replication fork processing;response to UV-C;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;female gonad development	nucleus;nuclear chromosome, telomeric region;secretory granule;BRCA2-MAGE-D1 complex;centrosome;nucleoplasm;cytoplasm;protein complex	gamma-tubulin binding;H4 histone acetyltransferase activity;histone acetyltransferase activity;protein binding;protease binding;single-stranded DNA binding;H3 histone acetyltransferase activity	TISSUE SPECIFICITY: Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.; 	.	.	0.0386491604149342	0.789966583251953	0.21840648076363972	350.0	0.0261966250836849	0.627283990383148	0.1532959161153974	227.0	0.00360413757152855	0.508728742599487	0.08873969377660802	145.0	0.0275050234049559	0.439617872238159	0.14775150204409981	224.0	0.0134975835680962	0.434071570634842	0.1415261957458311	133.0	0.00311911990866065	0.625425577163696	0.09565634742597993	332.0	0.0131933083757758	0.346350371837616	0.13482188628139824	11.0	0.0	0.0764816179871559	0.025678130798041824	72.0	0.0	0.089766912162304	0.02264447471437355	84.0	0.0	0.159767091274261	0.02878004898372878	117.0	0.0	0.0668455138802528	0.028201542113951983	105.0	0.00414298707619309	0.096252977848053	0.027465961769223213	125.0	0.00183988490607589	0.144220739603043	0.027416063834128812	114.0	0.0	0.197936370968819	0.029612684359394573	108.0	0.0	0.0860378742218018	0.021427220280995554	94.0	0.0	0.0860995203256607	0.029131149455982566	96.0	0.0	0.0796989724040031	0.02534040163757395	113.0	0.0	0.103563718497753	0.02345568586870567	97.0	0.0	0.254904985427856	0.037821265649129174	71.0	0.00130503869149834	0.0912929400801659	0.027300415592016798	63.0	0.0152158234268427	0.754492402076721	0.17172436485780734	214.0	0.924876928329468	6.95442008972168	4.2121621602672645	118.0	0.0822805389761925	5.31887531280518	1.2939329475531696	284.0	0.0469802878797054	0.51663327217102	0.1733355304847161	6.0	0.0811218246817589	0.214063838124275	0.1291183471679686	5.0	0.00338022876530886	0.19717313349247	0.05506244508999606	149.0	0.0219646636396646	0.766862213611603	0.2041167096729029	196.0	0.0	0.23247866332531	0.05357713536268065	153.0	0.0192123018205166	1.51587378978729	0.36972343315976064	286.0	0.00363687612116337	0.402099043130875	0.05411798112388505	247.0	0.0666519775986671	0.271506130695343	0.11361012856165568	6.0	0.0036618581507355	0.156499445438385	0.04247624001144096	194.0	0.0	0.53164404630661	0.030785672040869815	218.0	0.00811624340713024	0.484728544950485	0.09076629715855232	32.0	0.00217394577339292	0.593903601169586	0.08869283164640057	119.0	0.0242612492293119	1.11004567146301	0.3051230304117781	320.0	0.0430110394954681	0.540771007537842	0.19247657413545408	57.0	0.0	0.106620170176029	0.02000922083876334	430.0	0.0187872592359781	0.38687852025032	0.10597535470917233	304.0	0.0272566229104996	0.341938108205795	0.1153565020943733	97.0	0.010019063949585	0.360765546560287	0.08702453699681843	171.0	0.00478192046284676	0.111925005912781	0.03669655274201944	103.0	0.0196626707911491	0.402852416038513	0.09553105016854012	106.0	0.033243291079998	0.554867744445801	0.2041259383559227	250.0	0.0342679992318153	1.075843334198	0.2125019361199785	357.0	0.0465507991611958	1.1457953453064	0.392270712139593	88.0	0.0803521052002907	1.53617215156555	0.46940724300937003	104.0	0.00582461943849921	1.06559646129608	0.18674498396669875	193.0	0.801662147045135	2.97125601768494	1.600011796798817	172.0	0.0106517914682627	0.327193021774292	0.0850142633899954	323.0	0.0150496633723378	0.242446079850197	0.09555354816502477	83.0	0.0148512851446867	0.642841041088104	0.18005569372326133	96.0	0.00371881085447967	1.29646110534668	0.102415874589154	393.0	24	66	192	0.97144	0.70346	.	3.731883424	99.58716678	-0.142205075	40.50358412	775.59808	5.51436	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	8.96E-02	E	Brca2	limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; tumorigenesis; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 	brca2	spermatocyte	apoptotic	abnormal
13	32914401	.	C	T	13	32340264	C	T	S	L	rs80358824	13	32914401	13	31812401	BRCA2	+	TCA	2	0	C	C/C	C/C	ENSG00000139618	ENST00000380152;ENST00000544455	ENSP00000369497;ENSP00000439902	1970	0.3	0.14474	T	P51587	BRCA2_HUMAN	1970	0.002	0.08966	B	0.002	0.06334	B	0.789749	0.06699	N	1.099340	1;1	0.08979	N;N	simple_aae;simple_aae	S1970L;S1970L	BRCA2_HUMAN	S1970L	2.315	0.66462	M	5.75;5.75	0.00743	T;T	-4.61	0.79023	D	NM_000059.3;CCDS9344.1;ENST00000544455;ENST00000380152	S1970L;S1970L;S1970L;S1970L	0.44;0.122;0.396;0.44	0.49452	-0.8950	0.48511	T	0.0023	0.00738	T	10	0.0308301847198	0.53204	D	0.556846	0.14726	7.852	0.86773380276285195	0.16216	0.11068	0.16204	N	AEFBI	c	-1.18494489752182	0.2378076	-1.17690473288727	0.3026782	0.06191	0.799111642649993	0.24129	0.660377	0.49457	0	0.633656	0.55475	0	0.696353	0.63449	0	0.655142	0.61628	0	5.57	1.27	0.20496	0.053000	0.13956	-0.417000	0.05990	0.000000	0.06329	0.000000	0.01567	0.3315:0.3935:0.0:0.275	4.0812	0.09333	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FANCD1;FACD;FANCD	FAD;FAD1;BRCC2;XRCC11	P51587	BRCA2_HUMAN	675	CCDS9344	NM_000059	uc001uub.1	600185	breast cancer 2	.	atrbrcaPathway	Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);Homologous recombination - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Integrated Breast Cancer Pathway;Homologous recombination;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;Validated transcriptional targets of deltaNp63 isoforms;Double-Strand Break Repair;Fanconi Anemia pathway;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;DNA Repair;Fanconi anemia pathway;p73 transcription factor network;FOXM1 transcription factor network;ATR signaling pathway;role of brca1 brca2 and atr in cancer susceptibility	hsa03440;hsa05212	Homologous recombination;Pancreatic cancer	FUNCTION: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SHFM1/DSS1, and is required to prevent R-loop- associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). {ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	114480;605724;612555;613029;613347;	[MIM:114480]Breast cancer;[MIM:613347]Pancreatic cancer 2;[MIM:612555]Breast-ovarian cancer, familial, 2;[MIM:605724]Fanconi anemia complementation group D1;[MIM:613029]Glioma 3;	LDL cholesterol[24097068];Breast cancer[23535733;23535729];Lung cancer[24880342;24880342];	cytokinesis;chromosome breakage;brain development;spermatogenesis;mammary gland development;response to X-ray;positive regulation of transcription, DNA-templated;histone H4 acetylation;DNA repair;histone H3 acetylation;cell aging;multicellular organism growth;double-strand break repair;establishment of protein localization to telomere;double-strand break repair via synthesis-dependent strand annealing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;inner cell mass cell proliferation;centrosome duplication;male meiosis I;positive regulation of mitotic cell cycle;homologous chromosome orientation involved in meiotic metaphase I plate congression;nucleotide-excision repair;response to estradiol;double-strand break repair via homologous recombination;response to nutrient;response to gamma radiation;hemopoiesis;oocyte maturation;replication fork protection;regulation of cytokinesis;homologous recombination-dependent replication fork processing;response to UV-C;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;female gonad development	nucleus;nuclear chromosome, telomeric region;secretory granule;BRCA2-MAGE-D1 complex;centrosome;nucleoplasm;cytoplasm;protein complex	gamma-tubulin binding;H4 histone acetyltransferase activity;histone acetyltransferase activity;protein binding;protease binding;single-stranded DNA binding;H3 histone acetyltransferase activity	TISSUE SPECIFICITY: Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.; 	.	.	0.0386491604149342	0.789966583251953	0.21840648076363972	350.0	0.0261966250836849	0.627283990383148	0.1532959161153974	227.0	0.00360413757152855	0.508728742599487	0.08873969377660802	145.0	0.0275050234049559	0.439617872238159	0.14775150204409981	224.0	0.0134975835680962	0.434071570634842	0.1415261957458311	133.0	0.00311911990866065	0.625425577163696	0.09565634742597993	332.0	0.0131933083757758	0.346350371837616	0.13482188628139824	11.0	0.0	0.0764816179871559	0.025678130798041824	72.0	0.0	0.089766912162304	0.02264447471437355	84.0	0.0	0.159767091274261	0.02878004898372878	117.0	0.0	0.0668455138802528	0.028201542113951983	105.0	0.00414298707619309	0.096252977848053	0.027465961769223213	125.0	0.00183988490607589	0.144220739603043	0.027416063834128812	114.0	0.0	0.197936370968819	0.029612684359394573	108.0	0.0	0.0860378742218018	0.021427220280995554	94.0	0.0	0.0860995203256607	0.029131149455982566	96.0	0.0	0.0796989724040031	0.02534040163757395	113.0	0.0	0.103563718497753	0.02345568586870567	97.0	0.0	0.254904985427856	0.037821265649129174	71.0	0.00130503869149834	0.0912929400801659	0.027300415592016798	63.0	0.0152158234268427	0.754492402076721	0.17172436485780734	214.0	0.924876928329468	6.95442008972168	4.2121621602672645	118.0	0.0822805389761925	5.31887531280518	1.2939329475531696	284.0	0.0469802878797054	0.51663327217102	0.1733355304847161	6.0	0.0811218246817589	0.214063838124275	0.1291183471679686	5.0	0.00338022876530886	0.19717313349247	0.05506244508999606	149.0	0.0219646636396646	0.766862213611603	0.2041167096729029	196.0	0.0	0.23247866332531	0.05357713536268065	153.0	0.0192123018205166	1.51587378978729	0.36972343315976064	286.0	0.00363687612116337	0.402099043130875	0.05411798112388505	247.0	0.0666519775986671	0.271506130695343	0.11361012856165568	6.0	0.0036618581507355	0.156499445438385	0.04247624001144096	194.0	0.0	0.53164404630661	0.030785672040869815	218.0	0.00811624340713024	0.484728544950485	0.09076629715855232	32.0	0.00217394577339292	0.593903601169586	0.08869283164640057	119.0	0.0242612492293119	1.11004567146301	0.3051230304117781	320.0	0.0430110394954681	0.540771007537842	0.19247657413545408	57.0	0.0	0.106620170176029	0.02000922083876334	430.0	0.0187872592359781	0.38687852025032	0.10597535470917233	304.0	0.0272566229104996	0.341938108205795	0.1153565020943733	97.0	0.010019063949585	0.360765546560287	0.08702453699681843	171.0	0.00478192046284676	0.111925005912781	0.03669655274201944	103.0	0.0196626707911491	0.402852416038513	0.09553105016854012	106.0	0.033243291079998	0.554867744445801	0.2041259383559227	250.0	0.0342679992318153	1.075843334198	0.2125019361199785	357.0	0.0465507991611958	1.1457953453064	0.392270712139593	88.0	0.0803521052002907	1.53617215156555	0.46940724300937003	104.0	0.00582461943849921	1.06559646129608	0.18674498396669875	193.0	0.801662147045135	2.97125601768494	1.600011796798817	172.0	0.0106517914682627	0.327193021774292	0.0850142633899954	323.0	0.0150496633723378	0.242446079850197	0.09555354816502477	83.0	0.0148512851446867	0.642841041088104	0.18005569372326133	96.0	0.00371881085447967	1.29646110534668	0.102415874589154	393.0	24	66	192	0.97144	0.70346	.	3.731883424	99.58716678	-0.142205075	40.50358412	775.59808	5.51436	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	8.96E-02	E	Brca2	limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; tumorigenesis; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 	brca2	spermatocyte	apoptotic	abnormal
13	32920985	.	T	C	13	32346848	T	C	L	S	rs80358923	13	32920985	13	31818985	BRCA2	+	TTG	2	0	T	T/T	T/T	ENSG00000139618	ENST00000380152;ENST00000544455	ENSP00000369497;ENSP00000439902	2320	0.046	0.40524	D	P51587	BRCA2_HUMAN	2320	0.965	0.54054	D	0.656	0.50848	P	0.388433	0.13281	N	0.626255	0.952156;0.952156	0.26422	N;N	simple_aae;simple_aae	L2320S;L2320S	BRCA2_HUMAN	L2320S	2.625	0.77092	M	-1.33;-1.33	0.79865	T;T	-1.52	0.36956	N	NM_000059.3;CCDS9344.1;ENST00000544455;ENST00000380152	L2320S;L2320S;L2320S;L2320S	0.738;0.227;0.731;0.738	0.73505	-0.5072	0.68412	T	0.4793	0.80091	T	10	0.222611581507	0.87906	D	5.482461	0.74437	26.2	0.99422325846767634	0.63540	0.70778	0.34455	D	AEFDBI	c	0.227896270489682	3.428942	0.183561055987304	3.103936	0.49335	0.900566056530312	0.26045	0.615465	0.37169	0	0.633656	0.55475	0	0.658983	0.55576	0	0.655142	0.61628	0	5.03	2.36	0.28128	0.946000	0.28467	1.043000	0.66262	1.000000	0.71511	0.995000	0.60354	0.1706:0.0:0.1777:0.6517	5.583	0.16429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	FANCD1;FACD;FANCD	FAD;FAD1;BRCC2;XRCC11	P51587	BRCA2_HUMAN	675	CCDS9344	NM_000059	uc001uub.1	600185	breast cancer 2	.	atrbrcaPathway	Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);Homologous recombination - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Integrated Breast Cancer Pathway;Homologous recombination;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;Validated transcriptional targets of deltaNp63 isoforms;Double-Strand Break Repair;Fanconi Anemia pathway;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;DNA Repair;Fanconi anemia pathway;p73 transcription factor network;FOXM1 transcription factor network;ATR signaling pathway;role of brca1 brca2 and atr in cancer susceptibility	hsa03440;hsa05212	Homologous recombination;Pancreatic cancer	FUNCTION: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SHFM1/DSS1, and is required to prevent R-loop- associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). {ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	114480;605724;612555;613029;613347;	[MIM:114480]Breast cancer;[MIM:613347]Pancreatic cancer 2;[MIM:612555]Breast-ovarian cancer, familial, 2;[MIM:605724]Fanconi anemia complementation group D1;[MIM:613029]Glioma 3;	LDL cholesterol[24097068];Breast cancer[23535733;23535729];Lung cancer[24880342;24880342];	cytokinesis;chromosome breakage;brain development;spermatogenesis;mammary gland development;response to X-ray;positive regulation of transcription, DNA-templated;histone H4 acetylation;DNA repair;histone H3 acetylation;cell aging;multicellular organism growth;double-strand break repair;establishment of protein localization to telomere;double-strand break repair via synthesis-dependent strand annealing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;inner cell mass cell proliferation;centrosome duplication;male meiosis I;positive regulation of mitotic cell cycle;homologous chromosome orientation involved in meiotic metaphase I plate congression;nucleotide-excision repair;response to estradiol;double-strand break repair via homologous recombination;response to nutrient;response to gamma radiation;hemopoiesis;oocyte maturation;replication fork protection;regulation of cytokinesis;homologous recombination-dependent replication fork processing;response to UV-C;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;female gonad development	nucleus;nuclear chromosome, telomeric region;secretory granule;BRCA2-MAGE-D1 complex;centrosome;nucleoplasm;cytoplasm;protein complex	gamma-tubulin binding;H4 histone acetyltransferase activity;histone acetyltransferase activity;protein binding;protease binding;single-stranded DNA binding;H3 histone acetyltransferase activity	TISSUE SPECIFICITY: Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.; 	.	.	0.0386491604149342	0.789966583251953	0.21840648076363972	350.0	0.0261966250836849	0.627283990383148	0.1532959161153974	227.0	0.00360413757152855	0.508728742599487	0.08873969377660802	145.0	0.0275050234049559	0.439617872238159	0.14775150204409981	224.0	0.0134975835680962	0.434071570634842	0.1415261957458311	133.0	0.00311911990866065	0.625425577163696	0.09565634742597993	332.0	0.0131933083757758	0.346350371837616	0.13482188628139824	11.0	0.0	0.0764816179871559	0.025678130798041824	72.0	0.0	0.089766912162304	0.02264447471437355	84.0	0.0	0.159767091274261	0.02878004898372878	117.0	0.0	0.0668455138802528	0.028201542113951983	105.0	0.00414298707619309	0.096252977848053	0.027465961769223213	125.0	0.00183988490607589	0.144220739603043	0.027416063834128812	114.0	0.0	0.197936370968819	0.029612684359394573	108.0	0.0	0.0860378742218018	0.021427220280995554	94.0	0.0	0.0860995203256607	0.029131149455982566	96.0	0.0	0.0796989724040031	0.02534040163757395	113.0	0.0	0.103563718497753	0.02345568586870567	97.0	0.0	0.254904985427856	0.037821265649129174	71.0	0.00130503869149834	0.0912929400801659	0.027300415592016798	63.0	0.0152158234268427	0.754492402076721	0.17172436485780734	214.0	0.924876928329468	6.95442008972168	4.2121621602672645	118.0	0.0822805389761925	5.31887531280518	1.2939329475531696	284.0	0.0469802878797054	0.51663327217102	0.1733355304847161	6.0	0.0811218246817589	0.214063838124275	0.1291183471679686	5.0	0.00338022876530886	0.19717313349247	0.05506244508999606	149.0	0.0219646636396646	0.766862213611603	0.2041167096729029	196.0	0.0	0.23247866332531	0.05357713536268065	153.0	0.0192123018205166	1.51587378978729	0.36972343315976064	286.0	0.00363687612116337	0.402099043130875	0.05411798112388505	247.0	0.0666519775986671	0.271506130695343	0.11361012856165568	6.0	0.0036618581507355	0.156499445438385	0.04247624001144096	194.0	0.0	0.53164404630661	0.030785672040869815	218.0	0.00811624340713024	0.484728544950485	0.09076629715855232	32.0	0.00217394577339292	0.593903601169586	0.08869283164640057	119.0	0.0242612492293119	1.11004567146301	0.3051230304117781	320.0	0.0430110394954681	0.540771007537842	0.19247657413545408	57.0	0.0	0.106620170176029	0.02000922083876334	430.0	0.0187872592359781	0.38687852025032	0.10597535470917233	304.0	0.0272566229104996	0.341938108205795	0.1153565020943733	97.0	0.010019063949585	0.360765546560287	0.08702453699681843	171.0	0.00478192046284676	0.111925005912781	0.03669655274201944	103.0	0.0196626707911491	0.402852416038513	0.09553105016854012	106.0	0.033243291079998	0.554867744445801	0.2041259383559227	250.0	0.0342679992318153	1.075843334198	0.2125019361199785	357.0	0.0465507991611958	1.1457953453064	0.392270712139593	88.0	0.0803521052002907	1.53617215156555	0.46940724300937003	104.0	0.00582461943849921	1.06559646129608	0.18674498396669875	193.0	0.801662147045135	2.97125601768494	1.600011796798817	172.0	0.0106517914682627	0.327193021774292	0.0850142633899954	323.0	0.0150496633723378	0.242446079850197	0.09555354816502477	83.0	0.0148512851446867	0.642841041088104	0.18005569372326133	96.0	0.00371881085447967	1.29646110534668	0.102415874589154	393.0	24	66	192	0.97144	0.70346	.	3.731883424	99.58716678	-0.142205075	40.50358412	775.59808	5.51436	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	8.96E-02	E	Brca2	limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; tumorigenesis; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 	brca2	spermatocyte	apoptotic	abnormal
13	32929225	.	C	T	13	32355088	C	T	T	I	rs397507384	13	32929225	13	31827225	BRCA2	+	ACT	2	0	C	C/C	C/C	ENSG00000139618	ENST00000380152;ENST00000544455	ENSP00000369497;ENSP00000439902	2412	0.009	0.57428	D	P51587	BRCA2_HUMAN	2412	0.995	0.65671	D	0.814	0.56987	P	0.084306	0.20692	N	0.493109	0.995772;0.995772	0.23180	N;N	simple_aae;simple_aae	T2412I;T2412I	BRCA2_HUMAN	T2412I	2.625	0.77092	M	-1.14;-1.14	0.77851	T;T	-1.35	0.33580	N	NM_000059.3;CCDS9344.1;ENST00000544455;ENST00000380152	T2412I;T2412I;T2412I;T2412I	0.638;0.2;0.647;0.638	0.66189	-0.4083	0.71785	T	0.5085	0.81524	D	10	0.149077614191	0.83156	D	5.851629	0.80163	27.3	0.99891196786616532	0.96484	0.57038	0.30017	D	AEFGBI	c	0.259838746995119	3.57912	0.174785054301088	3.062439	0.48855	0.993096780704128	0.33033	0.6512	0.46512	0	0.653731	0.59439	0	0.463624	0.06112	0	0.683762	0.67193	0	5.5	3.37	0.37533	0.947000	0.28480	0.077000	0.18463	0.637000	0.27822	0.989000	0.53598	0.0:0.798:0.0:0.202	8.9198	0.34576	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	8.237e-06	1	8.241e-06	0	0	0	0	0	0	0	0	0	0	1	6.059e-05	1	9.416e-06	1	9.420e-06	0	0	0	0	0	0	0	0	0	0	1	6.098e-05	1	1.102e-05	1	1.103e-05	0	0	0	0	0	0	0	0	0	0	1	6.063e-05	rs397507384	5	Breast-ovarian cancer, familial 2	0	.	.	.	FANCD1;FACD;FANCD	FAD;FAD1;BRCC2;XRCC11	P51587	BRCA2_HUMAN	675	CCDS9344	NM_000059	uc001uub.1	600185	breast cancer 2	.	atrbrcaPathway	Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);Homologous recombination - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Integrated Breast Cancer Pathway;Homologous recombination;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;Validated transcriptional targets of deltaNp63 isoforms;Double-Strand Break Repair;Fanconi Anemia pathway;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;DNA Repair;Fanconi anemia pathway;p73 transcription factor network;FOXM1 transcription factor network;ATR signaling pathway;role of brca1 brca2 and atr in cancer susceptibility	hsa03440;hsa05212	Homologous recombination;Pancreatic cancer	FUNCTION: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SHFM1/DSS1, and is required to prevent R-loop- associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). {ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	114480;605724;612555;613029;613347;	[MIM:114480]Breast cancer;[MIM:613347]Pancreatic cancer 2;[MIM:612555]Breast-ovarian cancer, familial, 2;[MIM:605724]Fanconi anemia complementation group D1;[MIM:613029]Glioma 3;	LDL cholesterol[24097068];Breast cancer[23535733;23535729];Lung cancer[24880342;24880342];	cytokinesis;chromosome breakage;brain development;spermatogenesis;mammary gland development;response to X-ray;positive regulation of transcription, DNA-templated;histone H4 acetylation;DNA repair;histone H3 acetylation;cell aging;multicellular organism growth;double-strand break repair;establishment of protein localization to telomere;double-strand break repair via synthesis-dependent strand annealing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;inner cell mass cell proliferation;centrosome duplication;male meiosis I;positive regulation of mitotic cell cycle;homologous chromosome orientation involved in meiotic metaphase I plate congression;nucleotide-excision repair;response to estradiol;double-strand break repair via homologous recombination;response to nutrient;response to gamma radiation;hemopoiesis;oocyte maturation;replication fork protection;regulation of cytokinesis;homologous recombination-dependent replication fork processing;response to UV-C;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;female gonad development	nucleus;nuclear chromosome, telomeric region;secretory granule;BRCA2-MAGE-D1 complex;centrosome;nucleoplasm;cytoplasm;protein complex	gamma-tubulin binding;H4 histone acetyltransferase activity;histone acetyltransferase activity;protein binding;protease binding;single-stranded DNA binding;H3 histone acetyltransferase activity	TISSUE SPECIFICITY: Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.; 	.	.	0.0386491604149342	0.789966583251953	0.21840648076363972	350.0	0.0261966250836849	0.627283990383148	0.1532959161153974	227.0	0.00360413757152855	0.508728742599487	0.08873969377660802	145.0	0.0275050234049559	0.439617872238159	0.14775150204409981	224.0	0.0134975835680962	0.434071570634842	0.1415261957458311	133.0	0.00311911990866065	0.625425577163696	0.09565634742597993	332.0	0.0131933083757758	0.346350371837616	0.13482188628139824	11.0	0.0	0.0764816179871559	0.025678130798041824	72.0	0.0	0.089766912162304	0.02264447471437355	84.0	0.0	0.159767091274261	0.02878004898372878	117.0	0.0	0.0668455138802528	0.028201542113951983	105.0	0.00414298707619309	0.096252977848053	0.027465961769223213	125.0	0.00183988490607589	0.144220739603043	0.027416063834128812	114.0	0.0	0.197936370968819	0.029612684359394573	108.0	0.0	0.0860378742218018	0.021427220280995554	94.0	0.0	0.0860995203256607	0.029131149455982566	96.0	0.0	0.0796989724040031	0.02534040163757395	113.0	0.0	0.103563718497753	0.02345568586870567	97.0	0.0	0.254904985427856	0.037821265649129174	71.0	0.00130503869149834	0.0912929400801659	0.027300415592016798	63.0	0.0152158234268427	0.754492402076721	0.17172436485780734	214.0	0.924876928329468	6.95442008972168	4.2121621602672645	118.0	0.0822805389761925	5.31887531280518	1.2939329475531696	284.0	0.0469802878797054	0.51663327217102	0.1733355304847161	6.0	0.0811218246817589	0.214063838124275	0.1291183471679686	5.0	0.00338022876530886	0.19717313349247	0.05506244508999606	149.0	0.0219646636396646	0.766862213611603	0.2041167096729029	196.0	0.0	0.23247866332531	0.05357713536268065	153.0	0.0192123018205166	1.51587378978729	0.36972343315976064	286.0	0.00363687612116337	0.402099043130875	0.05411798112388505	247.0	0.0666519775986671	0.271506130695343	0.11361012856165568	6.0	0.0036618581507355	0.156499445438385	0.04247624001144096	194.0	0.0	0.53164404630661	0.030785672040869815	218.0	0.00811624340713024	0.484728544950485	0.09076629715855232	32.0	0.00217394577339292	0.593903601169586	0.08869283164640057	119.0	0.0242612492293119	1.11004567146301	0.3051230304117781	320.0	0.0430110394954681	0.540771007537842	0.19247657413545408	57.0	0.0	0.106620170176029	0.02000922083876334	430.0	0.0187872592359781	0.38687852025032	0.10597535470917233	304.0	0.0272566229104996	0.341938108205795	0.1153565020943733	97.0	0.010019063949585	0.360765546560287	0.08702453699681843	171.0	0.00478192046284676	0.111925005912781	0.03669655274201944	103.0	0.0196626707911491	0.402852416038513	0.09553105016854012	106.0	0.033243291079998	0.554867744445801	0.2041259383559227	250.0	0.0342679992318153	1.075843334198	0.2125019361199785	357.0	0.0465507991611958	1.1457953453064	0.392270712139593	88.0	0.0803521052002907	1.53617215156555	0.46940724300937003	104.0	0.00582461943849921	1.06559646129608	0.18674498396669875	193.0	0.801662147045135	2.97125601768494	1.600011796798817	172.0	0.0106517914682627	0.327193021774292	0.0850142633899954	323.0	0.0150496633723378	0.242446079850197	0.09555354816502477	83.0	0.0148512851446867	0.642841041088104	0.18005569372326133	96.0	0.00371881085447967	1.29646110534668	0.102415874589154	393.0	24	66	192	0.97144	0.70346	.	3.731883424	99.58716678	-0.142205075	40.50358412	775.59808	5.51436	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	8.96E-02	E	Brca2	limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; tumorigenesis; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 	brca2	spermatocyte	apoptotic	abnormal
13	32930658	.	T	C	13	32356521	T	C	L	P	rs80358979	13	32930658	13	31828658	BRCA2	+	CTG	2	0	T	T/T	T/T	ENSG00000139618	ENST00000380152;ENST00000544455	ENSP00000369497;ENSP00000439902	2510	0.0	0.91219	D	P51587	BRCA2_HUMAN	2510	1.0	0.89865	D	1.0	0.97092	D	0.000001	0.62918	D	0.000000	1;1	0.81033	A;A	simple_aae;simple_aae	L2510P;L2510P	BRCA2_HUMAN	L2510P	2.965	0.85452	M	-2.89;-2.89	0.91599	D;D	-2.1	0.47816	N	NM_000059.3;CCDS9344.1;ENST00000544455;ENST00000380152	L2510P;L2510P;L2510P;L2510P	0.955;0.253;0.756;0.955	0.95211	0.9713	0.96723	D	0.8804	0.96031	D	9	0.551476351949	0.95884	D	6.817226	0.92596	32	0.99900661987387684	0.97252	0.98202	0.80354	D	AEFBI	c	0.843937430935087	9.701159	0.79877242055219	10.08769	0.89365	0.999999788663333	0.74713	0.6512	0.46512	0	0.653731	0.59439	0	0.675528	0.61337	0	0.683762	0.67193	0	5.48	5.48	0.80601	7.054000	0.76180	1.061000	0.80716	1.000000	0.71511	1.000000	0.88762	0.0:0.0:0.0:1.0	15.8734	0.78827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs80358979	5	Fanconi anemia, complementation group D1	0	Breast cancer type 2 susceptibility protein, helical domain	.	.	FANCD1;FACD;FANCD	FAD;FAD1;BRCC2;XRCC11	P51587	BRCA2_HUMAN	675	CCDS9344	NM_000059	uc001uub.1	600185	breast cancer 2	.	atrbrcaPathway	Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);Homologous recombination - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Integrated Breast Cancer Pathway;Homologous recombination;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;Validated transcriptional targets of deltaNp63 isoforms;Double-Strand Break Repair;Fanconi Anemia pathway;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;DNA Repair;Fanconi anemia pathway;p73 transcription factor network;FOXM1 transcription factor network;ATR signaling pathway;role of brca1 brca2 and atr in cancer susceptibility	hsa03440;hsa05212	Homologous recombination;Pancreatic cancer	FUNCTION: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SHFM1/DSS1, and is required to prevent R-loop- associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). {ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	114480;605724;612555;613029;613347;	[MIM:114480]Breast cancer;[MIM:613347]Pancreatic cancer 2;[MIM:612555]Breast-ovarian cancer, familial, 2;[MIM:605724]Fanconi anemia complementation group D1;[MIM:613029]Glioma 3;	LDL cholesterol[24097068];Breast cancer[23535733;23535729];Lung cancer[24880342;24880342];	cytokinesis;chromosome breakage;brain development;spermatogenesis;mammary gland development;response to X-ray;positive regulation of transcription, DNA-templated;histone H4 acetylation;DNA repair;histone H3 acetylation;cell aging;multicellular organism growth;double-strand break repair;establishment of protein localization to telomere;double-strand break repair via synthesis-dependent strand annealing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;inner cell mass cell proliferation;centrosome duplication;male meiosis I;positive regulation of mitotic cell cycle;homologous chromosome orientation involved in meiotic metaphase I plate congression;nucleotide-excision repair;response to estradiol;double-strand break repair via homologous recombination;response to nutrient;response to gamma radiation;hemopoiesis;oocyte maturation;replication fork protection;regulation of cytokinesis;homologous recombination-dependent replication fork processing;response to UV-C;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;female gonad development	nucleus;nuclear chromosome, telomeric region;secretory granule;BRCA2-MAGE-D1 complex;centrosome;nucleoplasm;cytoplasm;protein complex	gamma-tubulin binding;H4 histone acetyltransferase activity;histone acetyltransferase activity;protein binding;protease binding;single-stranded DNA binding;H3 histone acetyltransferase activity	TISSUE SPECIFICITY: Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.; 	.	.	0.0386491604149342	0.789966583251953	0.21840648076363972	350.0	0.0261966250836849	0.627283990383148	0.1532959161153974	227.0	0.00360413757152855	0.508728742599487	0.08873969377660802	145.0	0.0275050234049559	0.439617872238159	0.14775150204409981	224.0	0.0134975835680962	0.434071570634842	0.1415261957458311	133.0	0.00311911990866065	0.625425577163696	0.09565634742597993	332.0	0.0131933083757758	0.346350371837616	0.13482188628139824	11.0	0.0	0.0764816179871559	0.025678130798041824	72.0	0.0	0.089766912162304	0.02264447471437355	84.0	0.0	0.159767091274261	0.02878004898372878	117.0	0.0	0.0668455138802528	0.028201542113951983	105.0	0.00414298707619309	0.096252977848053	0.027465961769223213	125.0	0.00183988490607589	0.144220739603043	0.027416063834128812	114.0	0.0	0.197936370968819	0.029612684359394573	108.0	0.0	0.0860378742218018	0.021427220280995554	94.0	0.0	0.0860995203256607	0.029131149455982566	96.0	0.0	0.0796989724040031	0.02534040163757395	113.0	0.0	0.103563718497753	0.02345568586870567	97.0	0.0	0.254904985427856	0.037821265649129174	71.0	0.00130503869149834	0.0912929400801659	0.027300415592016798	63.0	0.0152158234268427	0.754492402076721	0.17172436485780734	214.0	0.924876928329468	6.95442008972168	4.2121621602672645	118.0	0.0822805389761925	5.31887531280518	1.2939329475531696	284.0	0.0469802878797054	0.51663327217102	0.1733355304847161	6.0	0.0811218246817589	0.214063838124275	0.1291183471679686	5.0	0.00338022876530886	0.19717313349247	0.05506244508999606	149.0	0.0219646636396646	0.766862213611603	0.2041167096729029	196.0	0.0	0.23247866332531	0.05357713536268065	153.0	0.0192123018205166	1.51587378978729	0.36972343315976064	286.0	0.00363687612116337	0.402099043130875	0.05411798112388505	247.0	0.0666519775986671	0.271506130695343	0.11361012856165568	6.0	0.0036618581507355	0.156499445438385	0.04247624001144096	194.0	0.0	0.53164404630661	0.030785672040869815	218.0	0.00811624340713024	0.484728544950485	0.09076629715855232	32.0	0.00217394577339292	0.593903601169586	0.08869283164640057	119.0	0.0242612492293119	1.11004567146301	0.3051230304117781	320.0	0.0430110394954681	0.540771007537842	0.19247657413545408	57.0	0.0	0.106620170176029	0.02000922083876334	430.0	0.0187872592359781	0.38687852025032	0.10597535470917233	304.0	0.0272566229104996	0.341938108205795	0.1153565020943733	97.0	0.010019063949585	0.360765546560287	0.08702453699681843	171.0	0.00478192046284676	0.111925005912781	0.03669655274201944	103.0	0.0196626707911491	0.402852416038513	0.09553105016854012	106.0	0.033243291079998	0.554867744445801	0.2041259383559227	250.0	0.0342679992318153	1.075843334198	0.2125019361199785	357.0	0.0465507991611958	1.1457953453064	0.392270712139593	88.0	0.0803521052002907	1.53617215156555	0.46940724300937003	104.0	0.00582461943849921	1.06559646129608	0.18674498396669875	193.0	0.801662147045135	2.97125601768494	1.600011796798817	172.0	0.0106517914682627	0.327193021774292	0.0850142633899954	323.0	0.0150496633723378	0.242446079850197	0.09555354816502477	83.0	0.0148512851446867	0.642841041088104	0.18005569372326133	96.0	0.00371881085447967	1.29646110534668	0.102415874589154	393.0	24	66	192	0.97144	0.70346	.	3.731883424	99.58716678	-0.142205075	40.50358412	775.59808	5.51436	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	8.96E-02	E	Brca2	limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; tumorigenesis; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 	brca2	spermatocyte	apoptotic	abnormal
13	32937506	.	G	C	13	32363369	G	C	D	H	rs41293511	13	32937506	13	31835506	BRCA2	+	GAT	1	0	G	G/G	G/G	ENSG00000139618	ENST00000380152;ENST00000544455	ENSP00000369497;ENSP00000439902	2723	0.0	0.91219	D	P51587	BRCA2_HUMAN	2723	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	D2723H;D2723H	BRCA2_HUMAN	D2723H	3.925	0.96367	H	-3.97;-3.97	0.96247	D;D	-2.08	0.47479	N	NM_000059.3;CCDS9344.1;ENST00000544455;ENST00000380152	D2723H;D2723H;D2723H;D2723H	0.968;0.391;0.756;0.968	0.96788	1.0958	0.99482	D	0.9546	0.98529	D	10	0.573803191728	0.96172	D	5.802050	0.79377	27.1	0.99247668197855288	0.56404	0.99515	0.96930	D	AEFBI	c	0.895756195023755	10.94062	0.811275738333933	10.46602	0.90205	0.999999999997939	0.74713	0.6512	0.46512	0	0.708844	0.79302	0	0.658983	0.55576	0	0.655142	0.61628	0	5.49	5.49	0.80949	9.602000	0.97604	0.998000	0.61349	1.000000	0.71511	1.000000	0.88762	0.0:0.0:1.0:0.0	19.3535	0.94365	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs41293511	5|5|5|5	Hereditary breast and ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome	1|1|3|1	BRCA2, oligonucleotide/oligosaccharide-binding 1|Nucleic acid-binding, OB-fold	.	.	FANCD1;FACD;FANCD	FAD;FAD1;BRCC2;XRCC11	P51587	BRCA2_HUMAN	675	CCDS9344	NM_000059	uc001uub.1	600185	breast cancer 2	.	atrbrcaPathway	Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);Homologous recombination - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Integrated Breast Cancer Pathway;Homologous recombination;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;Validated transcriptional targets of deltaNp63 isoforms;Double-Strand Break Repair;Fanconi Anemia pathway;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;DNA Repair;Fanconi anemia pathway;p73 transcription factor network;FOXM1 transcription factor network;ATR signaling pathway;role of brca1 brca2 and atr in cancer susceptibility	hsa03440;hsa05212	Homologous recombination;Pancreatic cancer	FUNCTION: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SHFM1/DSS1, and is required to prevent R-loop- associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). {ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	114480;605724;612555;613029;613347;	[MIM:114480]Breast cancer;[MIM:613347]Pancreatic cancer 2;[MIM:612555]Breast-ovarian cancer, familial, 2;[MIM:605724]Fanconi anemia complementation group D1;[MIM:613029]Glioma 3;	LDL cholesterol[24097068];Breast cancer[23535733;23535729];Lung cancer[24880342;24880342];	cytokinesis;chromosome breakage;brain development;spermatogenesis;mammary gland development;response to X-ray;positive regulation of transcription, DNA-templated;histone H4 acetylation;DNA repair;histone H3 acetylation;cell aging;multicellular organism growth;double-strand break repair;establishment of protein localization to telomere;double-strand break repair via synthesis-dependent strand annealing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;inner cell mass cell proliferation;centrosome duplication;male meiosis I;positive regulation of mitotic cell cycle;homologous chromosome orientation involved in meiotic metaphase I plate congression;nucleotide-excision repair;response to estradiol;double-strand break repair via homologous recombination;response to nutrient;response to gamma radiation;hemopoiesis;oocyte maturation;replication fork protection;regulation of cytokinesis;homologous recombination-dependent replication fork processing;response to UV-C;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;female gonad development	nucleus;nuclear chromosome, telomeric region;secretory granule;BRCA2-MAGE-D1 complex;centrosome;nucleoplasm;cytoplasm;protein complex	gamma-tubulin binding;H4 histone acetyltransferase activity;histone acetyltransferase activity;protein binding;protease binding;single-stranded DNA binding;H3 histone acetyltransferase activity	TISSUE SPECIFICITY: Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.; 	.	.	0.0386491604149342	0.789966583251953	0.21840648076363972	350.0	0.0261966250836849	0.627283990383148	0.1532959161153974	227.0	0.00360413757152855	0.508728742599487	0.08873969377660802	145.0	0.0275050234049559	0.439617872238159	0.14775150204409981	224.0	0.0134975835680962	0.434071570634842	0.1415261957458311	133.0	0.00311911990866065	0.625425577163696	0.09565634742597993	332.0	0.0131933083757758	0.346350371837616	0.13482188628139824	11.0	0.0	0.0764816179871559	0.025678130798041824	72.0	0.0	0.089766912162304	0.02264447471437355	84.0	0.0	0.159767091274261	0.02878004898372878	117.0	0.0	0.0668455138802528	0.028201542113951983	105.0	0.00414298707619309	0.096252977848053	0.027465961769223213	125.0	0.00183988490607589	0.144220739603043	0.027416063834128812	114.0	0.0	0.197936370968819	0.029612684359394573	108.0	0.0	0.0860378742218018	0.021427220280995554	94.0	0.0	0.0860995203256607	0.029131149455982566	96.0	0.0	0.0796989724040031	0.02534040163757395	113.0	0.0	0.103563718497753	0.02345568586870567	97.0	0.0	0.254904985427856	0.037821265649129174	71.0	0.00130503869149834	0.0912929400801659	0.027300415592016798	63.0	0.0152158234268427	0.754492402076721	0.17172436485780734	214.0	0.924876928329468	6.95442008972168	4.2121621602672645	118.0	0.0822805389761925	5.31887531280518	1.2939329475531696	284.0	0.0469802878797054	0.51663327217102	0.1733355304847161	6.0	0.0811218246817589	0.214063838124275	0.1291183471679686	5.0	0.00338022876530886	0.19717313349247	0.05506244508999606	149.0	0.0219646636396646	0.766862213611603	0.2041167096729029	196.0	0.0	0.23247866332531	0.05357713536268065	153.0	0.0192123018205166	1.51587378978729	0.36972343315976064	286.0	0.00363687612116337	0.402099043130875	0.05411798112388505	247.0	0.0666519775986671	0.271506130695343	0.11361012856165568	6.0	0.0036618581507355	0.156499445438385	0.04247624001144096	194.0	0.0	0.53164404630661	0.030785672040869815	218.0	0.00811624340713024	0.484728544950485	0.09076629715855232	32.0	0.00217394577339292	0.593903601169586	0.08869283164640057	119.0	0.0242612492293119	1.11004567146301	0.3051230304117781	320.0	0.0430110394954681	0.540771007537842	0.19247657413545408	57.0	0.0	0.106620170176029	0.02000922083876334	430.0	0.0187872592359781	0.38687852025032	0.10597535470917233	304.0	0.0272566229104996	0.341938108205795	0.1153565020943733	97.0	0.010019063949585	0.360765546560287	0.08702453699681843	171.0	0.00478192046284676	0.111925005912781	0.03669655274201944	103.0	0.0196626707911491	0.402852416038513	0.09553105016854012	106.0	0.033243291079998	0.554867744445801	0.2041259383559227	250.0	0.0342679992318153	1.075843334198	0.2125019361199785	357.0	0.0465507991611958	1.1457953453064	0.392270712139593	88.0	0.0803521052002907	1.53617215156555	0.46940724300937003	104.0	0.00582461943849921	1.06559646129608	0.18674498396669875	193.0	0.801662147045135	2.97125601768494	1.600011796798817	172.0	0.0106517914682627	0.327193021774292	0.0850142633899954	323.0	0.0150496633723378	0.242446079850197	0.09555354816502477	83.0	0.0148512851446867	0.642841041088104	0.18005569372326133	96.0	0.00371881085447967	1.29646110534668	0.102415874589154	393.0	24	66	192	0.97144	0.70346	.	3.731883424	99.58716678	-0.142205075	40.50358412	775.59808	5.51436	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	8.96E-02	E	Brca2	limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; tumorigenesis; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 	brca2	spermatocyte	apoptotic	abnormal
13	32954180	.	C	T	13	32380043	C	T	R	W	rs45580035	13	32954180	13	31852180	BRCA2	+	CGG	1	2	C	C/C	C/C	ENSG00000139618	ENST00000380152;ENST00000544455	ENSP00000369497;ENSP00000439902	3052	0.0	0.91219	D	P51587	BRCA2_HUMAN	3052	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	0.999955;0.999955	0.52429	D;D	simple_aae;simple_aae	R3052W;R3052W	BRCA2_HUMAN	R3052W	2.87	0.83550	M	-2.31;-2.31	0.87764	D;D	-2.06	0.47140	N	NM_000059.3;CCDS9344.1;ENST00000544455;ENST00000380152;ENST00000470094	R3052W;R3052W;R3052W;R3052W;R37W	0.97;0.383;0.788;0.97;0.69	0.97032	0.6013	0.91922	D	0.7626	0.91921	D	10	0.483447941457	0.94900	D	7.118822	0.94236	34	0.99890508330905448	0.96406	0.84772	0.43567	D	AEFBI	c	0.260987174109095	3.58472	0.16170013168578	3.001875	0.48154	0.268747371521951	0.18866	0.6512	0.46512	0	0.708844	0.79302	0	0.658983	0.55576	0	0.528226	0.08382	0	5.5	1.4	0.21290	2.976000	0.48732	0.182000	0.24700	0.990000	0.36738	0.997000	0.65342	0.5964:0.4036:0.0:0.0	12.9995	0.57897	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	8.236e-06	1	8.283e-06	0	0	0	0	0	0	0	0	0	0	1	6.066e-05	1	9.415e-06	1	9.467e-06	0	0	0	0	0	0	0	0	0	0	1	6.105e-05	1	1.102e-05	1	1.109e-05	0	0	0	0	0	0	0	0	0	0	1	6.070e-05	rs45580035	5|5|5|5|5	Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 1|not provided	1|3|1|1|1	BRCA2, oligonucleotide/oligosaccharide-binding 3|Nucleic acid-binding, OB-fold	.	.	FANCD1;FACD;FANCD	FAD;FAD1;BRCC2;XRCC11	P51587	BRCA2_HUMAN	675	CCDS9344	NM_000059	uc001uub.1	600185	breast cancer 2	.	atrbrcaPathway	Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);Homologous recombination - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Pancreatic cancer - Homo sapiens (human);Integrated Breast Cancer Pathway;Homologous recombination;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;Validated transcriptional targets of deltaNp63 isoforms;Double-Strand Break Repair;Fanconi Anemia pathway;Presynaptic phase of homologous DNA pairing and strand exchange;Homologous DNA Pairing and Strand Exchange;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;DNA Repair;Fanconi anemia pathway;p73 transcription factor network;FOXM1 transcription factor network;ATR signaling pathway;role of brca1 brca2 and atr in cancer susceptibility	hsa03440;hsa05212	Homologous recombination;Pancreatic cancer	FUNCTION: Involved in double-strand break repair and/or homologous recombination. Binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). Acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. Part of a PALB2-scaffolded HR complex containing RAD51C and which is thought to play a role in DNA repair by HR. May participate in S phase checkpoint activation. Binds selectively to ssDNA, and to ssDNA in tailed duplexes and replication fork structures. May play a role in the extension step after strand invasion at replication-dependent DNA double-strand breaks; together with PALB2 is involved in both POLH localization at collapsed replication forks and DNA polymerization activity. In concert with NPM1, regulates centrosome duplication. Interacts with the TREX-2 complex (transcription and export complex 2) subunits PCID2 and SHFM1/DSS1, and is required to prevent R-loop- associated DNA damage and thus transcription-associated genomic instability. Silencing of BRCA2 promotes R-loop accumulation at actively transcribed genes in replicating and non-replicating cells, suggesting that BRCA2 mediates the control of R-loop associated genomic instability, independently of its known role in homologous recombination (PubMed:24896180). {ECO:0000269|PubMed:15115758, ECO:0000269|PubMed:15199141, ECO:0000269|PubMed:15671039, ECO:0000269|PubMed:18317453, ECO:0000269|PubMed:20729832, ECO:0000269|PubMed:20729858, ECO:0000269|PubMed:20729859, ECO:0000269|PubMed:21084279, ECO:0000269|PubMed:24485656, ECO:0000269|PubMed:24896180}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10399947, ECO:0000269|PubMed:10978364, ECO:0000269|PubMed:11139248, ECO:0000269|PubMed:11241844, ECO:0000269|PubMed:11948477, ECO:0000269|PubMed:12145750, ECO:0000269|PubMed:12373604, ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15026808, ECO:0000269|PubMed:15172753, ECO:0000269|PubMed:15365993, ECO:0000269|PubMed:8640237, ECO:0000269|PubMed:9150152, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9654203, ECO:0000269|PubMed:9971877}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 2 (PNCA2) [MIM:613347]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:9140390}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Breast-ovarian cancer, familial, 2 (BROVCA2) [MIM:612555]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Fanconi anemia complementation group D1 (FANCD1) [MIM:605724]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:12065746, ECO:0000269|PubMed:14670928, ECO:0000269|PubMed:16825431}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glioma 3 (GLM3) [MIM:613029]: Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes. {ECO:0000269|PubMed:15689453}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	114480;605724;612555;613029;613347;	[MIM:114480]Breast cancer;[MIM:613347]Pancreatic cancer 2;[MIM:612555]Breast-ovarian cancer, familial, 2;[MIM:605724]Fanconi anemia complementation group D1;[MIM:613029]Glioma 3;	LDL cholesterol[24097068];Breast cancer[23535733;23535729];Lung cancer[24880342;24880342];	cytokinesis;chromosome breakage;brain development;spermatogenesis;mammary gland development;response to X-ray;positive regulation of transcription, DNA-templated;histone H4 acetylation;DNA repair;histone H3 acetylation;cell aging;multicellular organism growth;double-strand break repair;establishment of protein localization to telomere;double-strand break repair via synthesis-dependent strand annealing;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;inner cell mass cell proliferation;centrosome duplication;male meiosis I;positive regulation of mitotic cell cycle;homologous chromosome orientation involved in meiotic metaphase I plate congression;nucleotide-excision repair;response to estradiol;double-strand break repair via homologous recombination;response to nutrient;response to gamma radiation;hemopoiesis;oocyte maturation;replication fork protection;regulation of cytokinesis;homologous recombination-dependent replication fork processing;response to UV-C;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;female gonad development	nucleus;nuclear chromosome, telomeric region;secretory granule;BRCA2-MAGE-D1 complex;centrosome;nucleoplasm;cytoplasm;protein complex	gamma-tubulin binding;H4 histone acetyltransferase activity;histone acetyltransferase activity;protein binding;protease binding;single-stranded DNA binding;H3 histone acetyltransferase activity	TISSUE SPECIFICITY: Highest levels of expression in breast and thymus, with slightly lower levels in lung, ovary and spleen.; 	.	.	0.0386491604149342	0.789966583251953	0.21840648076363972	350.0	0.0261966250836849	0.627283990383148	0.1532959161153974	227.0	0.00360413757152855	0.508728742599487	0.08873969377660802	145.0	0.0275050234049559	0.439617872238159	0.14775150204409981	224.0	0.0134975835680962	0.434071570634842	0.1415261957458311	133.0	0.00311911990866065	0.625425577163696	0.09565634742597993	332.0	0.0131933083757758	0.346350371837616	0.13482188628139824	11.0	0.0	0.0764816179871559	0.025678130798041824	72.0	0.0	0.089766912162304	0.02264447471437355	84.0	0.0	0.159767091274261	0.02878004898372878	117.0	0.0	0.0668455138802528	0.028201542113951983	105.0	0.00414298707619309	0.096252977848053	0.027465961769223213	125.0	0.00183988490607589	0.144220739603043	0.027416063834128812	114.0	0.0	0.197936370968819	0.029612684359394573	108.0	0.0	0.0860378742218018	0.021427220280995554	94.0	0.0	0.0860995203256607	0.029131149455982566	96.0	0.0	0.0796989724040031	0.02534040163757395	113.0	0.0	0.103563718497753	0.02345568586870567	97.0	0.0	0.254904985427856	0.037821265649129174	71.0	0.00130503869149834	0.0912929400801659	0.027300415592016798	63.0	0.0152158234268427	0.754492402076721	0.17172436485780734	214.0	0.924876928329468	6.95442008972168	4.2121621602672645	118.0	0.0822805389761925	5.31887531280518	1.2939329475531696	284.0	0.0469802878797054	0.51663327217102	0.1733355304847161	6.0	0.0811218246817589	0.214063838124275	0.1291183471679686	5.0	0.00338022876530886	0.19717313349247	0.05506244508999606	149.0	0.0219646636396646	0.766862213611603	0.2041167096729029	196.0	0.0	0.23247866332531	0.05357713536268065	153.0	0.0192123018205166	1.51587378978729	0.36972343315976064	286.0	0.00363687612116337	0.402099043130875	0.05411798112388505	247.0	0.0666519775986671	0.271506130695343	0.11361012856165568	6.0	0.0036618581507355	0.156499445438385	0.04247624001144096	194.0	0.0	0.53164404630661	0.030785672040869815	218.0	0.00811624340713024	0.484728544950485	0.09076629715855232	32.0	0.00217394577339292	0.593903601169586	0.08869283164640057	119.0	0.0242612492293119	1.11004567146301	0.3051230304117781	320.0	0.0430110394954681	0.540771007537842	0.19247657413545408	57.0	0.0	0.106620170176029	0.02000922083876334	430.0	0.0187872592359781	0.38687852025032	0.10597535470917233	304.0	0.0272566229104996	0.341938108205795	0.1153565020943733	97.0	0.010019063949585	0.360765546560287	0.08702453699681843	171.0	0.00478192046284676	0.111925005912781	0.03669655274201944	103.0	0.0196626707911491	0.402852416038513	0.09553105016854012	106.0	0.033243291079998	0.554867744445801	0.2041259383559227	250.0	0.0342679992318153	1.075843334198	0.2125019361199785	357.0	0.0465507991611958	1.1457953453064	0.392270712139593	88.0	0.0803521052002907	1.53617215156555	0.46940724300937003	104.0	0.00582461943849921	1.06559646129608	0.18674498396669875	193.0	0.801662147045135	2.97125601768494	1.600011796798817	172.0	0.0106517914682627	0.327193021774292	0.0850142633899954	323.0	0.0150496633723378	0.242446079850197	0.09555354816502477	83.0	0.0148512851446867	0.642841041088104	0.18005569372326133	96.0	0.00371881085447967	1.29646110534668	0.102415874589154	393.0	24	66	192	0.97144	0.70346	.	3.731883424	99.58716678	-0.142205075	40.50358412	775.59808	5.51436	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	8.96E-02	E	Brca2	limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; tumorigenesis; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 	brca2	spermatocyte	apoptotic	abnormal
17	41215948	.	G	C	17	43063931	G	C	R	G	.	17	41215948	17	38469474	BRCA1	-	CGG	1	2	G	G/G	G/G	ENSG00000012048	ENST00000357654;ENST00000352993;ENST00000468300;ENST00000586385;ENST00000591534;ENST00000493795;ENST00000471181;ENST00000491747;ENST00000484087;ENST00000478531;ENST00000493919	ENSP00000350283;ENSP00000312236;ENSP00000417148;ENSP00000465818;ENSP00000467329;ENSP00000418775;ENSP00000418960;ENSP00000420705;ENSP00000419481;ENSP00000420412;ENSP00000418819	1699;557;595;9;190;1652;1720;595;470;595;549	0.0;0.002;0.001;.;.;0.0;.;0.002;0.001;0.0;0.001	0.91219	D;D;D;.;.;D;.;D;D;D;D	E7EUM2;B4DES0;C6YB45;E7ETR2;P38398-3;Q6IN79;E9PFC7;P38398;P38398-2	.;.;.;.;.;.;.;BRCA1_HUMAN;.	595;548;9;594;596;595;1721;1699;1699	1.0;1.0;1.0;1.0;1.0;1.0;1.0;0.101;1.0	0.89865	D;D;D;D;D;D;D;B;D	1.0;0.999;1.0;1.0;0.999;1.0;1.0;0.025;1.0	0.97092	D;D;D;D;D;D;D;B;D	0.000278	0.46577	D	0.000000	0.99896;0.999828;0.999972;0.999828;0.99977;0.999939;0.999828;0.999828;0.999828;0.999828;0.998674;1;1;0.999269	0.81033	D;D;D;D;D;D;D;D;D;D;D;D;D;N	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;simple_aae	R1699G;R595G;R9G;R190G;R1652G;R1720G;R595G;R557G;R516G;R548G;R1403G;.;.;R1460G	BRCA1_HUMAN	R1699G	3.23	0.89746	M	-2.86;-2.86;-2.86;0.79;-2.86;-2.86;-2.86;-2.86;-2.86;-2.86;-2.86	0.91432	D;D;D;T;D;D;D;D;D;D;D	-0.98;-5.41;-5.22;.;.;-0.97;.;-5.46;-5.32;-2.7;-4.94	0.85510	N;D;D;.;.;N;.;D;D;D;D	NM_007294.3;ENST00000478531;ENST00000471181;ENST00000484087;ENST00000491747;CCDS11459.2;ENST00000352993;NM_007300.3;ENST00000357654;ENST00000493919;NM_007299.3;ENST00000351666;NM_007298.3;ENST00000493795;ENST00000309486;ENST00000346315;ENST00000468300;ENST00000393691;NM_007297.3	R1699G;R595G;R1720G;R470G;R595G;R1652G;R557G;R1720G;R1699G;R549G;R595G;R516G;R595G;R1652G;R1403G;R1460G;R595G;R548G;R1652G	0.907;0.752;0.779;0.741;0.927;0.442;0.929;0.907;0.907;0.928;0.912;0.925;0.924;0.907;0.907;0.918;0.919;0.906;0.907	0.92164	0.8811	0.95420	D	0.8598	0.95334	D	10	0.710699249182	0.97658	D	5.174256	0.69822	25.5	0.99907736619423915	0.97783	0.89724	0.50090	D	AEFBI	c	0.73399494166643	7.622338	0.695724044214695	7.672931	0.81866	0.00162126055490797	0.08758	0.706298	0.60946	0	0.724815	0.89291	0	0.709663	0.75158	0	0.613276	0.41441	0	5.83	4.83	0.61732	3.387000	0.51993	0.980000	0.59709	1.000000	0.71511	1.000000	0.88762	0.0:0.0:0.8338:0.1662	12.433	0.54739	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BRCT domain	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41219631	.	T	G	17	43067614	T	G	K	Q	rs397507239	17	41219631	17	38473157	BRCA1	-	AAA	1	0	T	T/T	T/T	ENSG00000012048	ENST00000357654;ENST00000352993;ENST00000468300;ENST00000591534;ENST00000493795;ENST00000471181;ENST00000491747;ENST00000484087;ENST00000478531;ENST00000493919	ENSP00000350283;ENSP00000312236;ENSP00000417148;ENSP00000467329;ENSP00000418775;ENSP00000418960;ENSP00000420705;ENSP00000419481;ENSP00000420412;ENSP00000418819	1690;548;586;181;1643;1711;586;461;586;540	0.0;0.025;0.017;.;0.0;.;0.022;0.005;0.003;0.006	0.91219	D;D;D;.;D;.;D;D;D;D	E7EUM2;B4DES0;E7ETR2;P38398-3;Q6IN79;E9PFC7;P38398;P38398-2	.;.;.;.;.;.;BRCA1_HUMAN;.	586;539;585;587;586;1712;1690;1690	0.997;0.989;0.994;0.995;0.964;0.994;0.73;0.986	0.68941	D;D;D;D;D;D;P;D	0.972;0.612;0.761;0.747;0.761;0.868;0.066;0.67	0.71043	D;P;P;P;P;P;B;P	0.001193	0.39885	N	0.112911	0.645834;0.916843;0.916843;0.645834;0.645834;0.916843;0.916843;0.916843;0.916843;0.754536;1;1;1;1	0.81033	D;D;D;D;D;D;D;D;D;D;D;D;D;D	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae	K1690Q;K586Q;K181Q;K1643Q;K1711Q;K586Q;K548Q;K507Q;K539Q;K1394Q;.;.;.;.	BRCA1_HUMAN	K1690Q	2.605	0.76452	M	-2.2;-2.2;-2.2;-2.2;-2.2;-2.2;-2.2;-2.2;-2.2;-2.2	0.86901	D;D;D;D;D;D;D;D;D;D	-0.66;-2.56;-2.54;.;-0.65;.;-2.75;-2.68;-1.2;-2.64	0.58361	N;D;D;.;N;.;D;D;N;D	NM_007294.3;ENST00000478531;ENST00000471181;ENST00000484087;ENST00000491747;CCDS11459.2;ENST00000352993;NM_007300.3;ENST00000493919;NM_007299.3;ENST00000351666;NM_007298.3;ENST00000493795;ENST00000309486;ENST00000357654;ENST00000468300;ENST00000393691;NM_007297.3	K1690Q;K586Q;K1711Q;K461Q;K586Q;K1643Q;K548Q;K1711Q;K540Q;K586Q;K507Q;K586Q;K1643Q;K1394Q;K1690Q;K586Q;K539Q;K1643Q	0.663;0.653;0.637;0.624;0.669;0.273;0.678;0.663;0.675;0.682;0.666;0.668;0.663;0.663;0.663;0.652;0.647;0.663	0.68940	0.4624	0.90016	D	0.6951	0.89492	D	10	0.786738699728	0.98333	D	4.020754	0.54036	23.6	0.99476007113602727	0.66357	0.91938	0.54317	D	AEFBI	c	0.405012566446439	4.374386	0.396440814528148	4.333309	0.61569	0.00982258699682715	0.11944	0.706298	0.60946	0	0.724815	0.89291	0	0.709663	0.75158	0	0.683762	0.67193	0	5.24	4.15	0.47809	4.786000	0.61882	0.871000	0.38010	1.000000	0.71511	0.942000	0.41588	0.0:0.0945:0.0:0.9055	7.9183	0.28822	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5	4.118e-05	5	4.127e-05	0	0	0	0	5	5.790e-04	0	0	0	0	0	0	2	1.883e-05	2	1.887e-05	0	0	0	0	2	2.548e-04	0	0	0	0	0	0	5	5.510e-05	5	5.522e-05	0	0	0	0	5	8.894e-04	0	0	0	0	0	0	rs397507239	3	Breast-ovarian cancer, familial 1	0	BRCT domain	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41234451	.	G	C	17	43082434	G	C	R	G	rs41293455	17	41234451	17	38487977	BRCA1	-	CGA	1	2	G	G/G	G/G	ENSG00000012048	ENST00000357654;ENST00000352993;ENST00000468300;ENST00000493795;ENST00000471181;ENST00000491747;ENST00000484087;ENST00000478531;ENST00000493919;ENST00000487825	ENSP00000350283;ENSP00000312236;ENSP00000417148;ENSP00000418775;ENSP00000418960;ENSP00000420705;ENSP00000419481;ENSP00000420412;ENSP00000418819;ENSP00000418212	1443;301;340;1396;1443;340;214;339;293;215	0.116;0.119;0.112;0.116;0.114;0.114;0.116;0.116;0.114;0.116	0.28861	T	E7EUM2;B4DES0;E7ETR2;P38398-3;Q6IN79;E9PFC7;P38398;P38398-2	.;.;.;.;.;.;BRCA1_HUMAN;.	339;293;339;340;340;1443;1443;1443	0.638;0.697;0.03;0.82;0.03;0.03;0.03;0.051	0.43741	P;P;B;P;B;B;B;B	0.118;0.128;0.026;0.228;0.026;0.026;0.018;0.036	0.36410	B	0.532283	0.05260	N	1.299590	1;1;1;1;1;1;1;1;1;1;1;1;1;1	0.08979	N;N;N;N;N;N;N;N;N;N;N;N;N;N	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae	R1443G;R340G;R1396G;R1443G;R340G;R1443G;R301G;R1443G;R260G;R293G;R1147G;.;.;.	BRCA1_HUMAN	R1443G	0	0.06535	N	0.53;0.53;0.53;0.53;0.53;0.53;0.53;0.53;0.53;0.53	0.55105	T;T;T;T;T;T;T;T;T;T	-0.61;-1.16;-0.96;-0.61;-0.6;-0.82;-1.82;-1.82;-1.76;-2.63	0.56421	N;N;N;N;N;N;N;N;N;D	ENST00000491747;ENST00000468300;ENST00000493795;ENST00000309486;ENST00000393691;ENST00000357654;ENST00000461574;ENST00000484087;ENST00000493919;CCDS11459.2;ENST00000352993;ENST00000471181;NM_007300.3;ENST00000487825;NM_007299.3;NM_007298.3;NM_007297.3;NM_007294.3;ENST00000478531;ENST00000346315;ENST00000354071;ENST00000351666	R340G;R340G;R1396G;R1147G;R293G;R1443G;R207G;R214G;R293G;R1396G;R301G;R1443G;R1443G;R215G;R340G;R340G;R1396G;R1443G;R339G;R1443G;R1443G;R260G	0.604;0.645;0.628;0.628;0.624;0.628;0.567;0.589;0.612;0.172;0.074;0.62;0.628;0.595;0.076;0.074;0.628;0.628;0.591;0.628;0.628;0.074	0.66033	-1.0255	0.21904	T	0.0788	0.31350	T	10	0.158035179594	0.83911	D	0.865231	0.17651	9.860	0.93644035699147565	0.22926	0.30120	0.23777	N	AEFDBI	c	-0.933081120196099	0.4797613	-0.921555591841996	0.5911436	0.11409	4.58983170507691E-4	0.07080	0.706298	0.60946	0	0.724815	0.89291	0	0.724815	0.87840	0	0.613276	0.41441	0	5.29	2.27	0.27373	1.527000	0.35356	0.142000	0.22639	0.160000	0.23578	0.001000	0.04339	0.2717:0.0:0.7283:0.0	7.1166	0.24442	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	3	2.471e-05	3	2.471e-05	0	0	0	0	0	0	0	0	3	4.496e-05	0	0	2	1.883e-05	2	1.883e-05	0	0	0	0	0	0	0	0	2	3.681e-05	0	0	3	3.306e-05	3	3.307e-05	0	0	0	0	0	0	0	0	3	7.120e-05	0	0	rs41293455	3|3	Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	1|1	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41243476	.	C	T	17	43091459	C	T	E	K	rs397509136	17	41243476	17	38497002	BRCA1	-	GAG	1	0	C	C/C	C/C	ENSG00000012048	ENST00000357654;ENST00000493795;ENST00000471181;ENST00000354071	ENSP00000350283;ENSP00000418775;ENSP00000418960;ENSP00000326002	1358;1311;1358;1358	0.01;0.011;0.009;0.012	0.57428	D	E7EMP0;E7ERL4;Q5YLB2;E9PFC7;P38398;P38398-2	.;.;.;.;BRCA1_HUMAN;.	1358;1317;1358;1358;1358;1358	0.651;0.799;0.651;0.651;0.255;0.763	0.42948	P;P;P;P;B;P	0.276;0.323;0.276;0.276;0.078;0.466	0.44825	B;B;B;B;B;P	0.059076	0.22339	N	0.400598	0.731402;0.731402;1;1;1;1;1;1;1;1;0.888615;0.888615;0.885863;0.888615	0.81033	D;D;D;D;D;D;D;D;D;D;N;N;N;N	simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;simple_aae;simple_aae;simple_aae;simple_aae	E1358K;E1358K;.;.;.;.;.;.;.;.;E1358K;E1311K;E1358K;E1062K	BRCA1_HUMAN	E1358K	2.43	0.70676	M	-2.16;-2.28;-2.16;-2.27	0.87526	D;D;D;D	-0.58;-0.57;-0.58;-0.58	0.17428	N	NM_007294.3;CCDS11459.2;ENST00000461574;ENST00000471181;ENST00000346315;ENST00000354071;NM_007300.3;ENST00000493795;ENST00000309486;ENST00000357654;NM_007297.3	E1358K;E1311K;E122K;E1358K;E1358K;E1358K;E1358K;E1311K;E1062K;E1358K;E1311K	0.648;0.306;0.567;0.636;0.653;0.653;0.648;0.648;0.648;0.648;0.648	0.66657	0.1403	0.84896	D	0.6349	0.87220	D	10	0.105726121774	0.78179	D	5.398145	0.73160	26.0	0.99707407882417809	0.80916	0.91757	0.53925	D	AEFDBI	c	0.31541115057634	3.859594	0.381225914618566	4.228044	0.60649	0.999995703217924	0.74713	0.706548	0.72963	0	0.653731	0.59439	0	0.724815	0.87840	0	0.683762	0.67193	0	5.31	5.31	0.74966	2.284000	0.42897	0.852000	0.36166	0.982000	0.35277	0.752000	0.32211	0.0:1.0:0.0:0.0	16.293	0.82509	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41243494	.	C	G	17	43091477	C	G	E	Q	.	17	41243494	17	38497020	BRCA1	-	GAA	1	0	C	C/C	C/C	ENSG00000012048	ENST00000357654;ENST00000493795;ENST00000471181;ENST00000354071	ENSP00000350283;ENSP00000418775;ENSP00000418960;ENSP00000326002	1352;1305;1352;1352	0.002	0.72092	D	E7EMP0;E7ERL4;Q5YLB2;E9PFC7;P38398;P38398-2	.;.;.;.;BRCA1_HUMAN;.	1352;1311;1352;1352;1352;1352	0.998;0.998;0.998;0.998;0.296;0.999	0.76378	D;D;D;D;B;D	0.863;0.863;0.81;0.796;0.046;0.907	0.62655	P;P;P;P;B;P	0.014355	0.28545	N	0.248358	0.784836;1;1;1;1;1;1;1;1;0.84149;0.84149;0.732114;0.732114;0.84149	0.81033	D;D;D;D;D;D;D;D;D;N;N;N;N;N	simple_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae	E1352Q;.;.;.;.;.;.;.;.;E1352Q;E1305Q;E1352Q;E1352Q;E1056Q	BRCA1_HUMAN	E1352Q	2.505	0.73163	M	-2.25;-2.38;-2.25;-2.37	0.88313	D;D;D;D	-0.59;-0.58;-0.59;-0.49	0.17635	N	NM_007294.3;CCDS11459.2;ENST00000461574;ENST00000471181;ENST00000346315;ENST00000354071;NM_007300.3;ENST00000493795;ENST00000309486;ENST00000357654;NM_007297.3	E1352Q;E1305Q;E116Q;E1352Q;E1352Q;E1352Q;E1352Q;E1305Q;E1056Q;E1352Q;E1305Q	0.58;0.287;0.507;0.582;0.578;0.578;0.58;0.578;0.578;0.58;0.578	0.61128	-0.8220	0.53837	T	0.1977	0.55313	T	10	0.0463249916954	0.62533	D	5.210504	0.70360	25.6	0.99739029914241339	0.83198	0.81734	0.40786	D	AEFDBI	c	0.153758061271486	3.104544	0.166942774096993	3.025986	0.48435	0.999974177987063	0.49965	0.706548	0.72963	0	0.653731	0.59439	0	0.724815	0.87840	0	0.683762	0.67193	0	4.95	4.95	0.64759	1.079000	0.30170	0.852000	0.36166	0.726000	0.28642	0.540000	0.27766	0.0:1.0:0.0:0.0	15.0377	0.71299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41243494	.	C	T	17	43091477	C	T	E	K	rs80357202	17	41243494	17	38497020	BRCA1	-	GAA	1	0	C	C/C	C/C	ENSG00000012048	ENST00000357654;ENST00000493795;ENST00000471181;ENST00000354071	ENSP00000350283;ENSP00000418775;ENSP00000418960;ENSP00000326002	1352;1305;1352;1352	0.002;0.002;0.001;0.002	0.78421	D	E7EMP0;E7ERL4;Q5YLB2;E9PFC7;P38398;P38398-2	.;.;.;.;BRCA1_HUMAN;.	1352;1311;1352;1352;1352;1352	0.987;0.987;0.987;0.956;0.915;0.992	0.62897	D;D;D;P;P;D	0.755;0.755;0.755;0.537;0.366;0.876	0.60381	P;P;P;P;B;P	0.014355	0.28545	N	0.248358	0.943709;0.627109;0.627109;1;1;1;1;1;1;1;1;0.535975;0.535975;0.535975	0.81033	D;D;D;D;D;D;D;D;D;D;D;N;N;N	simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;simple_aae;simple_aae;simple_aae	E1352K;E1352K;E1352K;.;.;.;.;.;.;.;.;E1352K;E1305K;E1056K	BRCA1_HUMAN	E1352K	2.505	0.73163	M	-2.14;-2.26;-2.14;-2.26	0.87366	D;D;D;D	-0.79;-0.78;-0.79;-0.65	0.21863	N	NM_007294.3;CCDS11459.2;ENST00000461574;ENST00000471181;ENST00000346315;ENST00000354071;NM_007300.3;ENST00000493795;ENST00000309486;ENST00000357654;NM_007297.3	E1352K;E1305K;E116K;E1352K;E1352K;E1352K;E1352K;E1305K;E1056K;E1352K;E1305K	0.656;0.332;0.515;0.644;0.65;0.65;0.656;0.658;0.658;0.656;0.658	0.67047	-0.5677	0.66132	T	0.2326	0.59917	T	10	0.0435373018383	0.61165	D	4.941538	0.66431	25.0	0.99782150375923029	0.86758	0.63765	0.31926	D	AEFDBI	c	0.153758061271486	3.104544	0.166942774096993	3.025986	0.48435	0.999974177987063	0.49965	0.706548	0.72963	0	0.653731	0.59439	0	0.724815	0.87840	0	0.683762	0.67193	0	4.95	4.95	0.64759	1.079000	0.30170	0.852000	0.36166	0.726000	0.28642	0.540000	0.27766	0.0:1.0:0.0:0.0	15.0377	0.71299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0.0	1	1.1627906976744187E-4	5	4.118e-05	5	4.121e-05	0	0	0	0	0	0	0	0	5	7.494e-05	0	0	5	4.708e-05	5	4.711e-05	0	0	0	0	0	0	0	0	5	9.204e-05	0	0	5	5.510e-05	5	5.514e-05	0	0	0	0	0	0	0	0	5	1.187e-04	0	0	.	.	.	.	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41243680	.	T	C	17	43091663	T	C	K	E	rs80357254	17	41243680	17	38497206	BRCA1	-	AAA	1	0	T	T/T	T/T	ENSG00000012048	ENST00000357654;ENST00000493795;ENST00000471181;ENST00000354071	ENSP00000350283;ENSP00000418775;ENSP00000418960;ENSP00000326002	1290;1243;1290;1290	0.312;0.313;0.27;0.242	0.17557	T	E7EMP0;E7ERL4;Q5YLB2;E9PFC7;P38398;P38398-2	.;.;.;.;BRCA1_HUMAN;.	1290;1249;1290;1290;1290;1290	0.0;0.001;0.0;0.001;0.003;0.001	0.10235	B	0.001;0.002;0.001;0.001;0.002;0.003	0.07978	B	0.467883	0.12304	N	0.744645	1;1;1;1;1;1;0.999976;0.999976;0.999976;0.999976;0.999976;0.999976;0.999976;0.999976	0.18614	N;N;N;N;N;N;N;N;N;N;N;N;N;N	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae	K1290E;K1243E;K1290E;K1290E;K1290E;K994E;.;.;.;.;.;.;.;.	BRCA1_HUMAN	K1290E	0.69	0.17010	N	-1.9;-2.03;-1.9;-2.03	0.85624	D;D;D;D	-0.62;-0.6;-0.67;-0.55	0.19305	N	NM_007294.3;CCDS11459.2;ENST00000461574;ENST00000471181;ENST00000346315;ENST00000354071;NM_007300.3;ENST00000493795;ENST00000309486;ENST00000357654;NM_007297.3	K1290E;K1243E;K54E;K1290E;K1290E;K1290E;K1290E;K1243E;K994E;K1290E;K1243E	0.555;0.166;0.476;0.524;0.565;0.565;0.555;0.557;0.557;0.555;0.557	0.59788	-0.7184	0.59570	T	0.3863	0.74182	T	10	0.0934443646411	0.76163	D	-0.451451	0.05834	0.290	0.93509627914623206	0.22723	0.09827	0.15320	N	AEFBI	c	-0.675759025588675	0.8539696	-0.650549132870871	0.971373	0.17916	0.28236511611147	0.18998	0.732398	0.92378	0	0.724815	0.89291	0	0.743671	0.96052	0	0.683762	0.67193	0	5.01	2.68	0.30700	1.286000	0.32660	0.913000	0.42452	0.421000	0.26108	0.542000	0.27801	0.0:0.4136:0.0:0.5864	4.3619	0.10563	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	8.236e-06	1	8.237e-06	0	0	0	0	0	0	0	0	1	1.498e-05	0	0	1	9.415e-06	1	9.416e-06	0	0	0	0	0	0	0	0	1	1.840e-05	0	0	1	1.102e-05	1	1.102e-05	0	0	0	0	0	0	0	0	1	2.373e-05	0	0	.	.	.	.	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41243800	.	C	G	17	43091783	C	G	E	Q	.	17	41243800	17	38497326	BRCA1	-	GAG	1	0	C	C/C	C/C	ENSG00000012048	ENST00000357654;ENST00000493795;ENST00000471181;ENST00000354071	ENSP00000350283;ENSP00000418775;ENSP00000418960;ENSP00000326002	1250;1203;1250;1250	0.408;0.405;0.361;0.339	0.12734	T	E7EMP0;E7ERL4;Q5YLB2;E9PFC7;P38398;P38398-2	.;.;.;.;BRCA1_HUMAN;.	1250;1209;1250;1250;1250;1250	0.359;0.359;0.359;0.119;0.128;0.19	0.32061	B	0.055;0.055;0.055;0.037;0.021;0.082	0.27574	B	0.204371	0.16509	N	0.550372	1;1;1;1;1;1;0.999997;0.999997;0.999997;0.999997;0.999997;0.999997;0.999997;0.999997	0.08979	N;N;N;N;N;N;N;N;N;N;N;N;N;N	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae	E1250Q;E1203Q;E1250Q;E1250Q;E1250Q;E954Q;.;.;.;.;.;.;.;.	BRCA1_HUMAN	E1250Q	1.145	0.29193	L	-0.96;-0.96;-0.96;-0.96	0.75560	T;T;T;T	-0.43;-0.45;-0.45;-0.33	0.14797	N	NM_007294.3;CCDS11459.2;ENST00000461574;ENST00000471181;ENST00000346315;ENST00000354071;NM_007300.3;ENST00000493795;ENST00000309486;ENST00000357654;NM_007297.3	E1250Q;E1203Q;E14Q;E1250Q;E1250Q;E1250Q;E1250Q;E1203Q;E954Q;E1250Q;E1203Q	0.603;0.224;0.339;0.649;0.603;0.603;0.603;0.593;0.593;0.603;0.593	0.66345	-0.9685	0.37522	T	0.2025	0.55988	T	10	0.134611261419	0.81772	D	2.057697	0.30825	16.58	0.7458212585505567	0.10396	0.10639	0.15909	N	AEFGBI	c	-0.814478539495675	0.6341114	-0.850100632096816	0.6883386	0.13086	0.268290638338159	0.18862	0.732398	0.92378	0	0.724815	0.89291	0	0.743671	0.96052	0	0.683762	0.67193	0	5.31	1.01	0.18961	0.505000	0.22189	-0.031000	0.12649	0.000000	0.06329	0.005000	0.08959	0.0:0.4715:0.3859:0.1426	7.9146	0.28801	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41243941	.	G	C	17	43091924	G	C	R	G	rs62625308	17	41243941	17	38497467	BRCA1	-	CGA	1	2	G	G/G	G/G	ENSG00000012048	ENST00000357654;ENST00000493795;ENST00000471181;ENST00000354071	ENSP00000350283;ENSP00000418775;ENSP00000418960;ENSP00000326002	1203;1156;1203;1203	0.024	0.47694	D	E7EMP0;E7ERL4;Q5YLB2;E9PFC7;P38398;P38398-2	.;.;.;.;BRCA1_HUMAN;.	1203;1162;1203;1203;1203;1203	0.135;0.36;0.0;0.088;0.0;0.0	0.32076	B	0.112;0.076;0.001;0.043;0.001;0.003	0.30033	B	0.386105	0.13311	N	0.685267	0.894689;0.894689;0.894689;0.894689;0.894689;0.894689;0.894689;0.894689;1;1;1;1;1;1	0.36020	D;D;D;D;D;D;D;D;N;N;N;N;N;N	without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae	.;.;.;.;.;.;.;.;R1203G;R1156G;R1203G;R1203G;R1203G;R907G	BRCA1_HUMAN	R1203G	0.55	0.14488	N	-1.07;-1.07;-1.07;-1.07	0.76956	T;T;T;T	-2.57;-2.56;-2.62;-2.47	0.56256	D;D;D;N	NM_007294.3;CCDS11459.2;ENST00000471181;ENST00000346315;ENST00000354071;NM_007300.3;ENST00000493795;ENST00000309486;ENST00000357654;NM_007297.3	R1203G;R1156G;R1203G;R1203G;R1203G;R1203G;R1156G;R907G;R1203G;R1156G	0.583;0.185;0.65;0.576;0.576;0.583;0.581;0.591;0.583;0.581	0.66423	-0.6708	0.61820	T	0.3091	0.67980	T	10	0.0653484769138	0.69662	D	2.322668	0.34033	18.31	0.96926067588991827	0.31079	0.26701	0.22848	N	AEFBI	c	-0.637975254412992	0.9197451	-0.639737091055634	0.9871725	0.18184	0.99801105449062	0.36259	0.732398	0.92378	0	0.653731	0.59439	0	0.743671	0.96052	0	0.683762	0.67193	0	5.1	4.13	0.47492	1.162000	0.31184	0.953000	0.55125	0.063000	0.21658	0.008000	0.10423	0.0:0.1487:0.8513:0.0	14.2221	0.65227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41244871	.	T	G	17	43092854	T	G	K	Q	rs80357170	17	41244871	17	38498397	BRCA1	-	AAG	1	0	T	T/T	T/T	ENSG00000012048	ENST00000357654;ENST00000493795;ENST00000471181;ENST00000354071	ENSP00000350283;ENSP00000418775;ENSP00000418960;ENSP00000326002	893;846;893;893	0.086;0.087;0.091;0.096	0.32566	T	E7EMP0;E7ERL4;Q5YLB2;E9PFC7;P38398;P38398-2	.;.;.;.;BRCA1_HUMAN;.	893;852;893;893;893;893	0.411;0.411;0.056;0.03;0.099;0.036	0.33283	B	0.187;0.187;0.038;0.063;0.098;0.037	0.34499	B	0.657411	0.05954	N	1.195290	1;1;1;1;1;1;0.999999;0.999999;0.999999;0.999999;0.999999;0.999999;0.999999;0.999999	0.08979	N;N;N;N;N;N;N;N;N;N;N;N;N;N	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae	K893Q;K846Q;K893Q;K893Q;K893Q;K597Q;.;.;.;.;.;.;.;.	BRCA1_HUMAN	K893Q	1.22	0.30713	L	-1.28;-1.28;-1.28;-1.28	0.79387	T;T;T;T	-0.86;-0.86;-0.9;-0.78	0.24242	N	NM_007294.3;CCDS11459.2;ENST00000471181;ENST00000346315;ENST00000354071;NM_007300.3;ENST00000493795;ENST00000309486;ENST00000357654;NM_007297.3	K893Q;K846Q;K893Q;K893Q;K893Q;K893Q;K846Q;K597Q;K893Q;K846Q	0.554;0.235;0.575;0.574;0.574;0.042;0.564;0.592;0.554;0.428	0.61911	-0.7244	0.59273	T	0.2922	0.66407	T	10	0.0807596659335	0.73628	D	0.335512	0.12630	6.032	0.90561519822841652	0.19231	0.17683	0.19738	N	AEFDGBI	c	-0.842664499558378	0.5949237	-0.857189745715345	0.6785669	0.12918	0.999999867917074	0.74713	0.706548	0.72963	0	0.724815	0.89291	0	0.608884	0.39442	0	0.553451	0.17037	0	4.8	2.44	0.28744	-0.058000	0.11612	0.107000	0.20183	0.000000	0.06329	0.004000	0.08276	0.0:0.0807:0.1543:0.765	6.5587	0.21528	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41244913	.	C	T	17	43092896	C	T	E	K	rs80357251	17	41244913	17	38498439	BRCA1	-	GAA	1	0	C	C/C	C/C	ENSG00000012048	ENST00000357654;ENST00000493795;ENST00000471181;ENST00000354071	ENSP00000350283;ENSP00000418775;ENSP00000418960;ENSP00000326002	879;832;879;879	0.016;0.016;0.015;0.015	0.52440	D	E7EMP0;E7ERL4;Q5YLB2;E9PFC7;P38398;P38398-2	.;.;.;.;BRCA1_HUMAN;.	879;838;879;879;879;879	0.44;0.44;0.974;0.78;0.736;0.907	0.55880	B;B;D;P;P;P	0.34;0.34;0.934;0.474;0.513;0.767	0.65169	B;B;D;P;P;P	0.454092	0.12463	N	0.715421	1;1;1;1;1;1;0.999997;0.999997;0.999997;0.999997;0.999997;0.999997;0.999997;0.999997	0.08979	N;N;N;N;N;N;N;N;N;N;N;N;N;N	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae	E879K;E832K;E879K;E879K;E879K;E583K;.;.;.;.;.;.;.;.	BRCA1_HUMAN	E879K	2.555	0.74789	M	-1.67;-1.67;-1.67;-1.67	0.82819	D;D;D;D	-2.97;-2.96;-3.01;-3.17	0.64320	D	NM_007294.3;CCDS11459.2;ENST00000471181;ENST00000346315;ENST00000354071;NM_007300.3;ENST00000493795;ENST00000309486;ENST00000357654;NM_007297.3	E879K;E832K;E879K;E879K;E879K;E879K;E832K;E583K;E879K;E832K	0.665;0.341;0.661;0.659;0.659;0.302;0.665;0.666;0.665;0.653	0.67675	-0.3553	0.73420	T	0.6148	0.86395	D	10	0.0293976049428	0.52068	D	4.863101	0.65305	24.9	0.99802976600272408	0.88634	0.05448	0.11190	N	AEFDGBI	c	-0.208883235140978	1.851763	-0.330547165073454	1.502508	0.26638	0.999997760129851	0.74713	0.562547	0.31002	0	0.653731	0.59439	0	0.608884	0.39442	0	0.553451	0.17037	0	4.51	1.28	0.20557	0.562000	0.23064	-0.057000	0.12175	0.007000	0.17507	0.256000	0.22885	0.0:0.4014:0.4509:0.1477	4.9599	0.13320	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41245159	.	C	T	17	43093142	C	T	E	K	rs62625306	17	41245159	17	38498685	BRCA1	-	GAA	1	0	C	C/C	C/C	ENSG00000012048	ENST00000357654;ENST00000493795;ENST00000471181;ENST00000354071	ENSP00000350283;ENSP00000418775;ENSP00000418960;ENSP00000326002	797;750;797;797	0.009;0.009;0.011;0.008	0.58573	D	E7EMP0;E7ERL4;Q5YLB2;E9PFC7;P38398;P38398-2	.;.;.;.;BRCA1_HUMAN;.	797;756;797;797;797;797	0.081;0.081;0.029;0.409;0.012;0.356	0.33215	B	0.078;0.078;0.087;0.348;0.193;0.185	0.40974	B	0.622325	0.10758	N	0.815429	1;1;1;1;1;1;0.991961;0.991961;0.991961;0.991961;0.991961;0.991961;0.991961;0.991961	0.23931	N;N;N;N;N;N;N;N;N;N;N;N;N;N	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae	E797K;E750K;E797K;E797K;E797K;E501K;.;.;.;.;.;.;.;.	BRCA1_HUMAN	E797K	1.04	0.26312	L	-0.58;-0.58;-0.58;-0.58	0.71434	T;T;T;T	-0.33;-0.33;-0.36;-0.32	0.13052	N	NM_007294.3;CCDS11459.2;ENST00000471181;ENST00000346315;ENST00000354071;NM_007300.3;ENST00000493795;ENST00000309486;ENST00000357654;NM_007297.3	E797K;E750K;E797K;E797K;E797K;E797K;E750K;E501K;E797K;E750K	0.501;0.184;0.547;0.559;0.559;0.501;0.558;0.126;0.501;0.537	0.59313	-0.7689	0.56946	T	0.2483	0.61787	T	10	0.0986750300511	0.77066	D	1.567933	0.25017	13.68	0.99097915283268523	0.52004	0.20547	0.20870	N	AEFDGBIJ	c	-0.633811201902557	0.9271495	-0.630634491325591	1.000572	0.18413	0.999999987021892	0.74713	0.706548	0.72963	0	0.724815	0.89291	0	0.724815	0.87840	0	0.683762	0.67193	0	5.36	4.39	0.52044	-0.022000	0.12324	0.935000	0.48983	0.000000	0.06329	0.048000	0.16278	0.0:0.8351:0.0:0.1649	9.318	0.36919	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41245239	.	G	A	17	43093222	G	A	S	L	rs80357063	17	41245239	17	38498765	BRCA1	-	TCA	2	0	G	G/G	G/G	ENSG00000012048	ENST00000357654;ENST00000493795;ENST00000471181;ENST00000354071	ENSP00000350283;ENSP00000418775;ENSP00000418960;ENSP00000326002	770;723;770;770	0.324;0.328;0.303;0.277	0.15640	T	E7EMP0;E7ERL4;Q5YLB2;E9PFC7;P38398;P38398-2	.;.;.;.;BRCA1_HUMAN;.	770;729;770;770;770;770	0.046;0.046;0.005;0.008;0.092;0.451	0.34242	B	0.04;0.04;0.029;0.074;0.282;0.363	0.41503	B	0.190103	0.16858	N	0.501171	1;1;1;1;1;1;0.999998;0.999998;0.999998;0.999998;0.999998;0.999998;0.999998;0.999998	0.08979	N;N;N;N;N;N;N;N;N;N;N;N;N;N	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae	S770L;S723L;S770L;S770L;S770L;S474L;.;.;.;.;.;.;.;.	BRCA1_HUMAN	S770L	1.48	0.37256	L	-1.19;-1.19;-1.19;-1.19	0.78436	T;T;T;T	-3.42;-3.42;-3.47;-4.22	0.75817	D	NM_007294.3;CCDS11459.2;ENST00000471181;ENST00000346315;ENST00000354071;NM_007300.3;ENST00000493795;ENST00000309486;ENST00000357654;NM_007297.3	S770L;S723L;S770L;S770L;S770L;S770L;S723L;S474L;S770L;S723L	0.61;0.152;0.609;0.62;0.62;0.61;0.604;0.152;0.61;0.605	0.64091	-0.7813	0.56257	T	0.3178	0.68757	T	10	0.0887800332129	0.75290	D	1.507051	0.24331	13.35	0.9757493092732209	0.34168	0.09203	0.14836	N	AEFDGBIJ	c	-0.657656997234428	0.8853075	-0.651999863984626	0.9692457	0.17882	0.999998004102224	0.74713	0.706548	0.72963	0	0.724815	0.89291	0	0.724815	0.87840	0	0.683762	0.67193	0	5.14	1.72	0.23384	1.107000	0.30514	1.048000	0.71291	0.016000	0.19054	0.908000	0.38594	0.2902:0.0:0.7098:0.0	8.9766	0.34914	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs80357063	5	Breast-ovarian cancer, familial 1	0	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41245390	.	C	T	17	43093373	C	T	E	K	rs80356875	17	41245390	17	38498916	BRCA1	-	GAA	1	0	C	C/C	C/C	ENSG00000012048	ENST00000357654;ENST00000493795;ENST00000471181;ENST00000354071	ENSP00000350283;ENSP00000418775;ENSP00000418960;ENSP00000326002	720;673;720;720	0.054;0.053;0.046;0.077	0.40524	T;T;D;T	E7EMP0;E7ERL4;Q5YLB2;E9PFC7;P38398;P38398-2	.;.;.;.;BRCA1_HUMAN;.	720;679;720;720;720;720	0.248;0.248;0.999;0.997;0.372;0.712	0.76378	B;B;D;D;B;P	0.103;0.103;0.992;0.977;0.678;0.395	0.78993	B;B;D;D;P;B	0.244106	0.15638	N	0.607423	1;1;1;1;1;1;0.999999;0.999999;0.999999;0.999999;0.999999;0.999999;0.999999;0.999999	0.08979	N;N;N;N;N;N;N;N;N;N;N;N;N;N	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae	E720K;E673K;E720K;E720K;E720K;E424K;.;.;.;.;.;.;.;.	BRCA1_HUMAN	E720K	2.695	0.79132	M	-1.45;-1.45;-1.45;-1.45	0.80912	T;T;T;T	-3.2;-3.24;-3.23;-3.5	0.68133	D	NM_007294.3;CCDS11459.2;ENST00000471181;ENST00000346315;ENST00000354071;NM_007300.3;ENST00000493795;ENST00000309486;ENST00000357654;NM_007297.3	E720K;E673K;E720K;E720K;E720K;E720K;E673K;E424K;E720K;E673K	0.765;0.32;0.753;0.708;0.706;0.765;0.735;0.367;0.765;0.735	0.75819	-0.2594	0.76121	T	0.6323	0.87116	D	10	0.275987676031	0.90092	D	3.365368	0.46289	22.9	0.99779592853469534	0.86582	0.12301	0.16997	N	AEFGBI	c	-0.156102354541634	2.003174	-0.275773406034856	1.614852	0.28386	0.999977899531037	0.49965	0.6512	0.46512	0	0.653731	0.59439	0	0.608884	0.39442	0	0.683762	0.67193	0	5.51	3.5	0.39021	0.574000	0.23244	0.070000	0.17697	0.004000	0.16453	0.002000	0.06231	0.0:0.7742:0.0:0.2258	9.1908	0.36172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2	1.647e-05	2	1.650e-05	0	0	0	0	0	0	0	0	2	2.999e-05	0	0	1	9.416e-06	1	9.429e-06	0	0	0	0	0	0	0	0	1	1.841e-05	0	0	2	2.204e-05	2	2.208e-05	0	0	0	0	0	0	0	0	2	4.750e-05	0	0	.	.	.	.	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41256153	.	C	T	17	43104136	C	T	E	K	rs80356991	17	41256153	17	38509679	BRCA1	-	GAA	1	0	C	C/C	C/C	ENSG00000012048	ENST00000357654;ENST00000352993;ENST00000468300;ENST00000493795;ENST00000471181;ENST00000491747;ENST00000484087;ENST00000478531;ENST00000493919;ENST00000487825;ENST00000354071;ENST00000470026;ENST00000477152;ENST00000494123;ENST00000476777	ENSP00000350283;ENSP00000312236;ENSP00000417148;ENSP00000418775;ENSP00000418960;ENSP00000420705;ENSP00000419481;ENSP00000420412;ENSP00000418819;ENSP00000418212;ENSP00000326002;ENSP00000419274;ENSP00000419988;ENSP00000419103;ENSP00000417554	143;143;143;96;143;143;59;143;96;59;143;143;117;143;143	0.096;0.191;0.367;0.099;0.083;0.38;0.293;0.171;0.36;0.196;0.062;0.105;0.074;0.08;0.206	0.36865	T	E7EUM2;B4DES0;E7ETR2;E7EMP0;E7ERL4;Q5YLB2;P38398-3;Q6IN79;E9PFC7;P38398;P38398-2	.;.;.;.;.;.;.;.;.;BRCA1_HUMAN;.	143;96;143;143;143;143;143;143;143;143;143	0.996;0.022;0.982;0.083;0.083;0.083;0.989;0.047;0.083;0.019;0.135	0.67003	D;B;D;B;B;B;D;B;B;B;B	0.539;0.006;0.559;0.012;0.012;0.012;0.744;0.007;0.012;0.006;0.016	0.54008	P;B;P;B;B;B;P;B;B;B;B	0.047381	0.23336	N	0.365958	1;1;1;1;1;1;1;1;1;1;0.999807;0.999807;0.999807;0.996723	0.22900	N;N;N;N;N;N;N;N;N;N;N;N;N;N	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae	E143K;E143K;E96K;E143K;E143K;E143K;E143K;E143K;E143K;E96K;.;.;.;.	BRCA1_HUMAN	E143K	1.5	0.37962	L	-2.27;-2.34;-2.21;-2.41;-2.28;-2.39;-2.02;-3.1;-2.3;-1.81;-2.39;-2.85;-4.29;-2.52;-3.1	0.97152	D;D;D;D;D;D;D;D;D;D;D;D;D;D;D	-0.32;-1.27;-1.1;-0.32;-0.34;-1.2;-0.67;-0.9;-1.02;-1.45;-0.32;-0.4;-0.34;-0.65;-1.81	0.42543	N	ENST00000470026;ENST00000491747;ENST00000468300;ENST00000493795;ENST00000393691;ENST00000357654;ENST00000484087;ENST00000493919;CCDS11459.2;ENST00000352993;ENST00000471181;NM_007300.3;ENST00000473961;ENST00000487825;ENST00000476777;NM_007299.3;NM_007298.3;NM_007297.3;NM_007294.3;ENST00000478531;ENST00000346315;ENST00000354071;ENST00000351666;ENST00000477152;ENST00000494123	E143K;E143K;E143K;E96K;E96K;E143K;E59K;E96K;E96K;E143K;E143K;E143K;E50K;E59K;E143K;E143K;E143K;E96K;E143K;E143K;E143K;E143K;E143K;E117K;E143K	0.597;0.661;0.09;0.637;0.65;0.076;0.69;0.644;0.207;0.084;0.609;0.076;0.676;0.687;0.683;0.076;0.084;0.078;0.076;0.69;0.076;0.076;0.084;0.663;0.6	0.69577	0.5017	0.90574	D	0.8767	0.95906	D	10	0.247707432623	0.89019	D	2.694995	0.38497	20.8	0.99087417036739323	0.51731	0.52521	0.28903	D	AEFBI	c	-0.366331149050496	1.457724	-0.342651888589345	1.478785	0.26268	9.14332313089864E-5	0.04969	0.706298	0.60946	0	0.653731	0.59439	0	0.709663	0.75158	0	0.635551	0.52750	0	5.32	3.28	0.36535	1.938000	0.39596	0.060000	0.16638	0.861000	0.30385	0.174000	0.21114	0.0:0.7452:0.163:0.0918	7.6425	0.27303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12	9.884e-05	12	9.885e-05	0	0	1	8.637e-05	5	5.780e-04	0	0	5	7.493e-05	1	6.057e-05	10	9.415e-05	10	9.417e-05	0	0	1	8.916e-05	5	6.360e-04	0	0	3	5.521e-05	1	6.095e-05	8	8.815e-05	8	8.817e-05	0	0	1	8.646e-05	2	3.550e-04	0	0	4	9.494e-05	1	6.061e-05	rs80356991	2|3|2	Breast-ovarian cancer, familial 1|Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	3|1|1	.	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41258474	.	T	C	17	43106457	T	C	R	G	rs80357382	17	41258474	17	38512000	BRCA1	-	AGG	1	2	T	T/T	T/T	ENSG00000012048	ENST00000357654;ENST00000352993;ENST00000468300;ENST00000493795;ENST00000471181;ENST00000491747;ENST00000478531;ENST00000493919;ENST00000354071;ENST00000470026;ENST00000494123;ENST00000476777	ENSP00000350283;ENSP00000312236;ENSP00000417148;ENSP00000418775;ENSP00000418960;ENSP00000420705;ENSP00000420412;ENSP00000418819;ENSP00000326002;ENSP00000419274;ENSP00000419103;ENSP00000417554	71;71;71;24;71;71;71;24;71;71;71;71	0.0;0.0;0.01;0.0;0.0;0.0;0.006;0.0;0.0;0.0;0.0;0.0	0.91219	D	B4DES0;E7ETR2;Q5YLB2;P38398-3;Q6IN79;E9PFC7;P38398	.;.;.;.;.;.;BRCA1_HUMAN	24;71;71;71;71;71;71	0.997;0.965;0.999;0.979;1.0;1.0;0.956	0.89865	D;D;D;D;D;D;P	0.954;0.834;0.997;0.946;0.994;0.996;0.444	0.85043	D;P;D;D;D;D;B	0.000039	0.55863	D	0.000000	0.999829;0.999829;0.997653;0.978538;0.997653;1;1;1;1;0.985735;0.985735;0.788144;0.865619;0.983619	0.81033	D;D;D;D;D;D;D;D;D;N;N;N;N;N	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae	R71G;R71G;R71G;R24G;R71G;.;.;.;.;R71G;R71G;R71G;R71G;R24G	BRCA1_HUMAN	R71G	2.455	0.71470	M	-3.11;-3.11;-3.11;-1.98;-3.11;-3.11;-3.11;-1.98;-3.11;-3.11;-3.11;-3.11	0.92729	D;D;D;D;D;D;D;D;D;D;D;D	-0.92;-1.4;-2.18;-0.93;-0.97;-1.74;-4.16;-1.05;-0.68;-0.83;-1.54;-6.67	0.92327	N;N;N;N;N;N;D;N;N;N;N;D	NM_007294.3;ENST00000478531;ENST00000471181;ENST00000470026;ENST00000491747;ENST00000354071;CCDS11459.2;ENST00000352993;NM_007300.3;ENST00000357654;ENST00000476777;ENST00000493919;NM_007299.3;ENST00000351666;NM_007298.3;ENST00000393691;ENST00000493795;ENST00000346315;ENST00000468300;ENST00000494123;NM_007297.3	R71G;R71G;R71G;R71G;R71G;R71G;R24G;R71G;R71G;R71G;R71G;R24G;R71G;R71G;R71G;R24G;R24G;R71G;R71G;R71G;R24G	0.914;0.694;0.845;0.905;0.913;0.885;0.332;0.872;0.914;0.914;0.711;0.907;0.872;0.872;0.872;0.909;0.863;0.885;0.86;0.921;0.835	0.91255	0.8364	0.94863	D	0.8394	0.94633	D	10	0.80065969883	0.98449	D	3.922859	0.52835	23.5	0.99887384451911465	0.96172	0.96450	0.68991	D	AEFBI	c	0.586117233560111	5.78522	0.5471513750929	5.618586	0.71240	0.0121160743239522	0.12304	0.6512	0.46512	0	0.708844	0.79302	0	0.658983	0.55576	0	0.683762	0.67193	0	4.64	4.64	0.57239	4.160000	0.57705	0.895000	0.41053	1.000000	0.71511	0.999000	0.74975	0.0:0.0:0.0:1.0	11.8302	0.51380	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs80357382	5|5|5	Breast-ovarian cancer, familial 1|not provided|Hereditary cancer-predisposing syndrome	1|1|1	Zinc finger, RING/FYVE/PHD-type	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
17	41267761	.	C	T	17	43115744	C	T	C	Y	rs80357498	17	41267761	17	38521287	BRCA1	-	TGT	2	0	C	C/C	C/C	ENSG00000012048	ENST00000357654;ENST00000352993;ENST00000468300;ENST00000471181;ENST00000491747;ENST00000478531;ENST00000354071;ENST00000470026;ENST00000477152;ENST00000494123;ENST00000476777;ENST00000489037	ENSP00000350283;ENSP00000312236;ENSP00000417148;ENSP00000418960;ENSP00000420705;ENSP00000420412;ENSP00000326002;ENSP00000419274;ENSP00000419988;ENSP00000419103;ENSP00000417554;ENSP00000420781	39	0.0;0.0;0.0;0.0;0.0;0.0;0.0;0.0;0.0;0.0;0.0;0.003	0.91219	D	E7ETR2;E7EMP0;Q5YLB2;P38398-3;Q6IN79;E9PFC7;P38398	.;.;.;.;.;.;BRCA1_HUMAN	39	1.0;1.0;1.0;1.0;1.0;1.0;0.996	0.89865	D	1.0;1.0;1.0;0.999;1.0;1.0;0.942	0.97092	D	0.000038	0.55863	D	0.000000	0.00890293;0.651086;0.999724;0.996224;0.999724;0.00890293;0.0878949;0.996224;1;1;1;1;1;1	0.81033	A;A;A;A;A;A;A;A;A;A;A;A;A;A	simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;simple_aae;without_aae;without_aae;without_aae;without_aae;without_aae;without_aae	C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;.;.;.;.;.;.	BRCA1_HUMAN	C39Y	4.01	0.96887	H	-6.43;-6.43;-6.43;-6.43;-6.43;-6.43;-6.43;-6.43;-6.43;-6.43;-6.43;0.55	0.99691	D;D;D;D;D;D;D;D;D;D;D;T	-1.66;-1.69;-2.37;-1.77;-2.01;-5.52;-1.29;-1.56;-1.48;-2.56;-10.36;-9.83	0.98988	N;N;N;N;N;D;N;N;N;D;D;D	NM_007294.3;ENST00000478531;ENST00000468300;ENST00000471181;ENST00000470026;ENST00000491747;ENST00000461221;ENST00000352993;NM_007300.3;ENST00000354071;ENST00000351666;ENST00000461798;ENST00000476777;NM_007299.3;ENST00000492859;NM_007298.3;ENST00000489037;ENST00000357654;ENST00000477152;ENST00000494123;ENST00000346315	C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y;C39Y	0.997;0.761;0.97;0.891;0.96;0.963;0.976;0.98;0.997;0.997;0.98;0.978;0.752;0.98;0.969;0.98;0.768;0.997;0.729;0.971;0.997	0.99915	0.9542	0.96460	D	0.9936	0.99852	D	10	0.830040555038	0.98690	D	6.689001	0.91553	32	0.99644327330626759	0.76689	0.89461	0.49655	D	AEFBI	c	1.02349914216731	14.67569	0.931298372454074	15.15955	0.96321	0.999493915182735	0.39945	0.732398	0.92378	0	0.743671	0.97427	0	0.709663	0.75158	0	0.655142	0.61628	0	5.97	5.97	0.96923	3.475000	0.52653	0.935000	0.48983	1.000000	0.71511	1.000000	0.88762	0.0:1.0:0.0:0.0	15.9389	0.79435	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs80357498	5|5	Hereditary cancer-predisposing syndrome|not provided	1|1	Zinc finger, C3HC4 RING-type|Zinc finger, RING-type|Zinc finger, RING-type, conserved site|Zinc finger, RING/FYVE/PHD-type;Zinc finger, C3HC4 RING-type|Zinc finger, RING/FYVE/PHD-type;Zinc finger, RING/FYVE/PHD-type	.	.	.	RNF53;BRCC1;PPP1R53;FANCS	P38398	BRCA1_HUMAN	672	CCDS11453;CCDS11454;CCDS11455;CCDS11456;CCDS11459;CCDS11455;CCDS11456;CCDS11459;CCDS11454	NM_007300;NM_007294	uc002ict.3	113705	breast cancer 1	PATHWAY: Protein modification; protein ubiquitination.; 	atmPathway;bard1Pathway;g2Pathway;atrbrcaPathway	ATM Signaling Pathway;BRCA1-dependent Ub-ligase activity;Cell Cycle: G2/M Checkpoint;Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility	Fanconi anemia pathway - Homo sapiens (human);PI3K-Akt signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);MicroRNAs in cancer - Homo sapiens (human);Androgen receptor signaling pathway;miRNA Regulation of DNA Damage Response;Signaling Pathways in Glioblastoma;Integrated Pancreatic Cancer Pathway;DNA Damage Response;brca1 dependent ub ligase activity;atm signaling pathway;Cell Cycle;Validated targets of C-MYC transcriptional repression;DNA Double Strand Breaks Response;G2/M DNA damage checkpoint;Double-Strand Break Repair;ATF-2 transcription factor network;TGF_beta_Receptor;ATM mediated phosphorylation of repair proteins;ATM mediated response to DNA double-strand break;Recruitment of repair and signaling proteins to double-strand breaks;Fanconi Anemia pathway;Homologous recombination repair of replication-independent double-strand breaks;Homologous Recombination Repair;G2/M Checkpoints;Cell Cycle Checkpoints;DNA Repair;SUMOylation;AndrogenReceptor;Validated nuclear estrogen receptor alpha network;Fanconi anemia pathway;Coregulation of Androgen receptor activity;BARD1 signaling events;FOXA1 transcription factor network;Aurora A signaling;ATM pathway;E2F transcription factor network;Meiotic synapsis;Meiosis;Post-translational protein modification;Metabolism of proteins;SUMOylation of DNA damage response and repair proteins;SUMO E3 ligases SUMOylate target proteins;role of brca1 brca2 and atr in cancer susceptibility;cell cycle: g2/m checkpoint	hsa04120	Ubiquitin mediated proteolysis	FUNCTION: E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). {ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165, ECO:0000269|PubMed:14990569, ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:20364141}.; 	DISEASE: Breast cancer (BC) [MIM:114480]: A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type. Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case. {ECO:0000269|PubMed:10323242, ECO:0000269|PubMed:12442275, ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:18285836, ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493, ECO:0000269|PubMed:7939630, ECO:0000269|PubMed:8554067, ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600, ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997, ECO:0000269|PubMed:9760198}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for 45% of inherited breast cancer. Moreover, BRCA1 carriers have a 4-fold increased risk of colon cancer, whereas male carriers face a 3- fold increased risk of prostate cancer. Cells lacking BRCA1 show defects in DNA repair by homologous recombination.; DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]: A condition associated with familial predisposition to cancer of the breast and ovaries. Characteristic features in affected families are an early age of onset of breast cancer (often before age 50), increased chance of bilateral cancers (cancer that develop in both breasts, or both ovaries, independently), frequent occurrence of breast cancer among men, increased incidence of tumors of other specific organs, such as the prostate. {ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:8968716}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Mutations in BRCA1 are thought to be responsible for more than 80% of inherited breast-ovarian cancer.; DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease. {ECO:0000269|PubMed:10196379, ECO:0000269|PubMed:10486320, ECO:0000269|PubMed:14746861}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	114480;167000;604370;614320;	[MIM:114480]Breast cancer;[MIM:604370]Breast-ovarian cancer, familial, 1;[MIM:167000]Ovarian cancer;[MIM:614320]Pancreatic cancer 4;	.	positive regulation of transcription from RNA polymerase II promoter;negative regulation of centriole replication;cellular response to tumor necrosis factor;response to estrogen;regulation of gene expression by genetic imprinting;positive regulation of protein import into nucleus, translocation;regulation of apoptotic process;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K4 methylation;positive regulation of histone H3-K9 acetylation;chromosome segregation;positive regulation of cell cycle arrest;positive regulation of vascular endothelial growth factor production;negative regulation of reactive oxygen species metabolic process;regulation of DNA methylation;positive regulation of DNA repair;intrinsic apoptotic signaling pathway in response to DNA damage;double-strand break repair via nonhomologous end joining;DNA replication;regulation of transcription from RNA polymerase III promoter;cell cycle;androgen receptor signaling pathway;brain development;protein ubiquitination;regulation of transcription from RNA polymerase II promoter;centrosome cycle;protein autoubiquitination;apoptotic process;positive regulation of angiogenesis;protein sumoylation;transcription, DNA-templated;double-strand break repair via homologous recombination;response to estradiol;postreplication repair;protein K6-linked ubiquitination;negative regulation of histone H3-K4 methylation;dosage compensation by inactivation of X chromosome;positive regulation of gene expression;positive regulation of histone H4-K16 acetylation;DNA recombination;DNA repair;positive regulation of protein ubiquitination;positive regulation of histone H3-K9 methylation;chromosome breakage;fatty acid biosynthetic process;double-strand break repair via synthesis-dependent strand annealing;positive regulation of histone acetylation;negative regulation of intracellular estrogen receptor signaling pathway;chordate embryonic development;cellular response to DNA damage stimulus;response to nutrient;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;positive regulation of histone H4-K20 methylation;cellular protein metabolic process;negative regulation of histone acetylation;positive regulation of transcription, DNA-templated;cellular response to indole-3-methanol;regulation of cell proliferation;negative regulation of fatty acid biosynthetic process;response to ionizing radiation;negative regulation of transcription, DNA-templated;post-translational protein modification;double-strand break repair;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;G2 DNA damage checkpoint	plasma membrane;chromosome;BRCA1-BARD1 complex;condensed nuclear chromosome;mitochondrial matrix;cytoplasm;intracellular ribonucleoprotein complex;gamma-tubulin ring complex;BRCA1-A complex;protein complex;nucleus;nucleoplasm;integral component of membrane;ubiquitin ligase complex	chromatin binding;zinc ion binding;ubiquitin protein ligase binding;enzyme binding;ubiquitin-protein transferase activity;damaged DNA binding;protein binding;ligase activity;tubulin binding;androgen receptor binding;transcription regulatory region DNA binding;transcription coactivator activity;RNA binding;DNA binding	TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed. Isoform 3 is reduced or absent in several breast and ovarian cancer cell lines.; 	unclassifiable (Anatomical System);lymph node;ovary;islets of Langerhans;colon;skin;skeletal muscle;breast;bile duct;prostate;lung;endometrium;bone;placenta;visual apparatus;liver;testis;cervix;spleen;germinal center;kidney;brain;mammary gland;stomach;	dorsal root ganglion;superior cervical ganglion;testis;appendix;tumor;ciliary ganglion;atrioventricular node;pons;skeletal muscle;	0.110748410224915	1.62656819820404	0.6815141179731914	350.0	0.112919621169567	1.58927667140961	0.5698482189737752	227.0	0.0564291551709175	1.42357921600342	0.5950638822440444	145.0	0.123602874577045	1.12963998317719	0.4382053774315864	224.0	0.144251883029938	1.24127876758575	0.5145188650690523	133.0	0.0765886083245277	1.38521778583527	0.40839477186371764	332.0	0.634433388710022	0.973698556423187	0.8127289847894148	11.0	0.38342696428299	1.78218579292297	0.7472516890201301	72.0	0.197296261787415	1.78453159332275	0.43176961388616325	84.0	0.364046066999435	1.68806374073029	0.7771647180247511	117.0	0.123368978500366	0.601548135280609	0.2961417571419761	105.0	0.1640984416008	0.650766670703888	0.3570550551414489	125.0	0.200994446873665	2.25858950614929	0.5986020284002286	114.0	0.224362373352051	1.72004020214081	0.5121547702561927	108.0	0.189631402492523	2.15776896476746	0.8103053909032905	94.0	0.201691761612892	2.17292904853821	0.7418271646214029	96.0	0.158817961812019	1.61729538440704	0.6238999750498123	113.0	0.391434490680695	1.59575438499451	0.7933568146425424	97.0	0.213226437568665	2.20462942123413	1.2030287124741248	71.0	0.331096738576889	2.4402163028717	1.0731643783667728	63.0	0.109202444553375	1.49408626556396	0.6559944893712195	214.0	2.29216766357422	16.6480503082275	8.555951437707675	118.0	0.475273668766022	10.0711135864258	2.660816415304869	284.0	0.415969878435135	2.37516260147095	0.9404425173997883	6.0	0.467727512121201	1.19011414051056	0.7518904030323033	5.0	0.199393466114998	1.81734275817871	0.9514109549306383	149.0	0.168556779623032	3.51433253288269	1.0875571662826196	196.0	0.195299759507179	1.72464466094971	0.7613869977542778	153.0	0.272278606891632	5.8099570274353	1.4384961607572915	286.0	0.200209334492683	1.48971378803253	0.784289249765728	247.0	0.482896715402603	1.23497486114502	0.821666931112607	6.0	0.0666551366448402	1.74000680446625	0.7399788242332712	194.0	0.0794388428330421	2.19961762428284	0.700118646811728	218.0	0.0746229812502861	2.49481463432312	0.43638359126634907	32.0	0.0586989037692547	3.54525637626648	0.8234651454043486	119.0	0.0673296973109245	3.44296813011169	0.8331399056129157	320.0	0.089990384876728	1.37970089912415	0.62851142425809	57.0	0.0288423504680395	1.6231050491333	0.49199992744468674	430.0	0.198915541172028	1.98409187793732	0.9644635464800032	304.0	0.211225643754005	1.16977202892303	0.6466391764043532	97.0	0.0942205041646957	1.28646421432495	0.3733470522695118	171.0	0.130182847380638	3.77595353126526	1.214564916144297	103.0	0.178591549396515	1.69133794307709	0.6497037916813256	106.0	0.101550154387951	2.08872056007385	0.9048522709906102	250.0	0.173532351851463	2.54890298843384	0.8078638449603436	357.0	0.238402798771858	3.82696008682251	1.11065989817408	88.0	0.567279040813446	2.53296136856079	1.2402174071623726	104.0	0.0899865999817848	2.64910960197449	0.7556981061792745	193.0	1.76059293746948	8.73015975952148	5.464834859204847	172.0	0.173231944441795	9.70385265350342	2.4337903918127526	323.0	0.378877371549606	1.59695386886597	0.852439240518823	83.0	0.24253012239933	2.18691515922546	0.9559511848104497	96.0	0.0356383770704269	2.65895009040833	0.5852046977283087	393.0	81	510	791	0.99897	0.94795	.	0.464695413	78.59754659	-0.546858258	20.09517499	3823.01219	12.15413	Medium	Medium	Medium	Medium	Medium	High	Medium	High	Medium	High	2.07E-03	E	Brca1	mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); normal phenotype; reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; tumorigenesis; pigmentation phenotype; embryogenesis phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; muscle phenotype; digestive/alimentary phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; 	.	.	.	.
7	117149123	.	C	T	7	117509069	C	T	P	L	rs368505753	7	117149123	7	116936359	CFTR	+	CCT	2	0	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	67	0.0	0.91219	D	P13569	CFTR_HUMAN	67	1.0	0.89865	D	0.999	0.91584	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	P67L;P67L	CFTR_HUMAN	P67L	3.95	0.96525	H	-3.08;-3.08	0.92568	D;D	-7.08	0.93914	D	ENST00000454343;NM_000492.3;ENST00000426809	P67L;P67L;P67L	0.956;0.956;0.66	0.95332	1.0572	0.98277	D	0.9225	0.97437	D	10	0.582214991557	0.96276	D	7.051307	0.93955	33	0.99867956776964828	0.94502	0.95358	0.64176	D	AEFGI	c	0.982546078411875	13.3833	0.905075770743637	13.97096	0.95332	0.999999954390332	0.74713	0.487112	0.13308	0	0.573888	0.26071	0	0.573888	0.22998	0	0.564101	0.26208	0	5.68	5.68	0.87975	6.124000	0.71148	0.892000	0.40251	1.000000	0.71511	0.992000	0.56220	0.0:1.0:0.0:0.0	19.7786	0.96389	.	.	.	.	.	.	.	.	.	.	.	.	1	2.6968716289104636E-4	0	0.0	0	0.0	1	1.1627906976744187E-4	4	3.295e-05	4	3.299e-05	0	0	0	0	0	0	0	0	4	5.998e-05	0	0	4	3.766e-05	4	3.770e-05	0	0	0	0	0	0	0	0	4	7.364e-05	0	0	4	4.408e-05	4	4.415e-05	0	0	0	0	0	0	0	0	4	9.503e-05	0	0	rs368505753	5	Cystic fibrosis	3	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117171005	.	A	G	7	117530951	A	G	Y	C	rs121909031	7	117171005	7	116958241	CFTR	+	TAT	2	0	A	A/A	A/A	ENSG00000001626	ENST00000446805;ENST00000003084;ENST00000426809	ENSP00000417012;ENSP00000003084;ENSP00000389119	28;109;109	0.0;0.001;0.001	0.91219	D	P13569	CFTR_HUMAN	109	1.0	0.89865	D	0.992	0.78993	D	0.000000	0.84324	D	0.050027	0.999995;0.999376	0.58814	D;D	simple_aae;simple_aae	Y109C;Y109C	CFTR_HUMAN	Y109C	1.845	0.48827	L	-6.1;-2.61;-2.92	0.99526	D;D;D	-7.77;-4.05;-4.05	0.95829	D	ENST00000454343;ENST00000446805;NM_000492.3;ENST00000426809	Y109C;Y28C;Y109C;Y109C	0.96;0.59;0.96;0.717	0.95814	1.0674	0.98523	D	0.9814	0.99431	D	10	0.839762204934	0.98769	D	5.791118	0.79206	27.1	0.99807581333407269	0.89084	0.95145	0.63367	D	AEFI	c	0.717326833619516	7.368012	0.705060920282935	7.848254	0.82562	0.999263853624541	0.38878	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.564101	0.26208	0	5.73	5.73	0.89690	6.592000	0.73792	1.199000	0.96014	1.000000	0.71511	0.995000	0.60354	1.0:0.0:0.0:0.0	16.3143	0.82663	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs121909031	5	Cystic fibrosis	0	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117175317	.	C	T	7	117535263	C	T	H	Y	rs121908802	7	117175317	7	116962553	CFTR	+	CAT	1	0	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	199;169	0.006;0.002	0.72092	D	P13569	CFTR_HUMAN	199	1.0	0.89865	D	0.999	0.91584	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	H199Y;H199Y	CFTR_HUMAN	H199Y	2.915	0.84490	M	-2.5;-2.5	0.89234	D;D	-3.42;-3.66	0.70022	D	ENST00000454343;NM_000492.3;ENST00000426809	H199Y;H199Y;H169Y	0.981;0.981;0.449	0.98362	0.8556	0.95100	D	0.8463	0.94873	D	10	0.687919564382	0.97438	D	6.662652	0.91310	32	0.99842879435228715	0.92252	0.99028	0.90102	D	AEFI	c	0.895088366160234	10.9238	0.849711265663592	11.76158	0.92594	0.999999999987643	0.74713	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.613276	0.41441	0	5.52	5.52	0.82084	7.519000	0.80566	0.852000	0.36166	1.000000	0.71511	0.976000	0.47648	0.0:1.0:0.0:0.0	19.4464	0.94820	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs121908802	5	Cystic fibrosis	3	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117175335	.	C	T	7	117535281	C	T	P	S	rs121908803	7	117175335	7	116962571	CFTR	+	CCT	1	0	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	205;175	0.0	0.91219	D	P13569	CFTR_HUMAN	205	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	P205S;P205S	CFTR_HUMAN	P205S	3.03	0.86670	M	-2.87;-2.87	0.91488	D;D	-6.51	0.91634	D	ENST00000454343;NM_000492.3;ENST00000426809	P205S;P205S;P175S	0.983;0.983;0.474	0.98598	0.9191	0.95947	D	0.8695	0.95663	D	10	0.581204160101	0.96264	D	5.473435	0.74300	26.2	0.99903492282595918	0.97481	0.99028	0.90102	D	AEFI	c	0.747790954121698	7.843004	0.650407527753186	6.917199	0.78527	0.999999999987643	0.74713	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.613276	0.41441	0	5.52	5.52	0.82084	7.519000	0.80566	0.852000	0.36166	1.000000	0.71511	0.860000	0.35897	0.0:1.0:0.0:0.0	19.4464	0.94820	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs121908803	5	Cystic fibrosis	3	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117175339	.	T	G	7	117535285	T	G	L	W	rs121908752	7	117175339	7	116962575	CFTR	+	TTG	2	0	T	T/T	T/T	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	206;176	0.002	0.72092	D	P13569	CFTR_HUMAN	206	1.0	0.89865	D	0.999	0.91584	D	0.000001	0.84324	D	0.000000	0.999983;1	0.81033	A;A	simple_aae;simple_aae	L206W;L206W	CFTR_HUMAN	L206W	2.785	0.81518	M	-2.88;-2.88	0.91543	D;D	-3.16	0.64204	D	ENST00000454343;NM_000492.3;ENST00000426809	L206W;L206W;L176W	0.964;0.964;0.646	0.96299	0.9441	0.96309	D	0.8709	0.95710	D	9	0.666131789964	0.97219	D	4.827792	0.64807	24.8	0.96016851692814409	0.27883	0.99097	0.91117	D	AEFI	c	0.653355041984273	6.513947	0.559888415125611	5.755078	0.72115	0.999999949492863	0.74713	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.613276	0.41441	0	5.52	5.52	0.82084	7.624000	0.82173	0.964000	0.58031	1.000000	0.71511	0.902000	0.38187	0.0:0.0:0.0:1.0	15.6517	0.76751	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	2.2696323195642307E-4	2	2.3255813953488373E-4	27	2.224e-04	27	2.224e-04	0	0	6	5.182e-04	0	0	0	0	21	3.147e-04	0	0	24	2.260e-04	24	2.260e-04	0	0	6	5.350e-04	0	0	0	0	18	3.312e-04	0	0	20	2.204e-04	20	2.204e-04	0	0	6	5.188e-04	0	0	0	0	14	3.323e-04	0	0	rs121908752	5|5	Cystic fibrosis|not provided	3|0	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117180217	.	C	G	7	117540163	C	G	F	L	rs121909016	7	117180217	7	116967453	CFTR	+	TTC	3	2	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	311;281	0.2;0.11	0.29118	T	P13569	CFTR_HUMAN	311	0.747	0.41224	P	0.863	0.59599	P	0.000000	0.84324	D	0.000000	0.999999;0.999907	0.58814	A;A	simple_aae;simple_aae	F311L;F311L	CFTR_HUMAN	F311L	2.295	0.65612	M	-2.44;-2.44	0.88782	D;D	-1.39	0.34377	N	ENST00000454343;NM_000492.3;ENST00000426809	F311L;F311L;F281L	0.963;0.963;0.606	0.96177	0.7576	0.93891	D	0.7695	0.92163	D	9	0.638236938649	0.96924	D	3.279054	0.45299	22.8	0.99879754268730492	0.95536	0.94521	0.61188	D	AEFI	c	0.465166902212031	4.776281	0.449883423494079	4.732432	0.64871	0.0902832927329475	0.16116	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.613276	0.41441	0	5.39	4.51	0.54424	2.460000	0.44444	0.935000	0.48983	1.000000	0.71511	1.000000	0.88762	0.0:0.8508:0.0:0.1492	10.4138	0.43303	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs121909016	5	Cystic fibrosis	0	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117180284	.	C	T	7	117540230	C	T	R	W	rs121909011	7	117180284	7	116967520	CFTR	+	CGG	1	2	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	334;304	0.007;0.005	0.63171	D	P13569	CFTR_HUMAN	334	1.0	0.89865	D	1.0	0.97092	D	0.000019	0.62918	D	0.120650	0.99998;1	0.81033	A;A	simple_aae;simple_aae	R334W;R334W	CFTR_HUMAN	R334W	2.075	0.57234	M	-2.56;-2.56	0.89641	D;D	-3.42	0.67197	D	ENST00000454343;NM_000492.3;ENST00000426809	R334W;R334W;R304W	0.936;0.936;0.654	0.92972	0.7553	0.93862	D	0.7525	0.91567	D	9	0.625733430006	0.96786	D	6.006914	0.82606	27.9	0.99848293783411868	0.92690	0.93512	0.58160	D	AEFI	c	0.213702909071613	3.364366	0.127979099093899	2.852171	0.46366	0.582715988582395	0.21572	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.613276	0.41441	0	5.39	4.51	0.54424	2.807000	0.47406	0.935000	0.48983	1.000000	0.71511	0.855000	0.35672	0.1366:0.792:0.0:0.0714	10.1162	0.41573	1	1.9968051118210862E-4	1	7.564296520423601E-4	0	0.0	0	0.0	0	0.0	0	0.0	.	.	.	.	.	.	.	.	8	6.589e-05	8	6.594e-05	1	9.610e-05	3	2.599e-04	0	0	1	1.513e-04	3	4.497e-05	0	0	6	5.649e-05	6	5.653e-05	1	1.103e-04	1	8.943e-05	0	0	1	1.513e-04	3	5.524e-05	0	0	7	7.713e-05	7	7.720e-05	1	9.626e-05	3	2.601e-04	0	0	1	2.633e-04	2	4.750e-05	0	0	rs121909011	5|5	Cystic fibrosis|not provided	4|1	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117180297	.	C	T	7	117540243	C	T	T	I	rs77409459	7	117180297	7	116967533	CFTR	+	ACC	2	0	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	338;308	0.008	0.58573	D	P13569	CFTR_HUMAN	338	0.999	0.76378	D	0.997	0.85043	D	0.000000	0.84324	N	0.045984	1;1	0.81033	A;A	simple_aae;simple_aae	T338I;T338I	CFTR_HUMAN	T338I	1.565	0.39678	L	-2.79;-2.79	0.91030	D;D	-2.76	0.58523	D	ENST00000454343;NM_000492.3;ENST00000426809	T338I;T338I;T308I	0.977;0.977;0.643	0.97884	0.4821	0.90298	D	0.7855	0.92721	D	9	0.666699091542	0.97225	D	4.108218	0.55129	23.7	0.9990062597956697	0.97252	0.98154	0.79924	D	AEFI	c	0.582366956804072	5.748901	0.566202874430809	5.824747	0.72550	0.999999979089731	0.74713	0.638212	0.42790	0	0.573888	0.26071	0	0.653264	0.51336	0	0.613276	0.41441	0	5.39	5.39	0.77528	7.434000	0.79393	0.935000	0.48983	1.000000	0.71511	1.000000	0.88762	0.0:1.0:0.0:0.0	19.5067	0.95092	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5	4.118e-05	5	4.121e-05	0	0	0	0	0	0	0	0	5	7.495e-05	0	0	4	3.766e-05	4	3.769e-05	0	0	0	0	0	0	0	0	4	7.364e-05	0	0	2	2.204e-05	2	2.206e-05	0	0	0	0	0	0	0	0	2	4.749e-05	0	0	rs77409459	5	Cystic fibrosis	3	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117180305	.	T	C	7	117540251	T	C	S	P	rs397508144	7	117180305	7	116967541	CFTR	+	TCA	1	0	T	T/T	T/T	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	341;311	0.001	0.78421	D	P13569	CFTR_HUMAN	341	1.0	0.89865	D	0.999	0.91584	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	S341P;S341P	CFTR_HUMAN	S341P	2.605	0.76452	M	-2.93;-2.93	0.91809	D;D	-3.29	0.65699	D	ENST00000454343;NM_000492.3;ENST00000426809	S341P;S341P;S311P	0.98;0.98;0.682	0.98244	0.9025	0.95710	D	0.8555	0.95189	D	10	0.802636727405	0.98466	D	5.593069	0.76124	26.5	0.99888483948617157	0.96250	0.97991	0.78543	D	AEFI	c	0.714751463395763	7.330109	0.66339318184364	7.119239	0.79474	0.999973483006093	0.49965	0.638212	0.42790	0	0.573888	0.26071	0	0.653264	0.51336	0	0.613276	0.41441	0	5.39	5.39	0.77528	7.538000	0.80813	1.061000	0.80716	1.000000	0.71511	0.996000	0.62468	0.0:0.0:0.0:1.0	15.6942	0.77137	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs397508144	5	Cystic fibrosis	3	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117180330	.	C	T	7	117540276	C	T	A	V	rs121909021	7	117180330	7	116967566	CFTR	+	GCG	2	0	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	349;319	0.166;0.175	0.23149	T	P13569	CFTR_HUMAN	349	0.907	0.48079	P	0.531	0.46751	P	0.002541	0.36376	N	0.327188	0.996065;0.972138	0.43004	A;A	simple_aae;simple_aae	A349V;A349V	CFTR_HUMAN	A349V	0.205	0.09372	N	-2.64;-2.64	0.90160	D;D	-0.23	0.10674	N	ENST00000454343;NM_000492.3;ENST00000426809	A349V;A349V;A319V	0.841;0.841;0.636	0.82833	0.3259	0.87970	D	0.5732	0.84589	D	9	0.216626188561	0.87613	D	5.899453	0.80915	27.5	0.99916792528498455	0.98436	0.98412	0.82385	D	AEFI	c	0.399331249429356	4.338983	0.508091737644213	5.233329	0.68625	0.999999959441337	0.74713	0.638212	0.42790	0	0.573888	0.26071	0	0.653264	0.51336	0	0.613276	0.41441	0	5.26	5.26	0.73376	7.434000	0.79393	0.935000	0.48983	1.000000	0.71511	0.991000	0.55236	0.0:1.0:0.0:0.0	19.2222	0.93760	.	.	.	.	.	.	.	.	.	.	.	.	1	2.6968716289104636E-4	2	5.189413596263622E-4	0	0.0	4	4.6511627906976747E-4	16	1.318e-04	16	1.319e-04	0	0	1	8.661e-05	0	0	0	0	15	2.249e-04	0	0	15	1.412e-04	15	1.413e-04	0	0	1	8.941e-05	0	0	0	0	14	2.578e-04	0	0	13	1.432e-04	13	1.434e-04	0	0	1	8.670e-05	0	0	0	0	12	2.850e-04	0	0	rs121909021	5	Cystic fibrosis	0	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117180363	.	C	G	7	117540309	C	G	T	R	rs75053309	7	117180363	7	116967599	CFTR	+	ACA	2	0	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	360;330	0.012;0.013	0.54630	D	P13569	CFTR_HUMAN	360	0.628	0.38232	P	0.544	0.47180	P	0.000004	0.62918	D	0.137729	0.988892;0.607406	0.40848	D;N	simple_aae;simple_aae	T360R;T360R	CFTR_HUMAN	T360R	0.895	0.22495	L	-2.92;-2.92	0.91758	D;D	-1.5	0.36563	N	ENST00000454343;NM_000492.3;ENST00000426809	T360R;T360R;T330R	0.889;0.889;0.794	0.87744	-0.0459	0.81305	T	0.5967	0.85624	D	10	0.358280149931	0.92473	D	2.514537	0.36344	19.56	0.99168484487604158	0.53950	0.92425	0.55414	D	AEFI	c	-0.0676414834671108	2.279437	0.0101108380203197	2.394102	0.40403	0.00207884051298417	0.09176	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.613276	0.41441	0	5.26	2.4	0.28437	2.999000	0.48913	0.077000	0.18463	1.000000	0.71511	0.999000	0.74975	0.0:0.7688:0.0:0.2312	9.5986	0.38564	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117188858	.	G	T	7	117548804	G	T	G	V	rs121909009	7	117188858	7	116976094	CFTR	+	GGA	2	0	G	G/G	G/G	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	458;428	0.0	0.91219	D	P13569	CFTR_HUMAN	458	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;1	0.81033	A;A	simple_aae;without_aae	G458V;.	CFTR_HUMAN	G458V	5.065	0.99907	H	-7.27;-7.27	0.99862	D;D	-8.08	0.96642	D	NM_000492.3;ENST00000426809	G458V;G428V	0.994;0.819	0.99729	0.8941	0.95594	D	0.9961	0.99910	D	9	0.879296877789	0.99086	D	6.562068	0.90290	31	0.9973319705924093	0.82762	0.99672	0.98528	D	AEFGI	c	1.05433072275154	15.72761	0.938125844909866	15.48664	0.96547	0.999999831133784	0.74713	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.542086	0.14228	0	4.85	4.85	0.62229	9.095000	0.93469	0.953000	0.55125	1.000000	0.71511	0.980000	0.48980	0.0:0.0:1.0:0.0	18.3148	0.90113	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs121909009	5	Cystic fibrosis	0	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117199522	.	C	T	7	117559468	C	T	S	L	rs121908805	7	117199522	7	116986758	CFTR	+	TCA	2	0	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	466;436	0.001	0.78421	D	P13569	CFTR_HUMAN	466	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	S466L;S405L	CFTR_HUMAN	S466L	1.91	0.51300	L	-2.93;-2.93	0.91809	D;D	-5.03	0.82544	D	ENST00000454343;NM_000492.3;ENST00000426809	S405L;S466L;S436L	0.634;0.964;0.8	0.96299	0.9084	0.95794	D	0.8720	0.95747	D	10	0.840438419139	0.98774	D	7.074117	0.94055	33	0.99931206272550677	0.99382	0.98424	0.82509	D	AEFI	c	0.868691683360671	10.27263	0.843957461588488	11.55488	0.92253	0.999999986445387	0.74713	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.564101	0.26208	0	5.47	5.47	0.80270	7.440000	0.79450	0.935000	0.48983	1.000000	0.71511	0.999000	0.74975	0.0:1.0:0.0:0.0	19.6916	0.95983	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	8.236e-06	1	8.256e-06	0	0	0	0	0	0	0	0	1	1.501e-05	0	0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	1.102e-05	1	1.105e-05	0	0	0	0	0	0	0	0	1	2.379e-05	0	0	.	.	.	.	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117199525	.	T	C	7	117559471	T	C	L	P	rs139573311	7	117199525	7	116986761	CFTR	+	CTT	2	0	T	T/T	T/T	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	467;437	0.0	0.91219	D	P13569	CFTR_HUMAN	467	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	L467P;L406P	CFTR_HUMAN	L467P	4.71	0.99508	H	-4.26;-4.26	0.97082	D;D	-5.87	0.88602	D	ENST00000454343;NM_000492.3;ENST00000426809	L406P;L467P;L437P	0.724;0.999;0.907	0.99981	1.0697	0.98584	D	0.9726	0.99142	D	10	0.932155954588	0.99514	D	6.238799	0.86129	28.8	0.99912075147372903	0.98079	0.98312	0.81388	D	AEFI	c	1.04214034721688	15.30136	0.931224990881944	15.15605	0.96315	0.999980782866777	0.51697	0.487112	0.13308	0	0.573888	0.26071	0	0.573888	0.22998	0	0.564101	0.26208	0	5.47	5.47	0.80270	7.544000	0.80917	1.061000	0.80716	1.000000	0.71511	0.998000	0.69722	0.0:0.0:0.0:1.0	15.8443	0.78559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	2.2696323195642307E-4	2	2.3255813953488373E-4	1	8.236e-06	1	8.255e-06	1	9.688e-05	0	0	0	0	0	0	0	0	0	0	1	9.415e-06	1	9.436e-06	1	1.111e-04	0	0	0	0	0	0	0	0	0	0	1	1.102e-05	1	1.105e-05	1	9.705e-05	0	0	0	0	0	0	0	0	0	0	rs139573311	5	Cystic fibrosis	3	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117199600	.	C	T	7	117559546	C	T	S	F	rs121909017	7	117199600	7	116986836	CFTR	+	TCT	2	0	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	492;462	0.019;0.024	0.50080	D	P13569	CFTR_HUMAN	492	0.993	0.63734	D	0.951	0.67232	D	0.000010	0.62918	D	0.151419	0.999995;0.999995	0.58814	A;A	simple_aae;simple_aae	S492F;S431F	CFTR_HUMAN	S492F	0.755	0.19220	N	-3.25;-3.25	0.93538	D;D	-3.51	0.68254	D	ENST00000454343;NM_000492.3;ENST00000426809	S431F;S492F;S462F	0.385;0.9;0.845	0.88930	0.8358	0.94856	D	0.8354	0.94492	D	9	0.616588324998	0.96683	D	6.684566	0.91510	32	0.99839732509932078	0.91991	0.97852	0.77455	D	AEFDI	c	0.722612427307081	7.447215	0.749917312181302	8.798409	0.85878	0.999999999985272	0.74713	0.553676	0.24620	0	0.588015	0.36036	0	0.573888	0.22998	0	0.564101	0.26208	0	5.48	5.48	0.80601	7.440000	0.79450	0.935000	0.48983	1.000000	0.71511	0.998000	0.69722	0.0:1.0:0.0:0.0	19.7112	0.96074	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs121909017	5	Cystic fibrosis	3	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117227853	.	A	C	7	117587799	A	C	S	R	rs121908757	7	117227853	7	117015089	CFTR	+	AGT	1	0	A	A/A	A/A	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	549;519	0.0	0.91219	D	P13569	CFTR_HUMAN	549	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	S549R;S488R	CFTR_HUMAN	S549R	5.085	0.99917	H	-5.18;-5.18	0.98825	D;D	-4.72	0.79961	D	ENST00000454343;NM_000492.3;ENST00000426809	S488R;S549R;S519R	0.991;0.991;0.724	0.99469	1.0310	0.97738	D	0.9823	0.99460	D	10	0.863133836236	0.98957	D	6.387289	0.88187	29.5	0.99841053821939973	0.92078	0.96778	0.70690	D	AEFBCI	c	1.00899422436652	14.20738	0.892584807588959	13.43887	0.94793	0.999999999988611	0.74713	0.554377	0.28343	0	0.59043	0.45365	0	0.602189	0.34140	0	0.631631	0.49192	0	5.06	5.06	0.67712	8.218000	0.89644	1.199000	0.96014	1.000000	0.71511	1.000000	0.88762	1.0:0.0:0.0:0.0	15.1194	0.71981	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	8.238e-06	1	8.285e-06	0	0	0	0	0	0	0	0	1	1.506e-05	0	0	1	9.417e-06	1	9.471e-06	0	0	0	0	0	0	0	0	1	1.849e-05	0	0	1	1.102e-05	1	1.110e-05	0	0	0	0	0	0	0	0	1	2.386e-05	0	0	rs121908757	5|5|6	Cystic fibrosis|Cystic fibrosis|ivacaftor response - Efficacy	0|3|3	AAA+ ATPase domain|ABC transporter, conserved site|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117227855	.	T	G	7	117587801	T	G	S	R	rs121909005	7	117227855	7	117015091	CFTR	+	AGT	3	2	T	T/T	T/T	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	549;519	0.0	0.91219	D	P13569	CFTR_HUMAN	549	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	S549R;S488R	CFTR_HUMAN	S549R	5.085	0.99917	H	-5.18;-5.18	0.98825	D;D	-4.72	0.79961	D	ENST00000454343;NM_000492.3;ENST00000426809	S488R;S549R;S519R	0.991;0.991;0.724	0.99469	1.0623	0.98397	D	0.9786	0.99339	D	10	0.846147771871	0.98820	D	5.929006	0.81379	27.6	0.99802372610238399	0.88634	0.85950	0.44852	D	AEFBCI	c	0.634561405090432	6.294431	0.473104514849933	4.922948	0.66354	0.999966437911984	0.48880	0.554377	0.28343	0	0.59043	0.45365	0	0.602189	0.34140	0	0.631631	0.49192	0	5.06	2.67	0.30617	1.639000	0.36562	0.141000	0.22457	1.000000	0.71511	1.000000	0.88762	0.0:0.1452:0.0:0.8548	9.4966	0.37968	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0.0	1	1.1627906976744187E-4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs121909005	5|5|6	Cystic fibrosis|Cystic fibrosis|ivacaftor response - Efficacy	0|3|3	AAA+ ATPase domain|ABC transporter, conserved site|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117230454	.	G	C	7	117590400	G	C	G	A	rs1800098	7	117230454	7	117017690	CFTR	+	GGA	2	0	G	G/G	G/G	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	576;546	0.258;0.134	0.26263	T	P13569	CFTR_HUMAN	576	0.907	0.48079	P	0.697	0.52220	P	0.000006	0.62918	D	0.110509	0.999718;0.999048	0.48503	A;A	simple_aae;simple_aae	G515A;G576A	CFTR_HUMAN	G576A	0.07	0.08293	N	-2.46;-2.46	0.88938	D;D	0.11	0.05716	N	ENST00000454343;NM_000492.3;ENST00000426809	G515A;G576A;G546A	0.846;0.846;0.549	0.83327	0.2479	0.86715	D	0.4021	0.75326	T	9	0.253514146634	0.89253	D	1.474181	0.23962	13.18	0.99530655803949908	0.69589	0.90917	0.52228	D	AEFI	c	0.266962587308173	3.613699	0.379241281379065	4.214581	0.60532	0.999999993862349	0.74713	0.487112	0.13308	0	0.573888	0.26071	0	0.547309	0.14640	0	0.613276	0.41441	0	4.83	4.83	0.61732	5.669000	0.67532	1.048000	0.71291	1.000000	0.71511	1.000000	0.88762	0.0:0.0:1.0:0.0	17.9064	0.88785	12	0.0023961661341853034	0	0.0	10	0.009940357852882704	2	0.002881844380403458	0	0.0	0	0.0	40	0.010787486515641856	36	0.00934094447327452	11	0.0024965955515206537	57	0.006638714185883997	623	5.133e-03	623	5.167e-03	21	2.076e-03	49	4.265e-03	0	0	42	6.364e-03	506	7.621e-03	0	0	536	5.048e-03	536	5.079e-03	18	2.044e-03	48	4.309e-03	0	0	42	6.364e-03	425	7.853e-03	0	0	392	4.321e-03	392	4.360e-03	21	2.080e-03	49	4.270e-03	0	0	27	7.128e-03	292	6.985e-03	0	0	rs1800098	5	Congenital bilateral absence of the vas deferens	0	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117243666	.	A	G	7	117603612	A	G	Y	C	rs121909008	7	117243666	7	117030902	CFTR	+	TAT	2	0	A	A/A	A/A	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	913;883	0.001	0.78421	D	P13569	CFTR_HUMAN	913	0.992	0.62897	D	0.949	0.66952	D	0.000612	0.42932	D	0.275476	0.999999;1	0.81033	A;A	simple_aae;simple_aae	Y852C;Y913C	CFTR_HUMAN	Y913C	2.78	0.81377	M	-3.49;-3.49	0.94624	D;D	-3.84	0.72195	D	ENST00000454343;NM_000492.3;ENST00000426809	Y852C;Y913C;Y883C	0.873;0.873;0.705	0.86061	0.9491	0.96383	D	0.8981	0.96620	D	9	0.475122758068	0.94766	D	3.763713	0.50919	23.3	0.98611228890821045	0.43175	0.94739	0.61921	D	AEBI	c	0.0489203652777551	2.689694	-0.196994232525138	1.792951	0.31359	0.198651154661801	0.18092	0.615465	0.37169	0	0.573888	0.26071	0	0.658983	0.55576	0	0.564101	0.26208	0	5.82	-1.71	0.07652	1.701000	0.37214	1.140000	0.89307	1.000000	0.71511	0.583000	0.28534	0.4508:0.0:0.0:0.5492	12.2655	0.53811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	8.236e-06	1	8.245e-06	1	9.610e-05	0	0	0	0	0	0	0	0	0	0	1	9.415e-06	1	9.427e-06	1	1.103e-04	0	0	0	0	0	0	0	0	0	0	1	1.102e-05	1	1.103e-05	1	9.626e-05	0	0	0	0	0	0	0	0	0	0	rs121909008	5	Cystic fibrosis	0	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117243708	.	T	C	7	117603654	T	C	L	P	rs397508435	7	117243708	7	117030944	CFTR	+	CTT	2	0	T	T/T	T/T	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	927;897	0.002;0.001	0.78421	D	P13569	CFTR_HUMAN	927	0.971	0.55230	D	0.969	0.70345	D	0.000008	0.62918	D	0.113140	1;1	0.81033	D;D	simple_aae;simple_aae	L927P;L866P	CFTR_HUMAN	L927P	2.56	0.75006	M	-2.74;-2.74	0.90747	D;D	-3.27	0.65469	D	ENST00000454343;NM_000492.3;ENST00000426809	L866P;L927P;L897P	0.966;0.966;0.84	0.96543	0.8644	0.95210	D	0.8418	0.94717	D	10	0.859903377743	0.98931	D	6.465813	0.89179	29.9	0.99927858082839993	0.99156	0.98958	0.89093	D	AEFBI	c	0.816906301300623	9.120156	0.802088367021293	10.18565	0.89590	0.999999997580129	0.74713	0.615465	0.37169	0	0.573888	0.26071	0	0.658983	0.55576	0	0.564101	0.26208	0	5.76	5.76	0.90691	7.824000	0.84721	1.011000	0.63473	1.000000	0.71511	0.998000	0.69722	0.0:0.0:0.0:1.0	16.0589	0.80545	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs397508435	5	Cystic fibrosis	3	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117243762	.	C	T	7	117603708	C	T	S	L	rs397508442	7	117243762	7	117030998	CFTR	+	TCG	2	0	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	945;915	0.0	0.91219	D	P13569	CFTR_HUMAN	945	0.999	0.76378	D	0.981	0.73574	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	S945L;S884L	CFTR_HUMAN	S945L	4.095	0.97352	H	-2.57;-2.57	0.89706	D;D	-4.63	0.79192	D	ENST00000454343;NM_000492.3;ENST00000426809	S884L;S945L;S915L	0.972;0.972;0.749	0.97276	0.9880	0.96991	D	0.8898	0.96343	D	10	0.843208371076	0.98796	D	8.126787	0.95725	35	0.9993609891923424	0.99617	0.98938	0.88811	D	AEFBI	c	1.05096285049281	15.60768	0.984739329933977	17.93681	0.97811	0.999999999999747	0.74713	0.615465	0.37169	0	0.573888	0.26071	0	0.658983	0.55576	0	0.564101	0.26208	0	5.85	5.85	0.93642	7.715000	0.83556	0.935000	0.48983	1.000000	0.71511	0.397000	0.25368	0.0:1.0:0.0:0.0	20.16	0.98124	.	.	.	.	.	.	.	.	.	.	.	.	2	5.393743257820927E-4	0	0.0	.	.	.	.	12	9.884e-05	12	9.890e-05	0	0	3	2.608e-04	0	0	1	1.512e-04	7	1.049e-04	0	0	12	1.130e-04	12	1.131e-04	0	0	3	2.693e-04	0	0	1	1.512e-04	7	1.288e-04	0	0	4	4.408e-05	4	4.411e-05	0	0	3	2.611e-04	0	0	0	0	1	2.373e-05	0	0	rs397508442	5	Cystic fibrosis	3	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117243773	.	C	T	7	117603719	C	T	H	Y	rs121909035	7	117243773	7	117031009	CFTR	+	CAC	1	0	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	949;919	0.0	0.91219	D	P13569	CFTR_HUMAN	949	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	0.999999;0.999999	0.58814	A;A	simple_aae;simple_aae	H888Y;H949Y	CFTR_HUMAN	H949Y	4.335	0.98439	H	-3.49;-3.49	0.94624	D;D	-5.06	0.82733	D	ENST00000454343;NM_000492.3;ENST00000426809	H888Y;H949Y;H919Y	0.939;0.939;0.644	0.93321	1.0968	0.99525	D	0.9426	0.98120	D	9	0.68814430255	0.97440	D	6.357479	0.87790	29.4	0.9981522626874022	0.89801	0.97049	0.72203	D	AEFBI	c	0.895056670796575	10.92297	0.799779008457285	10.11734	0.89437	0.99977464931024	0.42800	0.615465	0.37169	0	0.573888	0.26071	0	0.658983	0.55576	0	0.564101	0.26208	0	5.86	4.97	0.65285	5.819000	0.68710	0.038000	0.15345	1.000000	0.71511	0.708000	0.31116	0.134:0.866:0.0:0.0	16.24	0.82146	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs121909035	5	Cystic fibrosis	0	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117251689	.	T	G	7	117611635	T	G	L	R	rs121909036	7	117251689	7	117038925	CFTR	+	CTT	2	0	T	T/T	T/T	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1065;1035	0.001	0.78421	D	P13569	CFTR_HUMAN	1065	0.996	0.67003	D	0.982	0.73889	D	0.000003	0.62918	D	0.061108	0.999999;0.999999	0.58814	D;D	simple_aae;simple_aae	L1065R;L1004R	CFTR_HUMAN	L1065R	2.545	0.74518	M	-2.66;-2.66	0.90285	D;D	-4.19	0.75578	D	ENST00000454343;ENST00000468795;NM_000492.3;ENST00000426809	L1004R;L6R;L1065R;L1035R	0.987;0.892;0.987;0.883	0.99053	0.8330	0.94821	D	0.8293	0.94276	D	10	0.892409581374	0.99191	D	6.538410	0.90028	31	0.99796064733129897	0.88007	0.99565	0.97481	D	AEFI	c	0.812030191172021	9.020555	0.798500462019775	10.07968	0.89345	0.999999851762762	0.74713	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.564101	0.26208	0	5.69	5.69	0.88301	7.967000	0.87423	0.961000	0.56703	1.000000	0.71511	1.000000	0.88762	0.0:0.0:0.0:1.0	15.9544	0.79568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117251694	.	G	C	7	117611640	G	C	A	P	rs121909020	7	117251694	7	117038930	CFTR	+	GCC	1	0	G	G/G	G/G	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1067;1037	0.002;0.0	0.91219	D	P13569	CFTR_HUMAN	1067	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	A1067P;A1006P	CFTR_HUMAN	A1067P	4.265	0.98156	H	-2.99;-2.99	0.92117	D;D	-4.01	0.74156	D	ENST00000454343;ENST00000468795;NM_000492.3;ENST00000426809	A1006P;A8P;A1067P;A1037P	0.999;0.805;0.999;0.83	0.99981	1.0179	0.97498	D	0.9096	0.97004	D	10	0.881300536335	0.99103	D	6.572547	0.90403	31	0.9978315295980279	0.86846	0.99765	0.99298	D	AEFI	c	1.05605559765561	15.78907	1.00162500552218	18.94149	0.98156	0.999999999971304	0.74713	0.638212	0.42790	0	0.573888	0.26071	0	0.653264	0.51336	0	0.564101	0.26208	0	5.69	5.69	0.88301	9.938000	0.98854	0.949000	0.53640	1.000000	0.71511	0.995000	0.60354	0.0:0.0:1.0:0.0	19.8211	0.96577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117251704	.	G	C	7	117611650	G	C	R	P	rs78769542	7	117251704	7	117038940	CFTR	+	CGG	2	0	G	G/G	G/G	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1070;1040	0.02;0.023	0.49561	D	P13569	CFTR_HUMAN	1070	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	R1070P;R1009P	CFTR_HUMAN	R1070P	3.1	0.87828	M	-2.7;-2.7	0.90521	D;D	-2.8	0.59180	D	ENST00000454343;ENST00000468795;NM_000492.3;ENST00000426809	R1009P;R11P;R1070P;R1040P	0.997;0.819;0.997;0.836	0.99915	0.8419	0.94931	D	0.8597	0.95331	D	10	0.713734438843	0.97687	D	7.355127	0.94936	34	0.99708783528942613	0.80987	0.99765	0.99298	D	AEFI	c	0.961308481085181	12.74691	0.935913962904296	15.37971	0.96473	0.999999999971304	0.74713	0.638212	0.42790	0	0.573888	0.26071	0	0.653264	0.51336	0	0.564101	0.26208	0	5.69	5.69	0.88301	9.938000	0.98854	0.949000	0.53640	1.000000	0.71511	0.979000	0.48620	0.0:0.0:1.0:0.0	19.8211	0.96577	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117251707	.	A	C	7	117611653	A	C	Q	P	rs121909037	7	117251707	7	117038943	CFTR	+	CAG	2	0	A	A/A	A/A	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1071;1041	0.005	0.63171	D	P13569	CFTR_HUMAN	1071	0.999	0.76378	D	0.999	0.91584	D	0.000000	0.84324	D	0.000000	1;1	0.81033	A;A	simple_aae;simple_aae	Q1010P;Q1071P	CFTR_HUMAN	Q1071P	3.63	0.94142	H	-2.88;-2.88	0.91543	D;D	-3.82	0.71953	D	ENST00000454343;ENST00000468795;NM_000492.3;ENST00000426809	Q1010P;Q12P;Q1071P;Q1041P	0.972;0.718;0.972;0.68	0.97276	0.3581	0.88468	D	0.5734	0.84598	D	9	0.667024218604	0.97228	D	5.884506	0.80683	27.4	0.99567527686626012	0.71966	0.99717	0.98915	D	AEFI	c	0.666544933288499	6.675686	0.692493868730981	7.614114	0.81632	0.999999851762762	0.74713	0.638212	0.42790	0	0.573888	0.26071	0	0.653264	0.51336	0	0.564101	0.26208	0	5.69	5.69	0.88301	9.265000	0.94758	1.083000	0.85292	1.000000	0.71511	0.994000	0.58705	1.0:0.0:0.0:0.0	15.9544	0.79568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs121909037	5	Cystic fibrosis	0	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117251725	.	T	C	7	117611671	T	C	L	P	rs139304906	7	117251725	7	117038961	CFTR	+	CTG	2	0	T	T/T	T/T	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1077;1047	0.022;0.075	0.48591	D;T	P13569	CFTR_HUMAN	1077	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	L1077P;L1016P	CFTR_HUMAN	L1077P	3.415	0.92021	M	-2.6;-2.6	0.89902	D;D	-1.3	0.32573	N	ENST00000454343;ENST00000468795;NM_000492.3;ENST00000426809	L1016P;L18P;L1077P;L1047P	0.979;0.746;0.979;0.789	0.98124	0.8711	0.95293	D	0.8410	0.94690	D	10	0.859691769497	0.98929	D	6.187301	0.85378	28.6	0.99922317684983397	0.98843	0.98460	0.82886	D	AEFI	c	0.879552192920767	10.53508	0.834480512155279	11.224	0.91683	0.999999851762762	0.74713	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.564101	0.26208	0	5.69	5.69	0.88301	7.929000	0.86958	0.961000	0.56703	0.987000	0.36084	0.999000	0.74975	0.0:0.0:0.0:1.0	15.9544	0.79568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0	0.0	1	1.1627906976744187E-4	1	8.239e-06	1	8.294e-06	0	0	0	0	0	0	0	0	1	1.508e-05	0	0	1	9.419e-06	1	9.481e-06	0	0	0	0	0	0	0	0	1	1.851e-05	0	0	1	1.102e-05	1	1.111e-05	0	0	0	0	0	0	0	0	1	2.392e-05	0	0	rs139304906	5	Cystic fibrosis	3	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117251749	.	A	G	7	117611695	A	G	H	R	rs79635528	7	117251749	7	117038985	CFTR	+	CAT	2	0	A	A/A	A/A	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1085;1055	0.078;0.081	0.33878	T	P13569	CFTR_HUMAN	1085	0.999	0.76378	D	0.997	0.85043	D	0.000000	0.84324	D	0.000000	1;1	0.81033	A;A	simple_aae;simple_aae	H1085R;H1024R	CFTR_HUMAN	H1085R	2.825	0.82485	M	-3.43;-3.43	0.94392	D;D	-2.12	0.48148	N	ENST00000454343;ENST00000468795;NM_000492.3;ENST00000426809	H1024R;H26R;H1085R;H1055R	0.984;0.734;0.984;0.735	0.98714	-0.0541	0.81131	T	0.4441	0.78120	T	9	0.796099407181	0.98412	D	4.221343	0.56565	23.9	0.99816694043489029	0.89890	0.99128	0.91576	D	AEFI	c	0.604549630155239	5.97001	0.65294833776446	6.955978	0.78713	0.999999851762762	0.74713	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.564101	0.26208	0	5.69	5.69	0.88301	9.219000	0.94268	1.083000	0.85292	1.000000	0.71511	1.000000	0.88762	1.0:0.0:0.0:0.0	15.9544	0.79568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117251797	.	T	G	7	117611743	T	G	M	R	rs36210737	7	117251797	7	117039033	CFTR	+	ATG	2	0	T	T/A	T/T	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1101;1071	0.003;0.002	0.72092	D	P13569	CFTR_HUMAN	1101	0.995	0.65671	D	0.943	0.66199	D	0.000000	0.84324	D	0.078231	0.999999;0.999999	0.58814	D;D	simple_aae;simple_aae	M1101R;M1040R	CFTR_HUMAN	M1101R	2.78	0.81377	M	-2.55;-2.55	0.89576	D;D	-3.32	0.66041	D	ENST00000454343;ENST00000468795;NM_000492.3;ENST00000426809	M1040R;M42R;M1101R;M1071R	0.972;0.817;0.972;0.828	0.97276	-0.3789	0.72705	T	0.3663	0.72685	T	10	0.547729976406	0.95834	D	5.914653	0.81154	27.5	0.98630117898804714	0.43445	0.98762	0.86428	D	AEFI	c	0.496144839551587	5.0057	0.567379947660777	5.837895	0.72623	0.999999845512961	0.74713	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.564101	0.26208	0	5.68	5.68	0.87975	7.929000	0.86958	0.961000	0.56703	1.000000	0.71511	1.000000	0.88762	0.0:0.0:0.0:1.0	15.9383	0.79429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117254753	.	G	C	7	117614699	G	C	D	H	rs75541969	7	117254753	7	117041989	CFTR	+	GAT	1	0	G	G/G	G/G	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1152;1122	0.005	0.63171	D	P13569	CFTR_HUMAN	1152	0.574	0.36810	P	0.572	0.48103	P	0.000043	0.53730	D	0.194425	0.999972;0.999972	0.53702	D;D	simple_aae;simple_aae	D1152H;D1091H	CFTR_HUMAN	D1152H	2.785	0.81518	M	-3.51;-3.51	0.94696	D;D	-2.68	0.57230	D	ENST00000454343;ENST00000468795;NM_000492.3;ENST00000426809	D1091H;D93H;D1152H;D1122H	0.785;0.474;0.785;0.426	0.77589	-0.3758	0.72802	T	0.4068	0.75659	T	10	0.786569289129	0.98332	D	6.537737	0.90018	31	0.99612921934690879	0.74725	0.97585	0.75547	D	AEFDI	c	0.491372762456021	4.969138	0.569735148007567	5.864187	0.72788	0.999999572218143	0.74713	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.564101	0.26208	0	5.9	5.9	0.94934	5.261000	0.65090	0.902000	0.41569	1.000000	0.71511	0.991000	0.55236	0.0:0.0:1.0:0.0	20.2704	0.98471	.	.	.	.	.	.	.	.	.	.	.	.	3	8.090614886731392E-4	1	2.594706798131811E-4	1	2.2696323195642307E-4	2	2.3255813953488373E-4	32	2.636e-04	32	2.644e-04	1	9.623e-05	6	5.236e-04	0	0	0	0	25	3.755e-04	0	0	25	2.354e-04	25	2.361e-04	1	1.104e-04	6	5.406e-04	0	0	0	0	18	3.319e-04	0	0	31	3.416e-04	31	3.429e-04	1	9.639e-05	6	5.241e-04	0	0	0	0	24	5.716e-04	0	0	rs75541969	5|5|5	Cystic fibrosis|Bronchiectasis|Congenital bilateral absence of the vas deferens	2|1|1	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117267579	.	C	G	7	117627525	C	G	R	G	rs79850223	7	117267579	7	117054815	CFTR	+	CGA	1	2	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1158;1128	0.114;0.101	0.30333	T	P13569	CFTR_HUMAN	1158	0.999	0.76378	D	0.997	0.85043	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	R1158G;R1097G	CFTR_HUMAN	R1158G	2.215	0.62746	M	-3.29;-3.29	0.93745	D;D	-1.53	0.37154	N	ENST00000454343;ENST00000468795;NM_000492.3;ENST00000426809	R1097G;R99G;R1158G;R1128G	0.978;0.445;0.978;0.603	0.98004	0.6699	0.92799	D	0.7232	0.90521	D	10	0.808458459314	0.98514	D	5.098610	0.68715	25.3	0.99844234037265323	0.92339	0.98415	0.82416	D	AEFI	c	0.25904836731299	3.575286	0.312289911873174	3.789204	0.56571	0.996220597992262	0.34552	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.564101	0.26208	0	5.77	3.92	0.44354	3.374000	0.51885	0.892000	0.40251	1.000000	0.71511	1.000000	0.88762	0.2538:0.7462:0.0:0.0	15.4107	0.74529	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ABC transporter type 1, transmembrane domain	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117267766	.	C	T	7	117627712	C	T	T	I	rs1800123	7	117267766	7	117055002	CFTR	+	ACA	2	0	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1220;1190	0.583;0.581	0.05962	T	P13569	CFTR_HUMAN	1220	0.0	0.02634	B	0.001	0.03956	B	0.121798	0.18970	N	0.610194	0.000230436;0.00173051	0.22238	A;A	simple_aae;simple_aae	T1159I;T1220I	CFTR_HUMAN	T1220I	0.805	0.20292	L	-2.7;-2.7	0.90521	D;D	-2.05	0.46972	N	ENST00000454343;ENST00000468795;NM_000492.3;ENST00000426809	T1159I;T161I;T1220I;T1190I	0.181;0.34;0.181;0.474	0.52364	-0.6949	0.60708	T	0.4007	0.75226	T	9	0.0587220982004	0.67533	D	-0.812149	0.03963	0.040	0.48022762586460011	0.03917	0.01978	0.05916	N	AEFDI	c	-1.3626861592857	0.1331236	-1.38306868164825	0.1600863	0.03371	0.582486596891906	0.21570	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.564101	0.26208	0	5.86	-4.44	0.03289	-0.302000	0.08191	-0.255000	0.08903	0.000000	0.06329	0.599000	0.28832	0.0951:0.4717:0.0978:0.3354	6.7943	0.22752	1	1.9968051118210862E-4	0	0.0	0	0.0	0	0.0	1	9.92063492063492E-4	0	0.0	1	2.6968716289104636E-4	0	0.0	0	0.0	1	1.1627906976744187E-4	16	1.318e-04	16	1.324e-04	0	0	0	0	8	9.372e-04	0	0	5	7.519e-05	3	1.819e-04	14	1.318e-04	14	1.324e-04	0	0	0	0	8	1.032e-03	0	0	3	5.536e-05	3	1.831e-04	16	1.763e-04	16	1.774e-04	0	0	0	0	8	1.449e-03	0	0	5	1.193e-04	3	1.820e-04	rs1800123	5	Cystic fibrosis	0	ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117267807	.	A	C	7	117627753	A	C	I	L	rs75389940	7	117267807	7	117055043	CFTR	+	ATA	1	0	A	A/A	A/A	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1234;1204	0.052;0.056	0.39048	T	P13569	CFTR_HUMAN	1234	0.002	0.08966	B	0.008	0.12740	B	0.000002	0.62918	D	0.134911	0.989237;0.924357	0.40913	D;D	simple_aae;simple_aae	I1234L;I1173L	CFTR_HUMAN	I1234L	1.02	0.25589	L	-3.11;-3.11	0.92729	D;D	-1.63	0.39092	N	ENST00000454343;ENST00000468795;NM_000492.3;ENST00000426809	I1173L;I175L;I1234L;I1204L	0.522;0.396;0.522;0.517	0.56342	-0.5980	0.64925	T	0.2515	0.62155	T	10	0.143140257827	0.82612	D	2.902043	0.40933	21.9	0.97718670382208916	0.35015	0.95730	0.65685	D	AEDI	c	0.234568486591608	3.459605	0.292454955462356	3.673219	0.55420	0.824422494935843	0.24554	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.564101	0.26208	0	5.86	4.7	0.58620	3.285000	0.51175	1.199000	0.96014	0.999000	0.42402	1.000000	0.88762	0.7438:0.0:0.0:0.2562	10.6301	0.44533	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117267807	.	A	G	7	117627753	A	G	I	V	rs75389940	7	117267807	7	117055043	CFTR	+	ATA	1	0	A	A/A	A/A	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1234;1204	0.191;0.198	0.21035	T	P13569	CFTR_HUMAN	1234	0.001	0.06737	B	0.006	0.11238	B	0.000002	0.62918	D	0.134911	0.974856;0.837533	0.39135	D;D	simple_aae;simple_aae	I1234V;I1173V	CFTR_HUMAN	I1234V	0.285	0.10085	N	-3.25;-3.25	0.93538	D;D	-0.5	0.15796	N	ENST00000454343;ENST00000468795;NM_000492.3;ENST00000426809	I1173V;I175V;I1234V;I1204V	0.775;0.312;0.775;0.594	0.76698	0.0435	0.83126	D	0.6173	0.86500	D	10	0.186350087381	0.85921	D	1.703611	0.26581	14.43	0.9627724450060926	0.28696	0.84700	0.43492	D	AEDI	c	-0.21798691881744	1.826541	-0.0182368256076624	2.297903	0.39082	0.824422494935843	0.24554	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.564101	0.26208	0	5.86	4.7	0.58620	3.285000	0.51175	1.199000	0.96014	0.999000	0.42402	1.000000	0.88762	0.7438:0.0:0.0:0.2562	10.6301	0.44533	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1	8.237e-06	1	8.314e-06	0	0	0	0	0	0	0	0	1	1.511e-05	0	0	1	9.416e-06	1	9.483e-06	0	0	0	0	0	0	0	0	1	1.849e-05	0	0	1	1.102e-05	1	1.116e-05	0	0	0	0	0	0	0	0	1	2.404e-05	0	0	rs75389940	5	Cystic fibrosis	3	ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117282537	.	T	C	7	117642483	T	C	S	P	rs121909041	7	117282537	7	117069773	CFTR	+	TCA	1	0	T	T/T	T/T	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1255;1225	0.044;0.045	0.41046	D	P13569	CFTR_HUMAN	1255	0.744	0.41123	P	0.529	0.46684	P	0.026510	0.25894	N	0.449653	1.85136e-07;1.87367e-06	0.08979	A;A	simple_aae;simple_aae	S1194P;S1255P	CFTR_HUMAN	S1255P	3.185	0.89121	M	-3.34;-3.34	0.93980	D;D	-2.1	0.47816	N	ENST00000454343;NM_000492.3;ENST00000426809	S1194P;S1255P;S1225P	0.91;0.91;0.771	0.90027	0.8339	0.94832	D	0.8292	0.94273	D	9	0.0767554104274	0.72706	D	2.500472	0.36178	19.47	0.99827178568757158	0.90863	0.26997	0.22932	N	AEFI	c	0.15881172136827	3.125721	0.0539923834887031	2.55342	0.42548	0.956409667811164	0.28204	0.554377	0.28343	0	0.588066	0.40457	0	0.602189	0.34140	0	0.613276	0.41441	0	5.2	2.5	0.29221	2.891000	0.48069	0.913000	0.42452	0.378000	0.25761	0.896000	0.37806	0.0:0.0776:0.1326:0.7898	8.0592	0.29610	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs121909041	5|6	Cystic fibrosis|Ivacaftor response	3|3	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117282582	.	G	C	7	117642528	G	C	D	H	.	7	117282582	7	117069818	CFTR	+	GAT	1	0	G	G/G	G/G	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1270;1240	0.001	0.78421	D	P13569	CFTR_HUMAN	1270	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;1	0.81033	D;D	simple_aae;simple_aae	D1270H;D1209H	CFTR_HUMAN	D1270H	3.01	0.86315	M	-2.97;-2.97	0.92016	D;D	-5.96	0.89185	D	ENST00000454343;NM_000492.3;ENST00000426809	D1209H;D1270H;D1240H	0.99;0.99;0.706	0.99370	0.9975	0.97148	D	0.8956	0.96537	D	10	0.645467293285	0.97002	D	6.828155	0.92674	33	0.99521159395855363	0.68968	0.99067	0.90674	D	AEFI	c	0.948612892021707	12.3777	0.891413356188946	13.38962	0.94738	0.999999999995256	0.74713	0.554377	0.28343	0	0.588066	0.40457	0	0.602189	0.34140	0	0.613276	0.41441	0	5.2	5.2	0.71609	9.432000	0.96696	0.902000	0.41569	1.000000	0.71511	0.926000	0.39999	0.0:0.0:1.0:0.0	19.0826	0.93141	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117292929	.	A	C	7	117652875	A	C	N	H	rs121909042	7	117292929	7	117080165	CFTR	+	AAC	1	0	A	A/A	A/A	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1303;1273	0.0	0.91219	D	P13569	CFTR_HUMAN	1303	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;1	0.81033	A;A	simple_aae;simple_aae	N1242H;N1303H	CFTR_HUMAN	N1303H	2.895	0.84073	M	-3.48;-3.48	0.94587	D;D	-4.26	0.76137	D	ENST00000454343;NM_000492.3;ENST00000426809	N1242H;N1303H;N1273H	0.584;0.584;0.622	0.64246	1.0886	0.99184	D	0.9334	0.97806	D	9	0.307119513628	0.91100	D	5.353096	0.72482	25.9	0.99687992653484969	0.79539	0.96970	0.71751	D	AEBI	c	0.886002010762874	10.69471	0.801779467050644	10.17647	0.89569	0.999995932491594	0.74713	0.559995	0.30148	0	0.573888	0.26071	0	0.527494	0.10854	0	0.613276	0.41441	0	5.24	5.24	0.72756	6.607000	0.73852	1.199000	0.96014	1.000000	0.71511	1.000000	0.88762	1.0:0.0:0.0:0.0	15.1039	0.71856	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	rs121909042	5	Cystic fibrosis	0	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117292931	.	C	G	7	117652877	C	G	N	K	rs80034486	7	117292931	7	117080167	CFTR	+	AAC	3	2	C	C/C	C/C	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1303;1273	0.0	0.91219	D	P13569	CFTR_HUMAN	1303	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	0.999996;0.999995	0.58814	A;A	simple_aae;simple_aae	N1303K;N1242K	CFTR_HUMAN	N1303K	3.88	0.96074	H	-3.45;-3.45	0.94472	D;D	-5.11	0.83061	D	ENST00000454343;NM_000492.3;ENST00000426809	N1242K;N1303K;N1273K	0.554;0.554;0.663	0.67440	1.0615	0.98377	D	0.9299	0.97687	D	9	0.303735822701	0.90998	D	6.023766	0.82870	27.9	0.99816332402211705	0.89890	0.53198	0.29064	D	AEFBI	c	0.476104063142961	4.855309	0.291073277893765	3.665296	0.55342	0.810187126373519	0.24315	0.559995	0.30148	0	0.573888	0.26071	0	0.527494	0.10854	0	0.613276	0.41441	0	5.13	1.26	0.20435	0.670000	0.24656	0.071000	0.17872	0.833000	0.29934	0.999000	0.74975	0.0:0.6408:0.0:0.3592	10.4134	0.43301	1	1.9968051118210862E-4	0	0.0	1	9.940357852882703E-4	0	0.0	0	0.0	0	0.0	2	5.393743257820927E-4	0	0.0	0	0.0	3	3.488372093023256E-4	18	1.483e-04	18	1.496e-04	0	0	2	1.750e-04	0	0	0	0	14	2.115e-04	1	6.078e-05	13	1.224e-04	13	1.232e-04	0	0	1	9.024e-05	0	0	0	0	10	1.848e-04	1	6.116e-05	16	1.763e-04	16	1.784e-04	0	0	2	1.752e-04	0	0	0	0	12	2.880e-04	1	6.081e-05	rs80034486	5|5	Cystic fibrosis|not provided	4|2	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
7	117304834	.	G	T	7	117664780	G	T	Q	H	rs113857788	7	117304834	7	117092070	CFTR	+	CAG	3	2	G	G/G	G/G	ENSG00000001626	ENST00000003084;ENST00000426809	ENSP00000003084;ENSP00000389119	1352;1322	0.0	0.91219	D	P13569	CFTR_HUMAN	1352	1.0	0.89865	D	1.0	0.97092	D	0.000000	0.84324	D	0.000000	1;0.999999	0.81033	D;D	simple_aae;simple_aae	Q1352H;Q1291H	CFTR_HUMAN	Q1352H	3.4	0.91850	M	-3.3;-3.3	0.93793	D;D	-4.19	0.75578	D	ENST00000454343;NM_000492.3;ENST00000426809	Q1291H;Q1352H;Q1322H	0.981;0.981;0.695	0.98362	0.9158	0.95900	D	0.9055	0.96867	D	10	0.75220450357	0.98036	D	5.638637	0.76827	26.6	0.99759159448382062	0.84805	0.93507	0.58147	D	AEFDGBI	c	0.644707014633611	6.411247	0.530312770082939	5.44702	0.70104	0.999999111758397	0.74713	0.553676	0.24620	0	0.573888	0.26071	0	0.618467	0.42703	0	0.633917	0.49468	0	5.63	3.56	0.39729	2.149000	0.41629	0.154000	0.24039	1.000000	0.71511	0.997000	0.65342	0.2565:0.0:0.7435:0.0	8.9068	0.34501	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	7	5.765e-05	7	5.769e-05	0	0	1	8.666e-05	0	0	0	0	0	0	6	3.634e-04	6	5.649e-05	6	5.652e-05	0	0	1	8.946e-05	0	0	0	0	0	0	5	3.047e-04	7	7.713e-05	7	7.719e-05	0	0	1	8.675e-05	0	0	0	0	0	0	6	3.636e-04	rs113857788	4	Congenital bilateral absence of the vas deferens	1	AAA+ ATPase domain|ABC transporter-like|P-loop containing nucleoside triphosphate hydrolase	.	.	CF;ABCC7	MRP7;ABC35;TNR-CFTR;dJ760C5.1;CFTR/MRP	P13569	CFTR_HUMAN	1080	CCDS5773	XM_011515751;NM_000492	uc003vjd.3	602421	cystic fibrosis transmembrane conductance regulator	.	.	.	Bile secretion - Homo sapiens (human);Gastric acid secretion - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);ABC transporters - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Pancreatic secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway;Defective CFTR causes cystic fibrosis;ABC transporter disorders;Disorders of transmembrane transporters;Disease;Transmembrane transport of small molecules;RHO GTPases regulate CFTR trafficking;RHO GTPase Effectors;Signal Transduction;Signaling by Rho GTPases;ABC-family proteins mediated transport	hsa02010;hsa05110	ABC transporters;Vibrio cholerae infection	FUNCTION: Involved in the transport of chloride ions. May regulate bicarbonate secretion and salvage in epithelial cells by regulating the SLC4A7 transporter. Can inhibit the chloride channel activity of ANO1. Plays a role in the chloride and bicarbonate homeostasis during sperm epididymal maturation and capacitation. {ECO:0000269|PubMed:22178883}.; 	DISEASE: Cystic fibrosis (CF) [MIM:219700]: A common generalized disorder of the exocrine glands which impairs clearance of secretions in a variety of organs. It is characterized by the triad of chronic bronchopulmonary disease (with recurrent respiratory infections), pancreatic insufficiency (which leads to malabsorption and growth retardation) and elevated sweat electrolytes. It is the most common genetic disease in Caucasians, with a prevalence of about 1 in 2'000 live births. Inheritance is autosomal recessive. {ECO:0000269|PubMed:10094564, ECO:0000269|PubMed:1284466, ECO:0000269|PubMed:1284468, ECO:0000269|PubMed:1284529, ECO:0000269|PubMed:1284530, ECO:0000269|PubMed:1695717, ECO:0000269|PubMed:1710600, ECO:0000269|PubMed:2236053, ECO:0000269|PubMed:7504969, ECO:0000269|PubMed:7505694, ECO:0000269|PubMed:7513296, ECO:0000269|PubMed:7517264, ECO:0000269|PubMed:7520022, ECO:0000269|PubMed:7522211, ECO:0000269|PubMed:7524909, ECO:0000269|PubMed:7524913, ECO:0000269|PubMed:7525450, ECO:0000269|PubMed:7537150, ECO:0000269|PubMed:7541273, ECO:0000269|PubMed:7541510, ECO:0000269|PubMed:7543567, ECO:0000269|PubMed:7544319, ECO:0000269|PubMed:7581407, ECO:0000269|PubMed:7680525, ECO:0000269|PubMed:7683628, ECO:0000269|PubMed:7683954, ECO:0000269|PubMed:8081395, ECO:0000269|PubMed:8522333, ECO:0000269|PubMed:8723693, ECO:0000269|PubMed:8723695, ECO:0000269|PubMed:8800923, ECO:0000269|PubMed:8829633, ECO:0000269|PubMed:8956039, ECO:0000269|PubMed:9101301, ECO:0000269|PubMed:9222768, ECO:0000269|PubMed:9375855, ECO:0000269|PubMed:9401006, ECO:0000269|PubMed:9443874, ECO:0000269|PubMed:9452048, ECO:0000269|PubMed:9452054, ECO:0000269|PubMed:9452073, ECO:0000269|PubMed:9482579, ECO:0000269|PubMed:9521595, ECO:0000269|PubMed:9554753, ECO:0000269|PubMed:9736778, ECO:0000269|PubMed:9921909}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Congenital bilateral absence of the vas deferens (CBAVD) [MIM:277180]: Important cause of sterility in men and could represent an incomplete form of cystic fibrosis, as the majority of men suffering from cystic fibrosis lack the vas deferens. {ECO:0000269|PubMed:10651488, ECO:0000269|PubMed:7529962, ECO:0000269|PubMed:7539342, ECO:0000269|PubMed:9067761, ECO:0000269|Ref.77}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	219700;277180;	[MIM:219700]Cystic fibrosis [recessive?];[MIM:277180]Congenital bilateral absence of the vas deferens;	Response to methotrexate in juvenile idiopathic arthritis[24709693;24709693];Response to platinum-based chemotherapy in non-small-cell lung cancer[22872573];	metabolic process;cholesterol biosynthetic process;respiratory gaseous exchange;vesicle docking involved in exocytosis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;small GTPase mediated signal transduction;cholesterol transport;positive regulation of exocytosis;transport;membrane hyperpolarization;intracellular pH elevation;cellular response to cAMP;bicarbonate transport;chloride transmembrane transport;sperm capacitation;positive regulation of cyclic nucleotide-gated ion channel activity;positive regulation of voltage-gated chloride channel activity;transmembrane transport	cell surface;chloride channel complex;extracellular exosome;lysosomal membrane;endoplasmic reticulum Sec complex;integral component of membrane;early endosome;plasma membrane;basolateral plasma membrane;Golgi-associated vesicle membrane;cytosol;recycling endosome;early endosome membrane;membrane;protein complex;apical plasma membrane;cytoplasm	chloride channel inhibitor activity;protein binding;ATPase activity, coupled to transmembrane movement of substances;chloride transmembrane transporter activity;bicarbonate transmembrane transporter activity;enzyme binding;ATP-binding and phosphorylation-dependent chloride channel activity;ATP binding;channel-conductance-controlling ATPase activity;chloride channel activity;PDZ domain binding;ATPase activity	TISSUE SPECIFICITY: Expressed in the respiratory airway, including bronchial epithelium, and in the female reproductive tract, including oviduct (at protein level). {ECO:0000269|PubMed:22207244}.; 	unclassifiable (Anatomical System);ovary;islets of Langerhans;colon;skeletal muscle;bile duct;uterus;pancreas;lung;endometrium;thyroid;liver;testis;kidney;brain;stomach;	superior cervical ganglion;pancreas;salivary gland;beta cell islets;ciliary ganglion;trigeminal ganglion;skeletal muscle;	0.0	4.89498233795166	0.05398133020415634	350.0	0.0	1.91699302196503	0.22012638875861787	227.0	0.0	0.044936865568161	0.011440302866735847	145.0	0.0	0.345227986574173	0.023764518536544137	224.0	0.0	0.188175395131111	0.021454312899885204	133.0	0.0	0.718104183673859	0.028838505493322706	332.0	0.0181644670665264	4.84104061126709	0.47810489938340406	11.0	0.0072463839314878	0.703783094882965	0.1325994936374223	72.0	0.0	0.388797670602798	0.060733536147468146	84.0	0.0376880988478661	0.934688448905945	0.293397515725631	117.0	0.00225602858699858	0.114365518093109	0.03743816538758221	105.0	0.00799663364887238	0.168229311704636	0.053185123421251784	125.0	0.00497593218460679	0.935866951942444	0.1261858496071542	114.0	0.00556990830227733	0.41991463303566	0.07253690807717958	108.0	0.0180006921291351	0.843788206577301	0.21203509214869204	94.0	0.0130463410168886	0.584062993526459	0.13937142544697662	96.0	0.0334579348564148	0.847866773605347	0.26142109528315804	113.0	0.0211279559880495	0.797763168811798	0.27408881053405326	97.0	0.0352041646838188	1.21679735183716	0.4745033603738731	71.0	0.0175072941929102	1.16247248649597	0.3205392344426067	63.0	0.0	1.03354501724243	0.07720146304166169	214.0	0.0	0.182632520794868	0.018023277319162694	118.0	0.0	0.261470198631287	0.01085608349506363	284.0	0.00567274354398251	0.0720839649438858	0.03683481427530447	6.0	0.0227180477231741	1.84974873065948	0.6402266658842555	5.0	0.0	6.54776287078857	0.2555570169883287	149.0	0.00474250083789229	32.1233406066895	12.023628803739816	196.0	0.0	0.10082396119833	0.022629875765833394	153.0	0.00504372268915176	0.997956335544586	0.20638807516519006	286.0	0.0	0.335104316473007	0.022517527245279202	247.0	0.0429753437638283	0.85432118177414	0.3221308744202059	6.0	0.0	1.04888617992401	0.040662475331139154	194.0	0.0	0.356684416532516	0.048631225354807156	218.0	0.0	1.93694245815277	0.829055939568207	32.0	0.0379490554332733	3.32517743110657	0.46641305774575514	119.0	0.0233717076480389	7.87660694122314	1.6606454007560387	320.0	0.336410880088806	24.336462020874	7.157264545298458	57.0	0.0	0.159700334072113	0.006996180911461801	430.0	0.0	0.303410321474075	0.03636686750810201	304.0	0.0	0.142875209450722	0.029311716842186666	97.0	19.954137802124	111.157417297363	49.320094894944575	171.0	0.0275158602744341	0.34689074754715	0.1064697305662829	103.0	0.0564914643764496	8.61686515808105	1.4357716596492058	106.0	0.0254911668598652	5.89566564559937	0.8711740337610245	250.0	0.0255612749606371	4.3403205871582	1.0035383151139783	357.0	0.0389981381595135	14.3027715682983	3.88696820072999	88.0	0.0	0.0836056545376778	0.02225606850026032	104.0	0.0	2.38886547088623	0.23456299485677348	193.0	0.318268150091171	1.2855681180954	0.8061348636483037	172.0	0.0	0.434236377477646	0.037302635315280906	323.0	0.00312276859767735	0.789945662021637	0.10976095637587088	83.0	0.00684245117008686	0.250644236803055	0.05819370646107321	96.0	0.0	0.0495715849101543	0.0036149086681272805	393.0	136	187	388	0.76593	0.87681	.	-0.50727808	21.73271998	1.571750997	96.6568279	637.50803	5.08064	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	Medium	2.35E-02	E	Cftr	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (characteristics involving the ability of an organism to live and age normally throughout development and life span); endocrine/exocrine gland phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; vision/eye phenotype; hematopoietic system phenotype; 	cftr	secondary islet	decreased amount	abnormal
